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Abstract 
The interior homeostasis of a solid organ, such as a kidney, is greatly altered during the 
surgical removal, storage and transplantation process from donor to recipient. 
Consequently, normal organ function may be delayed or prevented following 
transplantation. The main injury that organs have to withstand often occurs subsequent to 
the restoration of blood flow; this injury is known as ischaemia reperfusion-injury (I/R 
injury) and is associated with hypoxia, free radical formation and organ failure.  
Viral gene therapy, such as BacMam gene transfer technology (Baculovirus-based 
expression in mammalian cells) is an attractive option for reducing I/R injury due to its 
high safety profile compared to mammalian viruses. However, limiting factors, including 
the requirement of high-doses of viral vector and low transgene expression levels are still 
a hurdle for the successful use of this technology. Therefore, the initial objectives of this 
study were to develop and validate a number of methods for concentrating BacMam along 
with the use of a number of chemical compounds to improve BacMam gene delivery in 
kidney cells. Amongst all the approaches screened, high-speed (for small volumes) and 
low-speed (for large volumes) centrifugation methods were the most effective for 
concentrating BacMam virus (4x109 and 1x1010 pfu/ml, respectively). Transduction of HEK 
cells was improved between two- to 10-fold in the presence of sodium butyrate or 
hydroxyurea alone and significantly improved egfp (enhanced green fluorescence protein) 
expression (~40-fold) when both chemicals were used in combination. 
Subsequently, in the second part of this study an in vitro culture model was developed 
and evaluated for assessing ischaemic injury in kidney cells using antimycin A in 
combination with 2-deoxyglucose. It was shown that sod-2 and bcl-2 overexpression in 
injured kidney cells improved the effect of I/R injury by enhancing the recovery of ATP 
post-reperfusion  
Furthermore, to examine the possibility of reducing injury associated with cold 
preservation, an ex vivo hypothermic perfusion system of porcine kidney was established 
and validated using reporter and protective genes. Importantly, for the first time, BacMam 
has been used to transfer ex vivo a protective gene (sod-2), into kidneys which appeared 
to provide protection against hypothermic preservation-associated injury by improving the 
recovery of cellular ATP. 
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1.1 Baculovirus 
1.1.1 INTRODUCTION 
Many invertebrate viruses are insect-specific pathogens which mainly infect arthropods in 
both terrestrial and marine ecosystems (Miller, 1997). Amongst these, members of the 
Baculoviridae have received the greatest attention. Baculoviruses are rod-shaped, 
enveloped, DNA viruses with a large circular and supercoiled genome which encodes for 
100-200 predicted proteins (Miller, 1997). Members of this family contain a number of 
genes that are unique to individual baculovirus species as well as a group of genes 
conserved in all fifty-three baculoviruses sequenced to date (Oliveira et al., 2013).  
The baculovirus life cycle involves several sequential steps, including entry of the virus 
into the host, early and late gene expression, DNA replication, morphogenesis and the 
release of two distinct virion phenotypes (Miller, 1997). In an infected cell, the progeny 
egress from the nucleus and then bud through the cytoplasmic membrane where they 
acquire a lipid-containing envelope and membrane-bound glycoproteins before becoming 
mature budded virus (BV). In the very late phase of infection a second progeny is formed, 
the occlusion-derived virus (ODV); these nucleocapsids are retained in the nucleus to be 
enveloped and occluded in a paracrystalline matrix, polyhedrin, forming an occlusion body 
(OB).  
Although baculoviruses exhibit a high degree of host specificity towards the order 
Lepidoptera, they are capable of infecting more than six hundred insect species from the 
orders Hymenoptera, Diptera, Coleoptera and Trichoptera, predominantly during the larval 
stages (Miller, 1997; Miller & Lu, 1997). Due to this narrow host range, they were initially 
studied as a biological control agent to regulate insect pest populations (Bonning & 
Hammock, 1992).  
The discovery during the 1980s of a strong promoter, which drives the expression of one 
of the virus very late genes (polyhedrin, polh), led to the development of baculovirus as 
tool for biotechnological research (Miller, 1988). Recombinant baculovirus were 
constructed by placing a foreign gene under the control of the polh promoter and used to 
infect insect cells in culture to produce recombinant protein. This baculovirus expression 
vector system (BEVS) soon became extensively utilized by the biopharmaceutical industry 
(Gentilomi et al., 2006; Wu et al., 2012; Teng et al., 2013). In particular, two baculovirus 
species have been used for foreign gene expression: Autographa california multicapsid 
nucleuopolyhedrovirus (AcMNPV) and to a lesser extent Bombyx mori NPV (BmNPV).   
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1.1.2 BACULOVIRUS TAXONOMY 
Originally baculoviruses were classified based on OB morphology into two genera (Figure 
1.1): nucleopolyhedroviruses (NPVs) and granuloviruses (GV; reviewed by Blissard and 
Rohrmann, 1990). Members of the genus NPV have been isolated from the order 
Lepidoptera, Hymenoptera and Diptera; they produce a large OB between 0.15 to 15 μm 
occluding many ODV in a polyhedrin matrix. Whereas, GVs were isolated only from 
Lepidoptera and show small OBs, 0.13 to 0.50 μm, containing a single virion enclosed in 
granulin (Rohrmann, 1992). However, the two crystalline protein matrix structures have 
the same function, protecting the embedded ODV outside of the host e.g., against UV light 
and desiccation (reviewed by Blissard & Rohrmann, 1990). 
 
 
 
 
 
 
 
Figure 1.1. Schematic representation of baculovirus OBs. MNPV polyhedral section and ODVs 
(left) and GV granulum and ODV (right). 
 
In 2004, the increasing number of sequenced baculovirus genomes and the development 
of sophisticated phylogenetic analysis models led to a different classification and 
nomenclature for the baculoviridae family (Jehel et al., 2006). The current classification 
system is based on phylogenetic, biological and morphological characteristics and 
comprises four genera: Alphabaculovirus, Betabaculovirus, Gammabaculovirus and 
Deltabaculovirus (Figure 1.2; Jehel et al., 2006). Alphabaculovirus and Betabaculovirus 
include lepidopteran-specific NPV and GVs, respectively, (Jehle et al., 2006). 
Furthermore, the Alphabaculovirus can be separated into two subgroups I and II 
depending on the type of envelope protein incorporated in the BV (Jehle et al., 2006). The 
envelope fusion protein used by the group I baculoviruses is GP64 and a furin-cleaved (F) 
protein is utilized by the group II baculoviruses (Herniou & Jehle, 2007).   
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Gammabaculovirus comprise the hymenopteran-specific NPVs, whose genomes are 
typically smaller and do not contain genes coding for envelope proteins suggesting that 
BV may not be produced (Jehle et al., 2006). Finally, the Deltabaculovirus include the 
diptera-specific baculoviruses whose OB protein shows no homology to polyhedrin or 
granulin proteins (Jehle et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. Baculovirus phylogeny. Baculovirus evolutionary tree based on the amino acid 
alignment of 29 baculovirus core genes. The family Baculoviridae consists of 4 major genera: 
Alphabaculovirus, Betabaculovirus, Gammabaculovirus, and Deltabaculovirus. Only subsets of 
characterized species within each group are shown. Figure modified from Au et al. (2013). 
 
1.1.3 BACULOVIRUS REPLICATION CYCLE: FROM INSECT HOST TO CELL 
CULTURE 
The most studied baculovirus is AcMNPV, isolated in 1971 from the Alfalfa looper (Vail et 
al., 1971). It was the first baculovirus to be sequenced and was found to be 134 kbp with 
154 predicted open reading frames (ORFs; Ayres et al., 1994). AcMNPV belongs to the 
Alphabaculovirus genus (section 1.1.2) and has been shown to be able to infect at least 
forty species within the order Lepidoptera (reviewed by Bonning, 2005). The virus used for 
the experiments in this thesis was derived from AcMNPV strain C6 (Ayres et al., 1994) 
and the following sections describe this virus.  
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AcMNPV utilizes a biphasic life cycle which is characterized by the production of two 
distinct forms of viral progeny, BV and ODV, which are subsequently occluded to form 
OBs (Figure 1.3; Blissard & Rohrmann, 1990). The roles of these two phenotypes, 
produced at different locations in the cell and at different times, differ significantly. BVs are 
produced in the late phase of infection and acquire their envelopes by budding through 
the host plasma membrane. They are responsible for spread of the infection cell-to-cell 
within the host or when the virus is amplified in cell culture. In contrast, ODVs are 
produced in the host cell nucleus, in the very late phase of infection and are enveloped in 
an occlusion matrix protein, polyhedrin, forming the OBs. ODVs mediate secondary 
infection and are also responsible for horizontal transmission between insect hosts 
(reviewed by Rohrmann, 2008).  
BVs are composed of a single nucleocapsid enclosed by an envelope membrane 
containing a glycoprotein at one end, GP64 (Figure 1.3 A). GP64 exists as a disulphide-
linked trimer of which each protein contains a signal peptide at the N-terminal and an 
anchor domain at the C-terminal. GP64 is essentially required for efficient viral budding 
and cell-to-cell transmission (Oomens & Blissard, 1999). In contrast to BV, the ODV 
envelope is more complex with five or more envelope proteins (Figure 1.3 B). Examples 
include ODV-E66, ODV-E25, ODV-E18 and several per os infectivity (PIF) proteins such 
as P74, localised on the outside of the ODV membrane. P74 was identified to play a 
crucial role in ODV entry into cells and may be involved in the fusion process (Faulkner et 
al. 1997). 
Despite the difference in lipid and protein components of their envelope membranes, BV 
and ODV share similar capsid compositions (Figure 1.3; reviewed by Funk et al., 1997). 
The major capsid proteins are represented by VP39 which is randomly distributed over the 
surface (Russell et al., 1991), P80 (Lu & Carstens, 1992), P24 and the essential structural 
protein ORF1629, located downstream from the polyhedrin gene (reviewed by Funk et al., 
1997). However, ODV-EC27 has been found in ODV but not in BV capsids (reviewed by 
Funk et al., 1997). This protein has a distinct functional characteristic; it acts as a 
multifunctional cyclin regulating the host cell cycle during baculovirus infection (Belyavskyi 
et al., 1998).  
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Figure 1.3. Schematic representation of the two baculovirus phenotypes and their structural 
proteins. (A) Budded virus (BV) and (B) occlusion-derived virions (ODV) occluded in the occlusion 
body (OB). 
 
I. Early and late stages of larval infection 
In the natural environment baculoviruses are found as OBs on plant surfaces and in the 
soil (reviewed by Rodriguez et al., 2012). The infection begins when an insect larva 
ingests food contaminated with OBs (Figure 1.4; Keddie et al., 1989). Upon ingestion, the 
high alkaline conditions in the midgut of the host cause dissolution of the OBs and the 
released ODV penetrate the midgut peritrophic membrane at the apical ends of the 
microvilli (Federici, 1997). The infection progresses with the ODVs entering the midgut 
epithelial cells, by clathrin-mediated adsorptive endocytosis (Long et al., 2006). In the 
cytoplasm, the virions are quickly unpackaged and from here nucleocapsids can have one 
of two destinations (Figure 1.4). Virions either exit immediately from the columnar 
epithelial cells into the haemolymph initiating a systemic infection within the host 
(Washburn et al., 2003) or are transported into the nucleus where viral transcription and 
replication occur immediately after the viral DNA is uncoated (reviewed by Rohrmann, 
2008). In the nucleus, the early viral genes are transcribed by host RNA polymerase II 
(Fuchs et al., 1983). The resulting early proteins are essential for regulation of early 
transcription, viral DNA replication and inhibition of apoptosis, a defence mechanism 
activated by the infected host. Immediate-early (ie) genes such as ie-0, ie-1, ie-2 and pe-
38 are the first to be expressed and their promoters can drive transcription in non-infected 
insect cells (reviewed by Prikhod’ko, 1999). In particular, the principal trans-regulator of 
baculovirus gene expression is ie-1, expressed in both early and late phases of infection. 
IE-1 is a multifunctional transcriptional regulatory protein, trans-activating a number of 
delayed-early genes and a small number of late genes such as the late capsid protein 
gene (vp39) and the very late polh gene (Guarino & Smith, 1990; Passarelli et al., 1993). 
The replicated DNA is then packaged to form new progeny capsids. The nucleocapsids 
bud first through the nuclear membrane and then through the cell membrane where they   
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obtain a lipid envelope containing the glycoprotein GP64. The BVs are then ready to 
propagate the infection from the midgut, through tracheal cells, to almost all of the larval 
tissues via the haemolymph, referred to as the secondary infection (Federici, 1997; 
Volkman, 1997). 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. Baculovirus life cycle in vivo. (A) Infection is initiated by the ingestion of a virus 
occlusion body (OB). (B) The OB is dissolved and occlusion-derived virions (ODV) are released 
initiating the primary infection in the midgut epithelial cells. (C) From the cell cytoplasm 
nucleocapsids are transported to the nucleus where viral transcription and replication begin. Two 
virus phenotypes are produced, budded virus (BV) and ODV occluded inside a polyhedrin matrix. 
(D) Late stages of virus infection trigger liquefaction of the host and release OBs into the 
environment. 
 
From approximately 24 hours post-infection (hpi), BV production declines and there is a 
shift to ODV/OB formation. ODV are produced when nucleocapsids become enveloped 
with viral-induced membranes in the intranuclear ring zone of the nucleus, referred to as 
the peristromal space (Summers & Volkman, 1976). In the nucleus, the enveloped ODVs 
are occluded inside the proteinaceous matrix polyhedrin to form polyhedra. Each 
polyhedron is further covered by an envelope or calyx, which is predominantly formed 
from carbohydrates and a phosphoprotein, PP34 (Whitt & Manning, 1988; Gombart et al., 
1989).  
In the very late stages of infection, OBs begin to be accumulated into tissues causing 
enlargement, weakening the basal lamina of the infected insect. The infected insect   
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eventually dies and liquefies within 5-10 days and the accumulated OBs are released into 
the environment where they can be ingested by more larvae (Blissard & Rohrmann, 
1990). The terminal liquefaction is accomplished by the coordinated activity of two late-
expressed virus genes, chiA (chitinase) and v-cath (cathepsin) (reviewed by Volkman, 
1997). 
II. Baculovirus replication in cell culture 
The in vivo and in vitro life cycles of baculovirus are very similar to each other. However, 
cultured insect cells need to be directly infected with BVs (Figure 1.5) because the ODV 
are approximately a thousand times less infectious (Lynn, 2003). 
The host insect cell lines most commonly used for AcMNPV studies are those derived 
from Spodoptera frugiperda IPLB-Sf21-AE (Sf21), S. frugiperda (Sf-9) and Trichoplusia ni 
BTI-Tn-5B1-4 (Tn-5). Sf21 cells were isolated from S. frugiperda pupal ovarian tissue 
(Vaughn et al., 1977) and the Sf9 cell line is a clonal isolate of the Sf21 cells. The Tn-5 
cells were derived from the cabbage looper Trichoplusia ni (McIntoh & Ignoffo, 1989; 
Granados et al., 1994; Patterson et al., 1995).  
 
 
 
 
 
 
 
 
 
 
Figure 1.5. Baculovirus in vitro replication. For insect cells growing in culture, infection begins 
when BV enter by endocytosis. The nucleocapsid is then transported into the nucleus where new 
progeny BVs are produced. BVs bud through the cell membrane to infect adjacent cells. BV: 
budded virus. 
 
In cell culture, infection begins when at least one virus particle has entered the cell and 
has successfully started its replication cycle. The first step of BV infection is to bind to the   
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cell surface of the target cells, a process mediated by the envelope glycoprotein GP64 
(Okano et al., 2006). Subsequently, following attachment, the virus enters the target cells 
via clathrin-mediated adsorptive endocytosis (Long et al., 2006). Endocytosis is rapidly 
followed by multistep processes which include vesicular transport, endosomal escape, 
intracytosol transport of the nucleocapsids to the nucleus, nuclear entry and capsid 
disassembly (Charlton & Volkman, 1993; Plonsky et al., 1999). Inside the nucleus, the 
baculovirus genome uncoats and viral gene expression initiates. These sequences of 
events ultimately lead to the production of new progeny BVs (see section 1.1.3-I). 
Different parameters are important for a successful baculovirus infection in cell culture. 
These include (1) the ratio between BV and cell number, referred to as multiplicity of 
infection (MOI; Licari & Bailey, 1991). High MOI results in a synchronous infection, where 
BVs simultaneously infect all the cells in the culture; low MOI leads to asynchronous 
infection which is characterized by different cell populations, comprising both infected and 
healthy cells; (2) cell cycle phase. Generally, BV infection of insect cells causes cell cycle 
arrest in the G2/M phase (reviewed by Monteiro et al., 2012).  
Lynn and Hink (1978) showed that infecting cells at either G1 or S phase resulted in a 
higher percentage of cells infected than cultures infected at the G2 phase. Later, Kioukia 
and colleagues suggested that baculovirus infection of Sf9 cells is very efficient in S 
phase (Kioukia et al., 1995). This was also confirmed by Saito et al. (2002) who showed 
an increased infection yield in cells at G1/S phase compared to cells infected at G2/M 
phases; (3) serial passage of baculovirus in cell culture, which can cause the development 
of a mutant form of virus (Cheng et al., 2013).  
In general, this mutant form is associated with the production of few polyhedra (FP) within 
the nucleus. The FP phenotype produces hypertrophied nuclei and larger plaques. It has 
been reported that the development of this phenotype is correlated to mutations in the 
fp25k gene (Fraser et al., 1983; Carstens, 1987). In addition to the formation of this 
baculovirus phenotype in cells, fp25k mutations lead to higher titres of BV in the cell 
culture medium, offering a selective advantage over the normal BV phenotype (Fraser et 
al., 1995; Cheng et al., 2013). 
 
1.1.4 BACULOVIRUS EXPRESSION VECTOR SYSTEM (BEVS) 
The first successful use of BEVS dates back to 1983 when Smith and colleagues used 
AcMNPV strain C6 as an expression vector to produce human β-interferon in insect cells   
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(Smith et al., 1983). During the last thirty years, BEVS has been developed into one of the 
most effective methods for expression of recombinant protein in insect cells (reviewed by 
Hitchman et al., 2011; reviewed by Li et al., 2012). Furthermore, BEVS has been 
successfully employed in surface display, gene therapy and vaccine production (reviewed 
by Sokolenko et al., 2012; Kawahara & Takaku, 2013; Yeh et al., 2014).  
I. Development of the BEVS 
Originally, many time-consuming and technically difficult steps such as the identification of 
a recombinant baculovirus and its subsequent isolation by plaque purification were 
required. Brief overviews of the main studies that have contributed to the evolution of a 
system are summarized in Table 1.1. 
The flashBAC system was used in this project and is described in more detail. FlashBAC 
was based on BacPAK6 vector, however, it lacks chiA, part of the essential gene orf1629 
and the polh coding region, which were replaced by a BAC replicon (reviewed by 
Hitchman et al., 2011). The essential gene deletion precludes virus replication within 
insect cells while the BAC replicon allows the viral DNA to be maintained and propagated 
in bacterial cells. A recombinant baculovirus is produced by co-transfecting insect cells 
with circular flashBAC DNA (there is no need to linearize the virus) and a transfer plasmid 
containing the foreign gene of interest. Homologous recombination in insect cells restores 
the function of the essential gene, allowing the virus DNA to replicate and at the same 
time inserting the foreign gene of interest under the control of the polh promoter replacing 
the BAC sequence. As it is not possible for parental virus to replicate there is no 
requirement for a selection system.  
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Table 1.1. Overview of BEVS major improvements  
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This one-step technology makes flashBAC very amenable to high throughput robotics, 
allowing production of multiple viruses and expression screening in multi-well plate format. 
flashBACTM has been further modified by the deletion of v-cath to produce 
flashBACGOLDTM. This has improved the efficacy of the secretory pathway and enhanced 
the yield of secreted or membrane targeted proteins (reviewed by Hitchman et al., 2011). 
The development of flashBACULTRA™ has taken the technology a step further by the 
deletion of three more genes, p10, p74 and p26 from the viral genome, further increasing 
protein yield and stability (Hitchman et al., 2010). 
 
II. BEVS vs. other recombinant protein expression systems 
BEVS offers several advantages compared to bacteria, yeast and mammalian expression 
systems, these are summarised in Table 1.2. 
 
Table 1.2. Advantages of BEVS compared to other gene delivery systems. 
 
 
 
 
 
 
 
 
 
 
 
Recently, due to the differences between mammalian and insect protein glycosylation 
patterns, concern over the use of BEVS for the production of recombinant therapeutic 
glycoproteins has been raised (reviewed by Geisler & Jarvis, 2010).   
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Mammalian cells produce complex N-glycans containing terminal sialic acids while, insect 
cells generally produce simpler N-glycans with terminal mannose residues (Figure 1.6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6. N-glycosylation pathways, mammalian cells vs insect cells. The N-glycosylation 
pathway of a new protein begins with the binding of a preassembled glycan. Generally this is 
followed by a number of reactions that produces a common intermediate. In insect cells this 
intermediate is further trimmed to paucimannose, while in mammalian cells it is elongated to 
produce complex N-glycans. Symbolic representations are shown in the legend. Modified from 
Geisler & Jarvis (2009).  
 
 
This structural difference can potentially induce allergenic reactions in humans, 
compromising the biomedical importance of recombinant glycoproteins produced using 
this system (Harrison & Jarvis, 2006). Reports have detailed that either the lack of 
terminal sialic acids or the presence of core α1,3-linked fucose residues on glycoproteins 
produced by BEVS negatively impacts their pharmacokinetic behaviour and limits their 
safety and therapeutic application (reviewed by Hillar & Jarvis, 2010).   
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In contrast, a different study suggested that the presence of mannose residues on 
recombinant glycoprotein vaccines, produced using BEVS, positively impacted their 
efficacy by modulating the mammalian immune system (Hervas-Stubbs et al., 2007). 
III. BEVS for pharmaceutical production 
The BEVS technology has been used for the production of pharmaceutical proteins and 
vaccines. Five different vaccines for human and veterinary use are commercially available 
and many others are progressing to clinical trials, these are summarized in Table 1.3 
(reviewed by Cox, 2012).  
 
Table 1.3. Baculovirus based vaccines. 
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1.2 Gene Therapy 
1.2.1 GENERAL OVERVIEW 
In the last two decades, rapid progress in biotechnology has driven gene therapy to the 
forefront of medical research. Gene therapy (the use of genes as medicines) comprises a 
broad approach for the treatment of pathological conditions caused by a single recessive 
gene, acquired genetic diseases and viral infections (reviewed by Misra, 2013). Generally, 
there are two types of gene therapy, germ line and somatic. In germ line therapy, the 
germ cells are modified by the introduction of a therapeutic gene which is integrated into 
the genome; therefore, any changes due to the therapy will be passed to the next 
generation (Matthews & Curiel, 2007). In contrast, somatic gene therapy is when the gene 
is inserted into target cells and any modifications are restricted to the patient being 
treated, e.g. they are not inherited by the next generation (Bank, 1996). The difference 
between these two approaches is important since to date only gene therapy on somatic 
cells has been allowed due to ethical reasons (reviewed by Wirth et al., 2013).  
Both viral and non-viral vectors have been used for gene therapy. However, there are still 
many limitations with these vectors and their safe use is still a major concern. Some of 
these issues include lack of tissue specificity, their inability to cross transport barriers and 
rapid clearance after systemic circulation in targeted tissues (Bone, 2007). Another major 
limitation of using delivery vectors is the activation of the host immune response which 
inhibits the effect of the delivered therapeutic protein (reviewed by Giacca & Zacchigna, 
2012). For these, and other reasons, much effort is now being put into the development of 
safer and more efficient vectors. 
 
1.2.2  HISTORICAL PERSPECTIVES – FROM FIRST STEPS TO CURRENT STATUS 
The milestones during the history of gene therapy are shown schematically in Figure 1.7. 
The foundations for gene therapy were first laid by Griffith’s in 1928; he observed a non-
virulent pneumococcal bacteria type transforming into a virulent type by mixing living non-
virulent bacteria with heat-inactivated virulent bacteria. These findings were subsequently 
confirmed by McCarty and colleagues which demonstrated that deoxyribonucleic acid 
(DNA) triggered this transformation (Avery et al., 1944). Few years later, in 1952 
Lederberg and Zinder discovered that certain bacteria can transfer genetic material by 
mating and also described the acquired resistance to the same antibiotic (reviewed by 
Wirth et al., 2013).   
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From there, DNA became a topic of great research interest and many important findings 
and in 1953 first Wilkins and Franklin then Watson and Crick developed the helix structure 
model of double stranded DNA. This discovery allowed the isolation of genes from DNA 
which escalated the knowledge of the molecular and genetic basis of human disease.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7. Timeline highlighting some of the main milestones in the gene therapy history. 
Modified from Wirth et al. (2013). 
 
Temin observed that chicken cells infected with the Rous sarcoma virus inherited 
mutations of viral specific genes (Temin, 1961). Motivated by this finding, Rogers and 
Pfuderer in 1973 performed the first human gene therapy trial on two sisters suffering from 
arginemia (a urea cycle disorder). In this trial the wild-type Shope papilloma virus was 
injected into the sisters with the intention of delivering the arginase gene. However, the 
therapy was unsuccessful as their arginine levels remained unchanged (Rogers et al., 
1973). In 1988, the US Recombinant DNA Advisory Committee (RAC) officially approved 
the introduction of foreign genes into humans in the form of naked-DNA. Rosenberg and 
co-workers traced the movements of tumour-infiltrating blood cells confirming that tumours 
do not grow at the injection site (Rosenberg et al., 1990; and 1993).   
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Furthermore, Blease achieved the first effective gene therapy study (Blease et al., 1995) 
using white blood cells to cure a rare genetic immune system disorder. Only one of the 
two patients exhibited a successful and temporary response after the start of the therapy.  
In 1999, an 18 year old boy, Jesse Gelsinger, died during a clinical trial for ornithine 
transcarbamylase deficiency (a rare metabolic disorder) at the University of Pennsylvania 
Philadelphia; as a consequence, the FDA placed a temporarily ban on all gene therapy 
trials using virus in human subjects. Important issues were identified and new rules, aimed 
to protect patient’s safety, were put into place after a public three-day investigation was 
carried out by the National Institute of Health (NIH) (reviewed by Cavazzana-Calvo et al., 
2004). More recently, in November 2006, a group of scientists from the University of 
Pennsylvania developed a lentivirus-based immunotherapy for the treatment of human 
immunodeficiency virus (HIV). This was the first human clinical trial evaluating a lentiviral 
vector where patients showed stable and increased immune response against HIV 
antigens over the course of the treatment (Levine et al., 2006).  
At present more than 1900 gene therapy studies have been approved and conducted 
worldwide. The most commonly used gene therapy vectors are adenovirus, retrovirus and 
naked plasmid DNA (reviewed by Wirth et al., 2013). Table 1.4 summarised the main 
gene therapy products for clinical use.  
 
1.2.3 BACMAM: AN INSECT VIRUS FOR GENE DELIVERY  
The first evidence of baculovirus entering vertebrate cells (including human cells), was 
reported during studies on its safety as a biological control agent (Volkman & Goldsmith, 
1983). In these experiments, many different vertebrate cells internalized wild-type 
baculovirus particles, although no viral replication was observed. It was concluded that 
only the population of cells exposed to virus were transduced, whereas the cells not in 
contact with the virus were unaffected (Tjia et al., 1983; Groner et al., 1984).  
Carbonell et al. (1985) used recombinant baculovirus carrying marker genes under either 
the Rous sarcoma virus long terminal repeat promoter (RSV) or the very late polh 
promoter to evaluate virus entry and gene expression in dipteran and mammalian cells.   
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The infections/transductions failed to produce detectable levels of chloramphenicol 
acetyltransferase and β-galactosidase gene expression in both cell lines. This study 
suggested that the gene promoter plays a crucial role in baculovirus mediated gene 
expression in non-permissive cells. 
 
Table 1.4. Gene therapy product for clinical use.  
 
 
 
 
 
 
 
 
 
 
 
 
In the mid-1990s, first Holfmann, and then Boyce with their respective co-workers, 
outfitted AcMNPV with a mammalian expression cassette, containing either 
cytomegalovirus immediate early promoter (CMV) or RSV to drive the expression of 
reporter genes. Using these viruses they were able to detect transgene expression in a 
range of cell lines derived from human, rabbit, and mouse. Hepatocytes in particular were 
transduced very efficiently (Holfmann et al., 1995; Boyce & Bucher, 1996). These 
pioneering studies increased interest in baculoviruses as novel non-human viral vectors 
for gene therapy application. Subsequent researchers have confirmed the safety of these 
vectors and high-levels of expression have been observed in vertebrate cells, including 
cells of non-hepatic origin, up to fourteen days post-transduction (Condreay et al., 1999; 
reviewed by Chen et al., 2011).   
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The list of cells susceptible to baculovirus transduction is extensive and still growing but 
includes cells derived from monkey, porcine, rat, feline, hamster, fish, avian, frog, and 
shrimp tissues (reviewed by Kost et al., 2005), also primary and progenitor cells, and 
more recently human embryonic stem cells and mesenchymal stem cells (Bak et al., 
2011; Lin et al., 2011). Baculovirus-based vectors for expression in mammalian cells are 
generally referred to as BacMam. Therefore, the same nomenclature will be used in this 
thesis. 
The exact molecular mechanism of BacMam entry into mammalian cells still remains 
poorly characterised and initially was thought to involve electrostatic interactions, heparin 
sulphate and phospholipids (Duisit et al., 1999; Tani et al., 2001). Other studies 
demonstrated that virions can be taken up by clathrin‐mediated endocytosis, 
macropinocytosis (Matilainen et al., 2005; Long et al., 2006) and phagocytosis 
(Laakkonen et al., 2009). Specific binding sites for baculovirus uptake have also been 
proposed (Wang et al., 1997). Furthermore, the role of GP64 in BacMam attachment on 
the cell surface has been investigated and it was shown that the virus can enter cells 
through direct fusion (Kaname et al., 2010; Kataoka et al., 2012). More recently, 
Makkonen et al. (2013) investigated the role of heparan sulfate proteoglycans (HSPG), 
subfamily syndecans, during BacMam entry in a number of mammalian cells. Makkonen 
and colleagues demonstrated that BacMam interacts with 6-O and N-sulfated chains of 
HSPG and most importantly, binds specifically to the receptor syndecan-1 which mediates 
the internalization of BacMam in vertebrate cells. 
 
1.2.4 APPLICATIONS OF BACMAM IN PRE-CLINICAL STUDIES 
Numerous experiments in animals have been performed using BacMam; in particular 
studies have been carried out in mice, rat and rabbit and have revealed that the brain, 
eyes and testis are immunoprivileged areas (reviewed by Airenne et al., 2010; 2013). 
These sites showed an intrinsic ability to prevent the activation of adaptive and innate 
immune responses to antigens (reviewed by Kaikkonen et al., 2011). Although pre-
existing immunity is not a concern for BacMam mediated gene delivery (Strauss et al., 
2007), both alternative and classical complement pathways may limit BacMam clinical 
evaluation (Hofmann & Strauss, 1998; Georgopoulos et al., 2009). For this reason the first 
pre-clinical study using BacMam as a gene delivery vector in an in vivo context was 
unsuccessful (Sanding et al., 1996). Although previous studies showed high transgene 
expression levels in primary cultures they failed to transduce in vitro liver tissue from rat 
and mice.   
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Following the Sanding et al. (1996) study, more investigations were conducted and a few 
years later Hofmann and colleagues confirmed that gene transfer in vivo was hampered 
by the inactivation of BacMam via the complement system (Hofmann & Strauss, 1998).  
Many strategies have been developed over the last decade to solve complement related 
problems and relevant examples included the use of complement inhibitors such as cobra 
venom factor (Hofmann & Strauss, 1998), a soluble complement receptor type 1 
(Hofmann et al., 1999). The use of a silastic collar device, to avoid complement attack, 
allowed the carotid arteries of New Zealand white rabbits to be successful transduced by 
BacMam (Airenne et al., 2000). Complement resistant BacMam have also been produced 
by fusing the CD55/decay accelerating factor (DAF) to GP64 (reviewed by Kaikkonen et 
al., 2011). The functional domain of the human DAF was genetically fused to the envelope 
protein GP64 and the fusion protein was efficiently displayed on the surface of BacMam. 
This modified BacMam showed strong complement resistance in in vitro assays and 
successfully mediated in vivo gene delivery in neonatal rat liver (Huser et al., 2001). Other 
approaches included the use of inhibitors for proteases that activate the complement 
system (Tani et al., 2003).  
Studies on cartilage and bone tissue engineering investigated potential approaches to 
exclude the complement effect. Chen and colleagues used a BacMam vector to transduce 
chrondrocyte cells before seeding them into a polymeric scaffold and culturing for three 
weeks (Chen et al., 2008). The transduced cells/scaffold developed cartilage like tissues 
and eight weeks after implantation into osteochondral defects of New Zealand white 
rabbits, hyaline cartilages were regenerated and efficiently integrated with adjacent host 
tissues (Chen et al., 2008). The potential use of BacMam in cartilage tissue engineering 
was also investigated by Chuang and co-workers who used a BacMam to genetically 
engineer human bone marrow stem cell. They demonstrated that BacMam transduction 
led to osteogenesis of bone marrow mesenchymal stem cells (BMSCs). In addition, they 
observed ectopic bone formation in nude mice and repair of calvarial bone in 
immunocompetent rats (Chuang et al., 2010). Other approaches used compstatin, a 
highly potent and selective C3 inhibitor (Georgopoulos et al., 2009) and positively charged 
polyethylenimine to coat the BacMam surface (Yang et al., 2009).  
More recently, the effect of DAF, factor H-like protein-1, C4b-binding protein, and 
membrane cofactor protein were investigated for protection of BacMam vectors from  
complement-mediated inactivation (Kaikkonen et al., 2010). These complement regulatory 
proteins were displayed on the vector surface as fusions to the membrane anchor of the 
vesicular stomatitis virus-G (VSV-G) protein.   
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Virus vectors exhibited complement resistance in vitro and intraportal delivery of DAF-
displaying BacMam led to increased survival and enhanced gene expression in 
immunocompetent mice. Macrophages treated with DAF-displaying BacMam produced 
lower levels of inflammatory cytokines compared to control virus. These data suggested 
that DAF-display can protect BacMam against complement inactivation and reduce 
complement-mediated inflammation injury (Kaikkonen et al., 2010). Recently, Paul et al., 
(2013) generated a nanohybrid baculovirus, using cationic polyamidoamine dendrimer 
synthetic nanoparticles, encapsulated within poly (lactic-co-glycolic acid) microspheres. 
The study showed successful protection of baculovirus from the host immune system as 
well as enhanced transduction in vivo. 
Although the complement system mediates inactivation of BacMam vectors in a in vivo 
context, a significant angiogenic response has been reported in immunocompetent rabbit 
skeletal muscle and rat heart after intramuscular and intramyocardial delivery, respectively 
(Paul et al., 2011; Heikura et al., 2012). This immunogenicity has been advantageous for 
cancer therapy (Heikura et al., 2012). BacMam harbouring suicide genes, tumour 
suppressor genes, pro-apoptotic genes, immune-potentiating genes, and anti-
angiogenesis genes have been tested in vivo in animal tumour models (reviewed by 
Wang & Balasundaram, 2010; Luo et al., 2012). Data from cancer immunotherapy studies 
using mice vaccinated with baculovirus exhibited protection against tumour cells (Hervas-
Stubbs et al., 2007). BacMam transduction of antigen-presenting dendritic cells produced 
encouraging results for melanoma therapy (Zeng et al., 2012). 
The new millennium started with two successful BacMam studies. Firstly Airenne et al. 
(2000) showed that BacMam was able to mediate efficient periadventitial gene delivery 
into rabbit carotid arteries. This was followed by another study where Sarkis et al. (2000) 
tested the ability of a BacMam vector containing a green fluorescent protein (GFP) 
expression cassette to transduce neural cells in vitro and in vivo. They concluded that 
various neuroblastomal and non-neuronal cell lines, as well as three human neural 
primary cultures, were efficiently transduced by the vector. Moreover, direct injection of 
the BacMam into rat and mouse brain allowed in vivo transduction, predominantly in glial 
cells (Sarkis et al., 2000). Recently, a bio-distribution experiment was performed by Räty 
et al. (2007) using Wistar rats. BacMam vectors coated with 99mTc-labelled polylys-ser-
DTPA-biotin peptide were administered to rats (intrafemoral, intramuscular, 
intracerebroventricular and intraperitoneal) before being imaged by 
microSPECT/computed tomography (CT) in vivo. Results suggested that BacMam spread 
through the rat’s lymphatic system which impacted transduction and its bio-distribution in 
the body.   
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Additionally, extensive expression was seen in kidneys and spleen after intraperitoneal 
administration. This study showed that administration of BacMam via the peritoneum 
might offer a new way to target kidney diseases (Räty et al., 2007). BacMam viruses have 
also been demonstrated to efficiently deliver genes in human embryonic stem cells (Zeng 
et al., 2007; 2009) and transduction did not compromise genome stability or pluripotency 
of stem cells (Yan et al., 2009). Moreover, they demonstrated the potential use of these 
vectors in assisting neural transplantation.  
More recently, BacMam, carrying the herpes simplex virus thymidine kinase (a suicide 
gene), was used to transduce mesenchymal stem cells before ganciclovir drug 
administration. Bak and colleagues observed inhibition of tumour growth and significantly 
prolonged survival of animals, suggesting BacMam was an attractive option as a targeting 
vehicle for systemic cancer therapy (Bak et al., 2011). Studies carried out by the Insect 
Virus Research Group (IVRG) at Oxford Brookes University suggested that baculovirus 
can up-regulate the immune response in vitro and no evidence of cellular injury or 
reduction in cell viability was observed in porcine kidneys transduced ex vivo (Hitchman et 
al., 2011; Murguía-Meca et al., 2011).  
 
1.3 Renal Ischaemia reperfusion-injury 
1.3.1 KIDNEY 
I. Structure and function 
Kidneys are paired bean-shaped organs situated in the retroperitoneum space and are 
highly specialized organs. Their main function is to maintain whole-body homeostasis. 
They also regulate acid-base balance, fluid electrolyte concentration and excrete 
metabolic waste products like urea, creatinine, uric acid, as well as foreign chemicals. In 
addition, the kidneys have a vital endocrine function by secreting renin, the active form of 
vitamin D, and erythropoietin. Both hormones are important for maintaining blood 
pressure, calcium metabolism and synthesis of erythrocytes. Owing to the overwhelming 
genetic similarity between pigs (porcine) and humans, pigs represent an important model 
for biomedical research.   
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In this study porcine kidneys (Figure 1.8 A) were used as a model to study I/R injury. 
Therefore, the porcine kidney will be described in this section. The coronal plane section 
of a kidney shows two distinct areas; an outer region known as the cortex and an inner 
region, the medulla (Figure 1.8 B). The medulla is divided into several striated conical 
masses named renal pyramids. The base of each pyramid is positioned at the 
corticomedullary boundary which extends towards the renal pelvis to form a structure 
called papilla. The surface of each papilla contains small openings from which urine 
droplets pass. This represents the distal ends of the collecting ducts or ducts of Bellini.  
The renal pelvis characterizes the extended portion of the upper urinary tract where two or 
three major calyces extend outward (Figure 1.8 C). Each major calyx is composed of 
several minor calyces that extend to the papillae. The major calyces function is to drain 
the urine produced by each pyramidal unit (Durben & Gerlach, 1979). From the lower 
region of the renal pelvis originates the ureters. Renal pelvis, calyces and ureters are 
formed of smooth muscle that contracts rhythmically to expel the urine to the bladder 
(Constantinou & Hrynczuk, 1976). 
In pigs as well as humans and most other mammals, the vascular flow is provided by the 
renal artery which originates directly from the aorta artery. The renal artery enters the hilar 
region of the kidney and divides to form an anterior and a posterior branch. The anterior 
branch is subsequently divided in three segmental or lobar arteries and supplies the 
upper, middle and lower regions of the anterior surface of the kidney. Instead, the 
posterior artery perfuses the posterior region and is formed by small apical segmental 
branch. The venous network is divided into a series of veins leading to the renal vein and 
the inferior vena cava. 
II Renal histology 
Histologically, the renal parenchyma is formed by glomeruli, tubules, interstitium and 
blood vessels (Figure 1.9). The cellular morphology of the different cell types forming the 
nephron correspond to their specific role in kidney functions (see Section 1.3.2). The tuft 
of capillaries is formed by unique endothelial cells perforated by fenestrae, held together 
by the mesangium that is formed by mesangial cells.   
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Figure 1.8. Porcine kidney anatomy. (A) Whole kidney, (B) coronal plan section highlights the 
outer cortex, the medulla and the renal pyramids where the collecting ducts drain off urine droplets 
in the central pelvis. (C) Schematic diagram of the upper urinary system; the renal pelvis divides 
into two or three major calices, each of which subdivides into several minor calices.   
(A) (B) 
(C) 
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The mesangial cells, containing contractile microfilaments, are responsible for maintaining 
structural integrity and, due to their similarity to smooth muscle cells, regulate blood flow 
by relaxation or contraction movements (Michael et al., 1980; Davies, 1994). Surrounding 
the capillaries tufts, are podocytes and parietal epithelial cells, which play a major role in 
glomerular filtration. However, it has been hypothesized that podocytes may function as 
structure-stabilizing cells by stabilizing the folding pattern of the tuft through linking 
neighbouring capillary loops to each other (Kriz et al., 1994; 1995).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9. Normal histology of human kidney tissue. (A) Section of renal tubules (arrows) 
stained with hematoxylin–eosin staining (magnification x200). (A1) Zoomed renal tubule; the 
section shows simple cuboidal epithelium cells, cell nuclei and intact brush border. Scale bar = 20 
µm. Image obtained from Prof I. Roberts (Department of Cellular Pathology, John Radcliffe 
Hospital, Oxford, UK). 
 
The proximal tubules are characterized by specialized cubdoidal cells (Figure 1.9), 
essential for active fluid transport. Similar cells, but with less complex morphology, are 
present in the thick descending loop of Henle. The descending and ascending limbs are 
formed by four different types of epithelial cells.   
Cuboidal  
epithelium 
Brush 
border 
Nucleus 
Tubules 
A 
Zoomed A1 
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The distal tubules and collecting ducts are formed by simple epithelial cells with a cuboidal 
morphology that do not display the deeply acidophilic, granular cytoplasm characteristic of 
the proximal tubule (Figure 1.9). The interstitium space contains specialized interstitial 
cells and connective tissue elements. The larger renal blood vessels are structurally 
similar to those in other body sites. 
1.3.2 The nephron 
The kidney’s basic functional unit is the nephron, a blood plasma filter (Rashidi & 
Khodarahmi, 2006; Derossi & Cohen, 2008). The nephron’s essential components are: 
glomerulus surrounded by Bowman's capsule, the proximal and distal tubules, the thin 
descending and ascending limbs of the loop of Henle and the collecting tubule (Figure 
1.10). Blood enters the kidney through the renal artery and passes through a series of 
small arteriole branches before arriving into the capillary system of the nephron to be 
filtered. Water and solutes are reabsorbed into the bloodstream during the transition of the 
filtrate from the nephron to the collecting tubes; the filtered fluid is then emptied into the 
bladder through the ureters. 
I. The glomerulus 
The basic filtration units of the kidney are glomeruli (Figure 1.10 A), formed of a unique 
capillary network surrounded by endothelium (Figure 1.10 B). The different cell types are 
separated from each other by a glomerular basement membrane into which the filtrate is 
collected (reviewed by Jarad & Miner, 2009). This membrane plays a key role in the ultra-
filtration of blood plasma by acting as charge-selectivity barrier (reviewed by Goode et al., 
1996; and Miner, 2012). The collected ultra-filtrate from the Bowman’s space enters the 
proximal tubules at the urinary pole of the glomerulus (Figure 1.11 A). 
II. The proximal tubule 
During glomerular filtration, the filtrated fluid moves to the proximal tubules where about 
80% of the ultra-filtrate is reabsorbed (Guyton, 1991). The proximal tubules are formed of 
a convoluted region, known as pars convoluta, followed by a straight portion named pars 
recta. However, morphologically they are divided in three distinct segments: S1, S2, and 
S3 as shown in Figure 1.12 (reviewed by Christensen et al., 2012).  
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Figure 1.10. Schematic representation of a kidney nephron.  
 
The S1 segment forms the initial portion of the proximal tubule which originates at the 
glomerulus pole. The end region of the pars convoluta together with the initial portion of 
the pars recta forms the S2 segment, while the S3 segment represents the last portion of 
the proximal tubule localized between the cortex and the outer medulla (Maunsbach, 
1966).  
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Figure 1.11. Diagram of glomerulus (A) and glomerulus filtration barrier (B). 
 
 
 
 
 
 
 
Figure 1.12. Diagrammatic representation of the proximal tubule. The proximal tubules are 
morphological divided in three segments, S1, S2 and S3. S1 and S2 are localized in the cortex 
while the S3 segment represents the proximal tubule portion between the cortex and the outer 
medulla.   
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Besides a reabsorption function, the proximal tubules are responsible for the excretion of 
drugs, toxins and other organic compounds; they are involved in a number of important 
metabolic functions (Wright, 2005) and it has been proposed that they might have 
immune-modulatory functions by acting as specific target cells during allograft rejection 
(Yard et al., 1992; Van Dorp et al., 1993). Nevertheless, due to their vast spectrum of 
functions it is not surprising that several inherited and acquired kidney disorders are 
closely linked to the proximal tubules (reviewed by Nakhoul & Batuman, 2011). Therefore, 
in light of this, the in vitro work carried out in this thesis was based on an immortalized 
proximal tubule epithelial cell line, human kidney-2 (HK-2; Ryan et al., 1994). 
III. The loop of Henle 
The loop of Henle is composed of two segments: the thin descending limb which is a 
continuation from the proximal tubule S3, and the thin and thick ascending limb (Figure 
1.13). The descending limb is mainly permeable to water (Kokko, 1970), whereas the 
ascending limb become impermeable to water and permeable to ions (Greger, 1985). The 
main function of the loop of Henle is to regulate the current exchange mechanism for the 
ionic compound sodium chloride (NaCl) between the filtrate and the interstitial fluid 
surrounding the loop (Thomas, 1998).  
 
 
 
 
 
 
 
 
 
Figure 1.13. Loop of Henle.  The loop of Henle limbs are localized at the medullar region. The thin 
descending limb, the thin and thick ascending limbs are parallel to the vasa recta vessels. 
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IV. The distal tubule and collecting ducts 
The cortical distal tubular portion is defined as the region between the macula densa and 
the collecting duct. This can be morphological divided into distal convoluted tubule and 
connecting tubule. The filtrate is collected from numerous distal tubules into the 
connecting tubule, a tubular segment that connects the collecting ducts system, at the 
cortical region, with the distal tubules. The ultra-filtrate is then drained from the connecting 
segment into the collecting ducts. The collecting ducts represent the final control of the 
urine composition and based on their location they are divided in cortical, outer medullary 
and inner medullary collecting ducts (reviewed by Muto, 2001). In addition, this portion of 
the kidney is almost completely impermeable to water and for this reason any excess will 
be lost in the urine (reviewed by Berridge, 2012). The urine from the medullary collecting 
ducts is excreted into the renal pelvis before being transported into the urinary bladder. 
 
1.3.3 RENAL FAILURE 
Renal failure is a well-known medical condition in which kidneys are unable to reabsorb 
water and solute and fail to remove waste products from the blood. Kidney failure can be 
divided into two main categories, acute renal failure (ARF) and chronic renal failure (CRF). 
ARF causes are grouped into three categories, pre-renal, intra-renal and post-renal, 
whereas, CRF occur when kidneys are not able to recover after one or more episodes of 
ARF (reviewed by Lameire et al., 2013). ARF has emerged as the most common renal 
disease in hospitalized patients producing serious morbidity and mortality and prolonged 
hospitalisation (Mehta et al., 2004). This thesis focused on one of the most common 
causes of intra-renal ARF, namely ischaemia reperfusion-injury (I/R injury) (Sheridan & 
Bonventre, 2001; Giraud et al., 2011).  
The term ischaemia is referred to as a progressive condition from a hypoxic state where 
interrupted blood flow causes intracellular oxygen depletion. Although ischaemia induces 
cell damage, the real injury is manifested after restoration of the blood flow and tissue 
oxygenation. The main mechanisms triggering the injury are reactive oxygen species 
(ROS), excessive inflammatory response and rapid electrolyte shifts (Cai et al., 2006; Zhu 
et al., 2007). I/R injury often occurs following kidney transplantation, due to the obligated 
interruption of blood flow during the transplant period. Two types of ischaemia may occur 
during renal transplantation, warm and cold ischaemia. In particular, warm ischaemia is 
further divided into donor warm ischaemia either after circulatory death or after brain death 
and recipient warm ischaemia.   
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In donors, the warm ischaemia starts from the time of asystole until the organ is preserved 
in a cold perfusion solution. While, in recipient warm ischaemia begins with the removal of 
the organ from ice up until the start of the reperfusion (reviewed by Halazum et al., 2007). 
Cold ischaemia occurs when kidneys collected from living donors are directly preserved in 
cold preservation solution. However, both types of ischaemia have a significant impact on 
short and long-term transplant outcome (Peters et al., 1995). It can lead to primary non-
function of the transplanted organ (<5% of recipients), delayed allograft function, which 
occurs in up to 50% of recipients (Abu Jawdeh & Rabb, 2011; Ghadiani et al., 2012) and 
multiple organ dysfunction (Yassin et al., 2002; Park et al., 2012). 
 
1.3.4 PATHOPHYSIOLOGY OF RENAL ISCHAEMIA REPERFUSION (I/R) INJURY 
The pathophysiology of I/R injury is complex and multifactorial affecting both the renal 
tubular epithelium and renal microvasculature (Bonventre & Weinberg, 2003). The key 
manifestation of ischaemia is a rapid decrease in the level of adenosine triphosphate 
(ATP) followed by mitochondrial dysfunction and enhanced production of ROS (Feldkamp 
et al., 2004). Decreased levels of ATP, which depend on the severity and duration of the 
blood flow interruption to the organ, can initiate a number of critical metabolic 
consequences (Figure 1.14; Devarajan, 2005). 
I. Ionic imbalance 
Following oxygen deprivation, epithelial cells are unable to maintain sufficient intracellular 
ATP levels for essential processes. This rapid degradation of ATP to adenosine 
diphosphate (ADP) and adenosine monophosphate (AMP) is recognised as the first 
consequence of ischaemia. AMP is further metabolized into adenine nucleotides and then 
into hypoxanthine which contributes to the generation of ROS. Furthermore, ATP 
depletion induces loss of cell membrane integrity followed by derangement of cellular ion 
homeostasis and, if severe enough, cell death by necrosis and apoptosis (Bonventre & 
Yang, 2011). Provision of exogenous adenine nucleotide or thyroxine, in order to stimulate 
ATP re-generation, has been studied in animal models (Wagener et al., 1995), however, 
this approach failed in a trial to treat human acute renal failure (Acker et al., 2000).  
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Figure 1.14. Pathways leading to cell death in I/R injury. During ischaemia the decline of ATP 
levels results in a decreased pH, increased cytosolic calcium (Ca
2+
) and
 
mitochondrial membrane 
potential (Δψ). This leads to increased mitochondrial Ca
2+ 
(Mito Ca
2+
) which results in the activation 
of the mitochondrial permeability pore (MPT). However, acid pH inhibits MPT. At the reperfusion 
stage, the re-introduction of O2 leads to the generation of ROS and activation of the MPT. 
Altogether, loss of ATP, ROS and MPT activates the apoptotic pathway causing a rapid loss of 
plasma membrane integrity and cell death. Modified from Murphy & Steenbergen (2008). 
 
 
Following ATP depletion, positively-charged protons accumulate in the cytoplasm, 
activating the Na+/H+ (sodium/hydrogen) exchanger (Figure 1.15 A). The Na+/K+ ATPase 
pump, which regulates Na+ levels in the cytoplasm, is unable to function due to the lack of 
ATP and consequently cells are loaded with excessive levels of Na+. As a result, Na+/Ca2+ 
(sodium/calcium) antiporter activity is enhanced, which leads to an increased 
concentration of cytosolic and mitochondrial Ca2+. As shown in Figure 1.15 (B), at the 
reperfusion stage the combinations of high Ca2+ levels, ROS and decreased hydrogen ion 
potential (pH) activate the mitochondrial permeability pore (mPTP). The conformational 
change of the mPTP causes further ROS production, depletion of ATP and rupture of the 
mitochondrial membrane releasing cytochrome c (cyt c) into the cytoplasm. Ultimately, 
these processes lead to cell death (Murphy & Steenbergen, 2008; Halestrap & Pasdois, 
2009). 
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Figure 1.15. Cellular response to ischaemia and reperfusion. (A) The ATP deletion during 
ischaemia leads to increased intracellular hydrogen ion (H
+
) and calcium (Ca
2+
). (B) Following 
reperfusion the generation of reactive oxygen species (ROS), changing pH and Ca
2+
 induce the 
conformational change of the mitochondrial permeability pore (MPP); this lead to cell death. 
Modified from Kharbanda (2010). 
 
II. Oxidative stress 
Within minutes following reperfusion, several factors contribute to renal tissue injury; the 
molecular oxygen (O2) reacts with the accumulated hypoxanthine generating xanthine and 
ROS (Chan, 2001). ROS can be generated by different systems, however the 
mitochondrion represents the major site of production (Greene & Paller, 1992; Nath & 
Norby, 2000). ROS are produced under normal cellular conditions to accomplish 
physiological roles (Nose, 2000) and are degraded by antioxidant enzymes, e.g., 
superoxide dismutase, glutathione peroxidase and catalase (Droge, 2002; Trachootham 
et al., 2008). However, during I/R injury an excessive production of ROS together with 
reduced antioxidant defences may cause a range of cellular damage, such as DNA strand 
breaks, lipid peroxidation and reduction of protein sulfhydryl bonds (Nath & Norby, 2000; 
Goswami et al., 2007).  
Following re-oxygenation the O2 molecule is quickly reduced by one-electron. This 
produces a relatively stable intermediate named superoxide anion (O2
·-) (Figure 1.16).   
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The O2
·- represents the precursor of most ROS generated in cells; its dismutation can 
occur either spontaneously or through a reaction catalysed by the superoxide dismutase 
enzyme (SOD) and produces hydrogen peroxide (H2O2). As shown in Figure 1.16, H2O2 is 
then further reduced via catalase or glutathione peroxidise (GSH-Px) into water (Becker, 
2004) or partially reduced to a hydroxyl radical (OH•) via the Fenton reaction (Mao et al., 
1993; Liochev & Fridovich, 1999). In addition, O2
·- can react with nitric oxide (NO•) 
producing peroxynitrite (ONOO-) a very powerful oxidant from the group of reactive 
nitrogen species (RNS) (Beckman & Koppenol, 1996; Radi et al. 2002).  
 
 
 
 
 
 
 
 
 
Figure 1.16. Generation of ROS in I/R injury. O2 reacts with an impaired electron (e-) to form O2
·-
. O2
·-
 is converted in H2O2 by the enzyme SOD. H2O2 undergoes spontaneous conversion to OH˙. 
Alternatively, it can be detoxified via glutathione peroxidase (GSH-Px) or catalase to H2O and O2. 
 
 
The primary cellular antioxidant defence system is the SOD family. The catalytic activity of 
SOD enzymes was first discovered in bovine erythrocytes by McCord & Fridovich (1969). 
In the years following this discovery a number of SODs have been identified that are 
characterized by their metal group and cellular localization. They have been found in both 
prokaryotic and eukaryotic cells including copper/zinc- (Cu/Zn, SOD-1/3), manganese- 
(Mn, SOD-2), nickel-, iron- and iron/zinc- enzyme (Yost & Fridovich, 1973; Steinman et al., 
1974; Whittaker et.al., 1998). Although they have some distinction, all SODs catalyse the 
dismutation of O2
·- . In human tissues three isoforms are present, SOD-1, SOD-2 and 
SOD-3 (Johnson & Giulivi, 2005).   
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Mn-SOD or SOD-2, localized in the mitochondrial matrix (Zelko et al., 2002), was the 
isoform utilized in the work described in this thesis. It exists as a homotetramer with a 
molecular weight of approximately 23 kDa (Barra et al., 1984) and contains one Mn atom 
per subunit. It cycles from Mn(III) to Mn(II) and then back to Mn (III) during the two step 
dismutation reaction. Many reports have shown that SOD-2 plays a key role in attenuating 
injury or death under conditions of enhanced oxidative stress (Kasahara et al., 2005; 
Fukui & Zhu, 2010; Aguirre & Culotta, 2012) and SOD-2 deficiency in mice leads to 
prenatal lethality (Huang et al., 2001). For this reason many researchers have aimed to 
up-regulate SOD-2 activity. Different studies have provided conclusive evidence that 
overexpression of SOD-2 protects against I/R injury (Cruthirds et al., 2005; Usui et al., 
2011). Moreover, several other studies have demonstrated the beneficial effects of 
pharmacological approaches in preventing excessive ROS formation during I/R injury e.g., 
administration of xanthine oxidase inhibitor such as allopurinol (Hu et al., 2012); 
exogenous administration either in vivo or in vitro of antioxidant mimetic enzymes e.g., 
SOD mimetics such as Tempol (Thomas & Sharifi, 2012).  
Recent studies support the hypothesis that ROS-mediated injury may occur several hours 
after reperfusion begins. Kulah et al., (2007) measured the accumulation of an oxidative 
stress biomarker, ox-LDL, in rat kidney tissue during I/R injury. They observed that the 
plasma ox-LDL levels did not increase significantly at twenty-four hours following the 
reperfusion. However, a peak and a decline of biomarker levels were observed at forty-
eight and seventy-two hours post I/R injury. In conclusion, Kulah and colleagues (2007) 
identified long term complications in addition to the immediate cellular damage of 
reperfusion as things to be considered in future strategy development.  
III. Apoptosis 
During I/R injury, the endogenous antioxidant system becomes inadequate to control ROS 
concentration and in this pathological scenario the increased oxidative stress/damage 
eventually leads to apoptotic cell death. The term apoptosis refers to programmed cell 
death and is used by the cell to eliminate redundant or damaged cells (Hoeberichts & 
Woltering, 2003). A schematic representation of apoptosis is shown in Figure 1.17. It can 
be activated by either extracellular signals including toxins, hormones, growth factors and 
nitric oxide (Popov et al., 2002; Brüne, 2003) or intracellular signals. Cells initiate 
intracellular apoptosis in response to stress such as oxidative stress (reviewed by Ozbek, 
2012). Under normal cellular homeostasis a number of anti-apoptotic factors inhibit the 
conformational change of mPTP, and consequently they prevent mitochondrial disruption 
and the release of cyt c (Cory & Adams, 2002).  
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However, an excessive formation of ROS in mitochondria triggers the activation of the 
intracellular apoptosis pathway. Cyt c released from mitochondria to the cytoplasm, 
together with the apoptotic protease activating factor 1 (Apaf-1) form a complex named 
the apoptosome (Chernyak, 1997). The apoptosome activates a cascade of proteolytic 
reactions that lead to cell death by cleaving cytoskeletal, metabolic and cell signalling 
proteins (Namura et al., 1998).  
BCL-2 proteins are the main regulators of apoptosis (Figure 1.17). Members of this family 
are classified into two groups: anti- and pro-apoptotic. The first anti-apoptotic gene was 
discovered in non-Hodgkin’s follicular B-cell lymphomas, known as B-cell lymphoma 2 
(bcl-2), between chromosomes 14 and 18 t (14; 18) (Bakhshi et al., 1985). Identification of 
BCL-2 as an inhibitor of apoptosis prompted the discovery of other members of this family. 
In particular, three members with protective function were characterized: bcl-x, mcl-1 and 
a1 (Boise et al., 1993, Kozopas et al., 1993). Additionally, other proteins were identified 
that interact with BCL-2 such as BAX which promotes apoptosis rather than protecting 
against cell death (Oltvai et al., 1993). Subsequently more pro- and anti-apoptotic proteins 
were characterized such as pro-apoptotic protein BIK, and the anti-apoptotic BCL-Xs 
(Aouacheria et al., 2001).  
In mammals, BCL-2 is related at least to twenty members, all of which share one or more 
conserved BCL-2 homology domains (reviewed by Cory & Adams, 2002) and regulate 
apoptosis through protein-protein interactions (Cory et al., 2003). Deletion of pro- or 
increased expression of anti-apoptotic proteins have been shown to reduce I/R injury 
mediated cell death (Hochhauser et al., 2003). In particular, overexpressing the anti-
apoptotic enzyme BCL-2 has been shown in a number of studies to reduce total cell death 
and apoptotic cell death following I/R injury in different organs (Suzuki et al., 2008). 
Saikumar et al. (1998) demonstrated that BCL-2 prevented hypoxic injury in kidney 
proximal tubule cells by inhibiting mitochondrial release of cyt c. Similarly, Isaka and 
colleagues showed that BCL-2 augmentation protected renal tubular epithelial cells from 
I/R injury by suppressing autophagosomal degradation of injured mitochondria (Isaka et 
al., 2009). 
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Figure 1.17. Apoptosis pathways. In the extracellular pathway, the binding of the ligand, FasL, to 
the receptor, Fas, results in the activation of caspase-8. In the intrinsic pathway, the intracellular 
signal e.g. high concentrations of ROS, induces the release of cyt c, formation of apoptosome and 
the activation of caspase-9. Caspase-8 and -9 activate caspase-3 which leads to cell death. BCL-2 
and BCL-XL play an important role in inhibiting cyt c release from mitochondria; this prevents the 
apoptosis activation. Modified from Berrou et al. (2012). 
 
1.3.5 HISTOLOGICAL CHANGES DUE TO I/R INJURY 
As described in Section 1.3.4, a number of mechanisms are implicated in the process of 
I/R injury that cause changes in the renal histology. A photomicrograph of a human renal 
biopsy with signs of ischaemic tubular necrosis is shown in Figure 1.18. Increase in ROS 
production, depletion of intracellular ATP and elevated Ca2+ levels interfere with normal 
metabolic processes. Under these conditions, ischaemic cells lose their actin cytoskeletal 
integrity, their membrane polarity changes which disrupts tubular transport function and 
they detach from the basement membrane. Histologically, these changes occur mainly in 
the renal tubules (Figure 1.18).  
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Renal tubules appear with sloughing of the brush border membrane into the lumen or 
invagination into the cytoplasm, which leads to the redistribution of integrins and Na+/K+ 
ATPase to the apical surface (Lameire & Vanholder, 2004). Furthermore, ischaemic 
tubules are characterized by the epithelium flattening, tubular dilatation and loss of cell 
nuclei (Figure 1.18). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.18. Representative image of human renal biopsy showing ischaemic tubular 
necrosis. (A) Section of renal tubules (arrows) stained with hematoxylin–eosin (magnification 
x200). (A1) Zoomed renal tubule; the section shows loss of brush border, loss of cell nuclei and 
thinning of the tubular endothelium. Asterisks indicate dilated tubules. Scale bar = 20 µm. Image 
obtained from Prof I. Roberts (Department of Cellular Pathology, John Radcliffe Hospital, Oxford, 
UK). 
 
1.3.6 EXPERIMENTAL MODELS 
Over the past decade numerous experimental models have been developed to explore 
the pathophysiology mechanisms of renal I/R injury. Various conditions have been used 
including animal models for ex vivo / in vivo studies as well as in vitro models such as 
oxygen and glucose deprived cultures of renal cells (Lee & Emala, 2002).  
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cell nuclei 
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These models have enhanced our understanding of renal diseases and played an 
important role in the search for adequate therapeutic treatment for I/R injury. Although 
animal experimentation is subject to legal and ethical restrictions, animal-based 
experimental models are crucial in renal I/R injury studies. Indeed, pre-clinical animal 
studies play a central role in either testing medical devices or assessing the efficacy of 
therapeutic treatment before their use in human patients.  
I. In vitro 
In vitro models are generally used to study molecular mechanisms, specific pathways 
involved in cellular damage and/ or death caused by I/R injury events. These experimental 
models can be performed using either primary cells or immortalized cell lines. The most 
frequently used cell lines are porcine kidney cells (LLC-PK1) which have a proximal 
tubular cell phenotype (Hull et al., 1976) and HK-2 cells which are proximal tubular cell 
(PTC) line derived from normal human kidney. The major areas of I/R injury investigation 
have included overexpression of protective genes, enhancing enzyme activity and 
suppressing the expression of genes that activate the cell death pathway. A wide variety 
of techniques that mimic I/R injury in vitro have been developed and are generally 
classified as either: (1) external cellular environment alteration such as the in vitro model 
of mineral oil immersion (Hitchman et al., 2011); (2) cellular metabolism manipulation 
using chemicals e.g., mitochondrial inhibitors such as antimycin A (Doctor et al., 1994). 
Over the past decade, a number of in vitro renal studies used antimycin A in combination 
with a non-metabolizable glucose analog, 2-deoxyglucose, to induce mild/severe 
intracellular ATP depletion (Iwata et al., 1995; Xie & Guo, 2006; Kumar et al., 2009).  
More recently, encouraging results have been achieved with pre- and post‐ conditioning 
approaches (Bon et al., 2012; Yuan et al., 2012). Murry et al. (1986) were the first to show 
that brief episodes of ischaemia decreased the extension of myocardial infarct induced by 
subsequent prolonged injury. This phenomenon named “ischaemia preconditioning” 
appears to be a body defence mechanism to an acute stress. However, its clinical use 
remains limited since it must be instituted before the ischaemia episode begins (reviewed 
by Selzner et al., 2012). In 2003 a new model was developed (ischaemia post-
conditioning) to overcome this limitation, by rapid and irregular interruption of blood flow 
during the initial phase of reperfusion.   
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II. In vivo / ex vivo 
In vivo whole animal and ex vivo organ models are crucial due to the limitations of in vitro 
models. Various animal models of ischaemia have been developed and currently two 
types of I/R injury models are mainly used, warm and cold ischaemia (Section 1.3.3). A 
number of research studies used rodents as I/R injury models, due to their availability, 
easy manipulation and because of their small size (Susa et al., 2009; Chen et al., 2012; 
Wei & Dong, 2012). Experimentally, mice or rat I/R injury is induced by temporarily 
clamping one of the arteries such as celebral or renal, followed by reperfusion (Willaam et 
al., 2006; reviewed by Kennedy & Erlich, 2008; Chen et al., 2012). This model allowed 
scientists to better understand the pathophysiological mechanisms of renal injury. The 
pigs (porcine) renal anatomy and vascular system is very similar to humans. Moreover, 
the pig genome showed high sequence homology with humans (reviewed by Kuzmuk & 
Schook, 2011). For these reasons pigs are an ideal model for studying I/R injury.  
Transplantation represents the only available treatment for patients with end-stage renal 
failure; however kidney graft is limited by a shortage of organ donors. During clinical 
practise cold-buffered solutions, reducing cold storage times and ex vivo perfusion have 
been adopted to reduce I/R injury (Moers et al., 2009). In particular, ex vivo graft 
preservation is an essential approach due to the specific set of injuries associated with it 
(reviewed by Bon et al., 2012).  
During the last thirteen years a number of genes have been identified for overexpression 
via ex vivo therapy during transplantation (van der Wouden et al., 2004). RNAi represents 
an novel strategy to reduce I/R injury and two recent ex vivo studies have demonstrated 
efficient silencing of proteins after administration of small interfering RNA (siRNAs) into 
the preservation solutions used for mouse cardiac grafts and pig kidney grafts (Yang et 
al., 2011). More recently, Nicholson & Hosgood (2013) announced a novel method of ex 
vivo preservation based on normothermic perfusion. This method restored circulation and 
allowed the pig kidney to recover function before begin transplanted. 
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1.4 AIMS OF THE THESIS 
1.4.1 Research background 
Renal transplantation represents the only choice of therapy for many patients in the end-
stages of renal disease; however, complications such as I/R injury present a significant 
hurdle to overcome during this procedure. The longer a kidney is exposed to an obligated 
interruption of blood flow the higher the risk of acute damage after transplantation due to 
reperfusion injury. Thus, minimizing or preventing I/R injury can lead to an improvement of 
short- and long-term graft survival. A number of viruses have been identified for use as 
gene therapy vectors (reviewed by Ghosh et al., 2002; Lin et al., 2010; Huang & Kamihira, 
2013); amongst these vectors, BacMam virus vectors possess many beneficial features 
and a number of in vivo gene delivery studies have demonstrated their therapeutic 
potential (reviewed by Airenne et al., 2010; and by Chen et al., 2011).  
Of particular relevance for this thesis was a pilot study carried out by Murguía-Meca and 
colleagues in the Insect Virus Research Group, Oxford Brookes University. They used 
BacMam to deliver a reporter gene into porcine kidneys ex vivo during a hypothermic 
static cold preservation study. Twelve kidneys from large pigs were perfused with 
University of Wisconsin (UW) solution containing BacMam virus carrying enhanced green 
fluorescence protein (egfp); viral particles were detected in transduced kidneys at different 
times and no evidence of additional injury or reduction in cell viability was observed 
between transduced organs and controls (Murguía-Meca et al., 2011). 
 
1.4.2 Research objectives 
Therefore, the overall objective of this thesis was to further develop the work initiated by 
Murguía-Meca et al. (2011) ultimately to demonstrate the utility of BacMam as a vector to 
deliver “protective” genes to reduce I/R injury in an ex vivo kidney model. Achieving this 
goal required a number of challenges to be overcome, including the development of 
BacMam-specific in vitro and ex vivo porcine kidney I/R models.  
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A brief description of the aims and objectives for each thesis chapter are detailed below:  
 
 Transduction of large organs is likely to require high amounts of virus, 
preferably concentrated in low volumes for ease of handling and improved 
transduction efficiency. High levels of BacMam expression are often correlated 
with increasing virus concentration. Therefore, the aim of the work described in 
Chapter 3 was to compare different concentration methods, both for small 
scale and large scale culture volumes, and identify the optimal method for 
future studies.  
 The aim of the work described in Chapter 4 was to evaluate the feasibility of 
using chemical compounds for improving BacMam gene expression and/or 
delivery in vitro, initially in different mammalian cells using reporter genes. 
Candidates showing potential would be optimised and tested further using 
protective genes in an in vitro model, as described in Chapter 5. 
 Having generated BacMam viruses and optimised their concentration, 
expression and delivery in previous chapters, the work described in Chapter 5 
focused on using BacMam to ameliorate I/R injury in vitro. To do this required 
the development of a BacMam-specific in vitro model of I/R injury in HK-2 cells. 
 The aim of the work described in Chapter 6 was to develop an ex vivo cold 
kidney preservation model of I/R injury and then use the learning gained from 
previous chapters to reduce the injury, by BacMam delivery of protective 
genes. 
 Chapter 7 contains a summary and discussion of all of the results chapters, 
including future work. 
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2.1 MATERIALS 
2.1.1 CHEMICALS AND GENERAL REAGENTS  
All chemicals were supplied by Sigma-Aldrich Co. Ltd and given as weight/ volume (w/v) 
unless otherwise stated (Tables 2.1 and 2.2). Solutions were sterilised by autoclaving at 
15 pounds pressure per square inch or by filtration through 0.45 μm or 0.2 μm filters 
supplied by Thermo Fisher Scientific Inc. Foetal bovine serum (FBS) was supplied by 
Lonza Group Ltd and heat inactivated at 56°C for 30 min. 
 
Table 2.1. Chemical compounds used as transduction enhancers 
Chemical 
Compounds 
Description Stock solution 
prepared in  
Butyrate Histone deacetylase inhibitor 1M in PBS* 
Etoposide Topoisomerase II inhibitor 0.01 M in DMSO** 
Hydroxyurea DNA synthesis inhibitor 1 M in PBS 
Protamine Polycationic molecule 50 mg/ml in dH2O*** 
Cyclohexamide Protein biosynthesis inhibitor 50 mg/ml in DMSO 
* PBS: phosphate buffered saline 
** DMSO: dimethyl sulfoxide 
*** dH2O: distilled water 
 
Table 2.2. Reagents used in western blot analysis (method 2.2.27) 
Chemical ID Stock 
solution 
Working 
volume  
Supplied by 
5-Bromo-4-Chloro-3'-
indolyphosphate p-toluidine 
(BCIP) 
50 mg/ml 
in dH2O 
33 µl Fermentas, Thermo 
Fisher Scientific Inc. 
Nitro blue tetrazolium (NBT) 50 mg/ml 
in 70% 
DMF* 
66 µl Life Technologies Ltd 
* DMF: dimethylformamide 
2.1.2 MOLECULAR BIOLOGY REAGENTS 
Molecular biology reagents such as restriction enzymes, DNA polymerase and T4 ligase 
were purchased from New England Biolabs Ltd. Appropriate buffers were supplied with 
each enzyme (Table 2.3). DNA purification kits were purchased from MACHEREY-
NAGEL, Thermo Fisher Scientific Inc. and Qiagen.   
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Table 2.3. Restriction enzymes  
Enzyme ID Recognition sequence Buffer 
Bgl II A/GATCT NEBuffer 3.1 
Eco R I G/AATTC NEBuffer 2.1 or NEBuffer EcoR I 
Not I GC/GGCCGC NEBuffer 3.1 
Sph I GCATG/C NEBuffer 2.1 
Xba I T/CTAGA NEBuffer 2.1 
Xho I C/TCGAG NEBuffer 2.1 or NEBuffer 3.1 
 
2.1.3 PLASMID DNA AND BACULOVIRUS TRANSFER VECTORS 
All plasmids used were stored at -20°C until required (Table 2.4). 
Table 2.4. Plasmid DNA and transfer vectors 
Name Description Source 
pBAC-1 AcMNPV transfer plasmid 
containing the full length polh 
promoter 
Novagen®, Merck 
Millipore 
pCI-neo Mammalian expression vector 
carrying the CMV-IE promoter 
Prof. I. Bermudez-
Diaz (Oxford Brookes 
University) 
pBAC-1_CMV40 AcMNPV transfer vector. The polh 
promoter was replaced with the 
mammalian CMV-IE promoter  
Generated by  
E. Locanto 
pMA_SOD-2 Plasmid DNA carrying sod-2 GeneArt®, Life 
Technologies Ltd 
pSOD-2 Transfer vector carrying sod-2 Generated by  
E. Locanto 
pMA_BCL-2 Plasmid DNA carrying bcl-2 GeneArt®, Life 
Technologies Ltd 
pBCL-2 Transfer vector carrying bcl-2 Generated by  
E. Locanto 
pGFP Transfer vector carrying the 
enhanced green fluorescence 
reporter gene (egfp) 
Generated by  
E. Locanto 
pHM840 Mammalian expression vector 
carrying the reporter gene lacZ 
Addgene, USA 
pLAcZ Transfer vector carrying the 
reporter gene lacZ 
Generated by  
E. Locanto 
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2.1.4 TRANSFECTION REAGENTS 
Transfection reagents used in this study are summarised in Table 2.5. The 
concentration used (5µl) per transfection was prepared according to the 
manufacturer’s protocol.  
 
Table 2.5. Transfection reagents 
Transfection 
reagents  
Description Supplied by 
Lipofectin cationic liposomes Life Technologies Ltd 
baculoFECTIN 
 
positively charged 
polymer embedded into 
a porous nanoparticle 
Oxford Expression 
Technologies Ltd 
 
2.1.5 VIRAL DNA 
flashBAC ULTRA™ DNA (Oxford Expression Technologies Ltd) was used to generate 
BacMam viruses. A number of BacMam viruses were produced for the purpose of this 
study and are listed in Table 2.6. 
Table 2.6. BacMam viruses generated and used in this study 
Virus name Modification/Description 
AcCMV_NULL* AcCMV with no transgene inserted 
AcCMV_EGFP AcCMV expressing egfp  
AcCMV_LacZ AcCMV expressingLacZ  
AcCMV_SOD-2 AcCMV expressing sod-2 
AcCMV_SOD-2•6His AcCMV expressingsod-2 with histidine-tag at the C-terminal  
AcCMV_Bcl-2 AcCMV  expressing bcl-2 
* AcMNPV with CMV promoter replacing the fully deleted polyhedrin promoter; this was named 
AcCMV. 
 
2.1.6 ANTIBODIES 
In Table 2.7 the primary antibodies used in this thesis are listed including their origin and 
working concentrations. Alkaline phosphatase-conjugated secondary antibodies were 
used for the detection of proteins. All secondary antibodies used were obtained 
commercially from Sigma-Aldrich Co. Ltd and are listed in Table 2.8.  
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Table 2.7. Primary antibodies used for immunofluorescence and western blot 
analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.8. Secondary antibodies used for immunofluorescence and western 
blot analysis 
 
 
 
 
 
 
2.1.7 CELL LINES AND MEDIA 
I. Insect cells 
The host cell lines susceptible to AcMNPV used in this study are listed in Table 2.9. Sf-21 
cells were maintained in suspension culture in a stirred flask; whereas, Sf-9 cells were 
grown in shaking flasks. Both insect cell lines were cultured at 28°C.  
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Table 2.9: Insect cell lines         
 
 
 
 
 
*Media was supplied with 10% (v/v) FBS (Lonza Group Ltd). 
 
II. Mammalian cells 
Mammalian cell lines used in this thesis and their culture conditions are listed in Table 
2.10. All cell lines were grown as monolayers and maintained at 37°C, 5% carbon dioxide 
(CO2). 
 
Table 2.10: Mammalian cell lines  
 
 
 
 
 
 
 
*Media was supplied with 10% (v/v) FBS, 100 U/ml penicillin (GIBCO, Life Technologies Ltd) and 
100 µg/ml streptomycin (GIBCO, Life Technologies Ltd). 
 
III. Bacterial cells 
The Escherichia coli (E. coli) strain, XL-1 Blue (genotype (endA1 gyrA96 (nalR) thi-1 recA1 
relA1 lac glnV44 F'[::Tn10 proAB+ lacIq Δ(lacZ)M15] hsdR17(rK- mK+) was used in this 
study for DNA amplification  and cloning (Section 2.2.11). XL-1 Blue cells were grown 
either in liquid LB (Luria-Bertani) medium (per Liter: 5.0 g yeast extract, 10.0 g Bacto-
trypton, 5 g NaCl, pH 7.2) or on LB agar plates containing 15 g/L bacto agar.   
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2.1.8 PORCINE KIDNEY ORGANS 
Experiments were performed in accordance with the principles and procedures of the 
Oxford Brookes University Ethics Committee. Porcine kidneys were obtained from a local 
slaughterhouse. Organs were collected within 10 minutes (min) after slaughter (22 week 
old large white pigs) and flushed in situ with SOLTRAN kidney perfusion fluid (0.86% w/v 
potassium citrate, 0.82% w/v sodium citrate, 3.38% w/v mannitol and 1% w/v magnesium 
sulphate; http://www.ecomm.baxter.com). Kidneys were then placed in a plastic bag 
surrounded by ice packs and immediately transported to the laboratory for analysis. 
 
2.2 METHODS 
2.2.1 MOLECULAR BIOLOGY TECHNIQUES 
2.2.1.I Designing primers 
All of the oligonucleotide primers required were designed using gene sequences from the 
human genome, available from the National Centre for Biotechnology Information (NCBI) 
website (www.ncbi.nml.com). All forward primers were designed as shown in Figure 2.1 
(A). The 5’ end of each forward oligonucleotide contained “spacer” bases, the chosen 
restriction enzyme sequence and the kozak sequence, GCACC (G: guanine; C: cytosine; 
A: adenine). These were followed by the start codon, ATG (T: thymine) of the leader 
strand (Figure 2.1 A). The “spacer” bases were used to increase the restriction enzyme 
efficiency whereas the Kozak sequence was included to enhance translation efficiency of 
the mRNA (Kozak, 1987). Similarly, the 5’ end of each reverse primer was designed to 
contain the “spacer” bases, a restriction enzyme sequence and a stop codon, TAA (Figure 
2.1B). All primers were supplied lyophilised by Eurofins MWG Operon and dissolved 
following the manufacturer guidelines.  
 
2.2.1.II Polymerase chain reaction (PCR) 
Polymerase chain reaction was carried out using a SureCycler 8800 Thermal Cycler 
(Agilent Technology). 
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Figure 2.1. Design of forward and reverse primers. (A) Forward and (B) reverse primers.  
Spacer bases (orange), enzyme sequence (black), Kozak sequence (red) start codon (blue) gene 
sequence (grey) and stop codon (green). 
 
Taq DNA polymerase (New England Biolabs) was used for analytical PCR and high 
fidelity Herculase II Fusion DNA Polymerases (Agilent Technologies) was used to amplify 
sequences for cloning. PCR reactions were prepared in a final volume of 50 μl in thin 
walled 0.2 ml PCR tubes. Each reaction consisted of DNA template (1-30 ng DNA), 
deoxynucleotide triphosphate mix (25 mM each dNTP), forward and reverse DNA primers 
(0.25 μM each primer), 1X reaction buffer and 1 unit (U) of polymerase enzyme. The 
conditions used for PCR are shown in Table 2.11. The optimal annealing temperature for 
each set of primers was determined using the temperature gradient option on the 
SureCycler 8800 Thermal Cycler. 
2.2.1.III Purification of PCR products 
Amplified PCR products were purified using a NucleoSpin® Extract II kit following 
manufacturer guidelines (MACHEREY-NAGEL). All buffers were supplied with the kit. The 
purified DNA was eluted in 20 µl of milli-Q H2O. 
2.2.1.IV DNA gel electrophoresis 
Agarose gel electrophoresis was generally used to separate and identify DNA fragments 
which were then visualized by staining with ethidium bromide. For this project, 1% 
agarose gels were prepared in 1X TAE buffer (stock solution 50X, per litre: 242 g of Tris, 
57.1 ml of glacial acetic acid and 100 ml of  0.5 M EDTA pH 8.0) containing 0.5 μg/ml of 
ethidium bromide (Severn Biotech Ltd). 2 µl of 6X loading dye (30% (v/v) glycerol and 
0.25% (w/v) bromophenol blue) was added to each DNA sample.   
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A DNA ladder (New England Biolabs Ltd) was used to determine the size of the separated 
DNA fragments. The electrophoresis apparatus was set to run at a 100 Voltage (V) for 
approximately 1 h. The stained gel was analysed and documented using a UV trans-
illuminator (Ingeneous system supplied by Syngene Bio Imaging). 
 
Table 2.11. Optimised cycling conditions for amplification of specific DNA 
fragments  
 
 
 
 
 
 
 
 
 
 
 
 
2.2.1.V Gel extraction and purification of DNA fragments 
DNA fragments to be purified were run on a 1% (w/v) agarose gel containing ethidium 
bromide (Section 2.2.1.IV). DNA migration patterns were visualised using an ultraviolet 
(UV) trans-illuminator and fragments were then excised from the gel using a sterile scalpel 
and weighed (Mettler PE360 Delta Range Balance). DNA samples were purified using 
NucleoSpin® Extract II kit (MACHEREY-NAGEL) following the manufacturers guidelines. 
The purified DNA was then eluted from the silica membrane using milli-Q H2O. 
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2.2.1.VI Restriction enzyme digestion 
Restriction digestions were carried out in a final reaction volume of 20 µl. Each reaction 
consisted of 500-1500 ng of DNA, 1-2 units (U) of restriction enzyme, 1X buffer as 
supplied by the manufacturer and if required 2 µl of 10X bovine serum albumin (BSA). 
Reactions were routinely left to incubate at 37°C for 1-2 h and analysed by ethidium 
bromide-stained agarose gels (Section 2.2.1.IV).  
2.2.1.VII 5’ end dephosphorylation 
Following restriction digestion, the 5’ end of DNA plasmids were dephosphorylated using 
shrimp alkaline phosphatase following the manufacturers guidelines (Promega). This 
treatment prevented relegation of the linearized plasmid. Treated samples were purified 
as described in Section 2.2.1.V. 
2.2.1.VIII DNA ligation 
A number of ligation reactions were set up to clone digested DNA fragments into digested 
and SAP treated plasmid DNA. T4 DNA ligase (New England Biolabs Ltd) was used 
according to manufacturer’s guidelines. A control sample containing vector DNA only was 
also prepared to test the restriction enzyme digestion efficiency. 2 µl of ligation reaction 
was then used to transform 100 µl competent bacteria cells (section 2.2.1.IX).  
2.2.1.IX Transformation of bacteria with plasmid DNA  
Competent bacteria cells (section 2.1.7.III) were transformed following the heat-shock 
protocol (Sambrook & Russell, 2001). 100 µl of cells were defrosted slowly on ice and 5 µl 
of the ligated product (section 2.2.1.IX) was added. Transformed cells were then plated 
onto LB agar plates (section 2.1.7-III) containing ampicillin antibiotic (stock solution: 50 
mg/ml in dH2O; working concentration: 50 μg/ml) and grown overnight at 37°C. 
2.2.1.X Screening bacteria for recombinant plasmids 
Cracking screening was used to screen bacteria colonies for the presence of recombinant 
DNA. Individual colonies (Section 2.2.1.IX) were picked using a sterile tooth pick and 
diluted into 25 µl of sterile dH2O by pipetting. 2 µl of the dissolved bacteria were then 
further diluted into 300 µl of LB media containing the appropriate antibiotic. 25 µl of 
cracking buffer (0.02 M NaOH, 10 mM EDTA, 1X SDS and 10% (v/v) glycerol) was then 
added to the 25 µl of distilled water (dH2O) containing bacteria cells. The reaction was 
quickly mixed and loaded on a 1% agarose gel (Section 2.2.1.IV). Two negative controls 
were included; a self-ligated control and circular parental plasmid DNA.   
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Samples were analysed under UV light for positive colonies as determined by the correct 
band size. Colonies corresponding to the correct DNA size were used to inoculate 5 ml 
bacteria cultures. 
2.2.1.XI Purification of plasmid DNA 
a. Small scale purification (mini-prep) 
Plasmid DNA purification was carried out using GeneJET™ plasmid miniprep kit following 
the manufacturer’s guidelines (Fermentas, Thermo Fisher Scientific Inc). The purified 
DNA was eluted from the columns using milli-Q H2O. 
b. Medium scale purification (midi-prep) 
100 ml of bacteria culture were purified using a midi-prep kit supplied by Qiagen. This 
methodology was similar to the plasmid DNA mini-prep described above. The plasmid 
DNA was eluted and precipitated using 0.7 volumes of isopropanol; DNA pellets were 
then air-dried at room temperature and resuspended in 100 µl of milli-Q H2O. 
2.2.1.XII Plasmid DNA sequencing 
Cloned DNA fragments were sequenced by Geneservice Ltd, Oxford to confirm their 
identity and integrity. Appropriate sequencing primers were designed or obtained from 
Geneservice Ltd. Sequence data was analysed using Gene Doc software V 2.7 developed 
by K. Nicholas (http://www.nrbsc.org/gfx/genedoc/).  
2.2.1.XIII Quantitative gene expression analysis 
Complementary DNA (cDNA) synthesis was performed in a two-step reaction using Cells-
to-cDNA II Kit (Ambion, Life Technologies Ltd) according to the manufacturer’s protocol. 
For reverse transcription a two-step RT-PCR protocol supplied by the manufacturer was 
followed. PCR amplification was performed using 5 µl of RT reaction and carried out as 
described in Section 2.2.1.II. The resulting PCR product was then analysed on a 1% 
agarose gel (Section 2.2.1.IV). 
2.2.1.XIV RT2 profiler™ PCR array 
RT2 Profiler™ PCR array (Arikawa et al., 2011), supplied by SABiosciences, Qiagen 
(PAHS-052), was used to analyse in vitro cellular response to baculovirus transduction. 
Total RNA was extracted using a mirVana miRNA isolation kit (Ambion®, Life 
Technologies Ltd) following the manufacture guideline.   
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The isolated RNA was quantified by measuring its absorbance at 260 nm using a 
spectrophotometer (DU® 730; Beckman Coulter, Inc.) and RNA quality was assessed by 
non-denaturing agarose gel electrophoresis. Briefly, 1X agarose gel (Ambion) was 
dissolved in 1X northern buffer (Ambion) previously treated with diethylpyrocarbonate 
(DEPC)-water. RNA was converted into cDNA using RT2 First Strand kit following the 
manufacturer’s guidelines (SABiosciences, Qiagen).  
The cDNA was loaded into a human innate and adptive immune response 96 well plate 
supplied by SABiosciences, (Qiagen) and amplified using an Applied Biosystems ABI 
7500 cycler. Data was analysed using the manufacturer’s data analysis software 
(http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php).  
Relative gene expression was calculated using the standard ΔΔCt method:  
ΔΔCt = ΔCt (experimental) -  ΔCt (control) 
The fold-change in gene expression was calculated as: 2(-ΔΔCt). 
 
2.2.2 CELL CULTURE TECHNIQUES 
2.2.2.I Insect cell culture 
Sf-9 and Sf-21 cells were maintained at 28°C in Erlermeyer flasks (Corning®) and glass 
Spinner flasks respectively. Sf-9 cells were agitated at 125 rpm using an orbital shaker 
(CERTOMAT® S II, Sartorius Ltd) and Sf-21 cells were cultured in a spinner shaker 
(MCS-104S, Bibby Scientific Ltd). Cell lines were passaged before reaching their 
stationary phase using appropriate medium (Section 2.1.7-I). The seeding density and cell 
viability was determined by trypan blue (0.2% solution) dye exclusion staining using a 
Countess® Automated Cell Counter (Life Technologies Ltd). 
For long term storage, insect cells were frozen in liquid nitrogen. Cells were pelleted by 
centrifugation for 10 min at 500 xg (Heraeus™ Fresco 21, Thermo Scientific). Cells were 
then re-suspended at a final density of 106-107 cells/ml in the required media (Section 
2.1.7-I) supplemented with 20% (v/v) FBS and 10% (v/v) DMSO. Subsequently, 1 ml 
aliquots of the cell suspension was dispensed into cryovials and placed into an 
isopropanol container for controlled cooling (rate 1°C/min; Mr. Frosty, Nalgene). The 
container was then placed into a -70°C freezer overnight. Cryovials containing the cells 
were then transferred to a liquid nitrogen storage tank. For recovery, insect cells were 
removed from the liquid nitrogen tank and rapidly thawed in a water bath at 28°C.   
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Cells were diluted into 10 ml of suitable media (Section 2.1.7-I) and pelleted by slow 
speed centrifugation (10 min at 500 xg). Re-suspended cells were dispensed into a T75 
tissue culture flask (Sarstedt Inc.) and incubated at 28°C. 
2.2.2.II Mammalian cell culture 
All mammalian cell lines were adherent and maintained at 37°C, 5% CO2 in 100 mm cell 
culture dishes (Sarsted Ltd). Cells were passaged when cell density reached 80% of 
confluence. Briefly, cell culture media was removed and cells were washed using 1X PBS. 
Cells were then incubated with 1X of 0.05% trypsin-ethylenediaminetetraacetic acid 
(GIBCO, Life Technologies Ltd) at 37°C for 5 min. Subsequently, pre-warmed medium 
was added to inactivate trypsin and remove EDTA. Cells were centrifuged at 500 xg for 5 
min and re-suspended in fresh media. At this stage cells were distributed into a new cell 
culture dish for sub-culturing or counted and aliquoted for future experimental analysis. 
For long term storage mammalian cells were frozen in liquid nitrogen. Cells were pelleted 
by centrifugation for 10 min at 500 xg (Heraeus™ Fresco 21, Thermo Scientific). Cell 
pellets were re-suspended in 70% (v/v) of medium (section 2.1.7-II), 10% (v/v) DMSO and 
20% (v/v) of FBS. Cells were aliquoted in cryovials and placed in an isopropanol container 
for controlled cooling (rate 1°C/min at -70°C freezer for 24 hours (h). For permanent 
storage the cryovials were transferred to a liquid nitrogen storage tank. Cells were 
recovered by thawing the cryovials at 37°C. Subsequently, cells were washed, centrifuged 
and then re-suspended into a 100 mm dish containing 10 ml of warm complete medium 
(Section 2.1.7-II). 
2.2.2.III Growth and storage of E. coli cells 
XL-1 Blue competent cells were generated using the calcium chloride (CaCl) method 
(Sambrook and Russell, 2001) and stored at -70°C in aliquots of 100 µl. When required, 
XL-1 Blue competent cells were thawed on ice and used to inoculate LB media. Bacterial 
cultures were grown overnight at 37°C in a shaking incubator in the presence of the 
ampicillin antibiotic (stock solution: 50 mg/ml in dH2O; working concentration: 50 μg/ml). 
For short term storage, cultures were stored at 4°C whereas for long term storage, 
bacterial cultures were stored at -70°C as glycerol stocks as follow: 590 µl of bacteria 
cultures were added to 160 µl of 80% glycerol in a 1 ml cryovial and gently mixed. 
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2.2.3 STANDARD BACMAM TECHNIQUES 
2.2.3.I Transfection of cells with DNA 
Transient gene expression and virus generation were carried out in insect cells using the 
liposome formulated transfection reagent Lipofectin® (Invitrogen). Transfections were 
carried out using the protocol supplied by the manufacturer. 
a. Transient gene expression in insect and mammalian cells 
1 µg of DNA was diluted in 100 μl of TC100 media (without FBS) in a 1.5 ml microfuge 
tube. Similar, 5 μl of lipofectin reagent was diluted in 100 μl of TC100 media in a separate 
microfuge tube. Subsequently, DNA and lipofectin were mixed together and left at room 
temperature for 30 min. 800 μl of TC100 was added to the lipofectin-DNA complex mix 
and applied to the cells to be transfected. After the transfection mix was applied to the 
cells, they were incubated for 5 h at 37°C before 1 ml of the relevant media was added to 
the transfected cells.  
 
The gene copy number of transiently transfected cells was calculated using the following 
formula: 
 
 
 
 
b. Virus generation in insect cells 
BacMam viruses were generated by homologous recombination between viral DNA 
(Section 2.1.4) and a transfer vector DNA. Sf-9 insect cells were co-transfected with viral 
DNA (flashBAC ULTRA™ and transfer vector DNA following the manufacturer guidelines 
(Oxford Expression Technologies Ltd). The virus containing supernatant was then 
harvested and stored at 4°C. FBS (5% v/v) was added to the inoculum to improve stability 
during storage. 
  
Number of copies1 =      (amount of DNA in ng) X (6.022x1023 molecules/mole)*  
                                    (length of template in bp) X (ng/g)** X (weight of a bp)*** 
* Avogadro's number 
** ng/g= 1 parts per billion (ppb) = 1X10
9
 
*** The average weight of a base pair (bp) is 650 Daltons 
1
 free-access copy number calculator developed by Staroscik, 2004 
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2.2.3.II Virus amplification  
Virus stocks were amplified in Sf-9 cells as described in King and Possee (1992). The 
virus containing supernatant was aliquoted into sterile tubes, supplemented with 5% (v/v) 
FBS and stored at 4°C. 
2.2.3.III Virus titration  
a. Plaque assay 
BacMam stocks were titrated by plaque assay as described by King and Possee (1992). 
Plaques were visualized by the addition of 1 ml of neutral red (0.5% neutral red stock 
solution was diluted in 15ml 1X PBS). Stained cells were incubated for 5 h at 28°C. The 
liquid overlay was then removed and dishes inverted in the dark to allow the dissipation of 
the colour. Plaques were counted and the virus titre determined using the calculation 
below. 
Plaque forming unit (pfu)/ml = average plaques counted X Dilution factor X10 
b. Quantitative real-time PCR (QPCR)  
QPCR titration was carried out using baculoQUANT ALL-IN-ONE™ (Oxford Expression 
Technologies Ltd) following the manufacturer’s instructions. The purified DNA was loaded 
into a 96-well plate and amplified using an Applied Biosystems ABI 7500 instrumentusing; 
the cycling conditions listed in Table 2.12 
 
Table2.12. QPCR cycling conditions 
 
 
 
On completion of the QPCR cycle programme, the unknown virus titre was calculated 
using Ct values which were calculated by the SDS software. Titres were expressed as 
Qpfu/ml. 
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2.2.3.IV BacMam concentration methods 
a. High-speed centrifugation 
Viral particles harvested with supernatant of infected Sf-9 cell medium were first clarified 
by centrifugation (4550 xg for 20 min at 4°C), then the viral particles were concentrated by 
high-speed centrifugation (Beckman Coulter Inc, J25-I rotor) at 75 600 xg for 1 h. Pelleted 
virus was re-suspended in 1 ml of 1X PBS and left to rest for 16 h at 4°C before were 
collected. 
b. Low-speed centrifugation 
A large volume of viral particles (1.2 litres) were concentrated by low-speed centrifugation. 
This methodology is similar to the high-speed centrifugation described above. BacMam 
viruses were initially harvested from Sf-9 cell by centrifugation (4550 xg for 20 min at 4°C) 
before be concentrated by low-speed centrifugation (Beckman Coulter Inc, JA-14 rotor) at 
25 800 xg for 16 h. Virus pellet was re-suspended in 10 ml of 1X PBS . The concentrated 
virus was left to rest a 4°C for approximately 20 h before were collected.  
2.2.3.V In vitro transduction of mammalian cells 
Mammalian cells (Table 2.10) were seeded at the appropriate concentration and 
incubated overnight at 37°C in a 5% CO2 incubator. The following day, cells were 
transduced with BacMam viruses (Table 2.6) at an MOI of 50-150 pfu/cell and incubated 
at 37°C for 1 h in 5% CO2 incubator. The virus inoculum was then replaced with suitable 
medium (Table 2.10) and cells were returned to 37°C in 5% CO2 incubator for the required 
time. In an experiment to improve transduction efficiency, cells were transduced in the 
presence and absence of different chemicals and transfection reagents (Tables 2.1 and 
2.5, respectively) following the manufacturer’s guidelines. 
2.2.3.VI Ex vivo transduction of porcine kidneys 
Flushed kidney organs (Section 2.1.8) were cannulated and perfused through the renal 
artery with 200 ml of cold Belzer University of Wisconsin (UW) solution (Bridge to Life Ltd) 
with BacMam virus (Group 1) or without virus (Group 2). During transduction, the solution 
was collected and recirculated using a low-speed (10 rpm) peristaltic pump (Watson 
Marlow 505 S, Gemini BV). Both groups of kidney were transduced for 24 h at 4°C. Tissue 
samples were collected using a 10 ml syringe at 0, 4 and 24 h post-transduction (hpt) and 
cells were immediately dissociated enzymatically using collagenase (Sigma-Aldrich Co. 
Ltd).  
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Tissue fragments were minced thoroughly using scalpel blades (Thermo Fisher Scientific 
Inc) and incubated in 1 mg/ml of collagenase enzyme (Sigma-Aldrich Co. Ltd) at 37°C for 
20 min. Cells were sieved sequentially through a 100-μm and 40-μm cell strainer (BD 
Bioscience Ltd) to remove the undigested tissue. The filtered single cell suspension was 
then pelleted (500 xg, 5 min), washed in 1X PBS three times and re-suspended in culture 
medium for further analysis.  
 
2.2.4 PROTEIN ANALYSIS TECHNIQUES 
2.2.4.I Protein sample preparation 
Protein samples from BacMam transduced mammalian cells (Sections 2.2.3.V and VI) 
were harvested, at different time points and analysed by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). Samples were centrifuged at 2000 xg 
for 5 min. Supernatant was discarded and cell pellet re-suspended in 80 µl of 1X PBS and 
20 µl of 5X loading buffer (250 mM Tris-HCl (pH 6.8), 25% (v/v) β-metacaptoethanol, 10% 
(v/v) SDS, 50% (v/v) glycerol and 0.5% bromophenol blue). Prepared samples were 
incubated for 10 min in a boiling water bath (100°C) before being loaded on a 12% SDS-
PAGE gel and electrophoresed using the mini-PROTEAN vertical gel electrophoresis 
system (Bio-Rad). 
2.2.4.II SDS-PAGE gel  
12% SDS-PAGE gels were prepared as described in Sambrook and Russell (2001). 
Samples (section 2.2.4.I) were then loaded and electrophoresed at 100 V during passage 
through the stacking gel and the voltage was then increased to 200 V during passage 
through the resolving gel.  
2.2.4.III Staining SDS-PAGE  
a. Coomassie brilliant blue staining  
Separated proteins (section 2.2.4.II) were visualized using the Coomassie blue staining 
method described in Meyer & Lambert, (1965). For long term storage, stained gels were, 
initially, equilibrated in a gel drying buffer (40% (v/v) methanol, 10% (v/v) glycerol and 
7.5% glacial acetic acid) for 30 min. The equilibrated gels were then placed between two 
cellophane sheets, previously soaked in dH2O. The cellophane sandwich was secured 
within a plastic drying frame (Bio-Rad Inc.) and left to air-dry at room temperature.  
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b. Silver staining 
Proteins fractioned by PAGE gels (Section 2.2.4.II) were visualized using FASTSilver™ 
following the manufacturer’s guidelines (G-Biosciences). All reagents and solutions except 
ethanol, glacial acetic acid and dH2O were supplied with the kit. Images were recorded 
using an EPSON stylus SX105 visible light scanner. 
2.2.4.IV Western blot 
Proteins separated on SDS-PAGE gels (section 2.2.4.II) were transferred onto a 
nitrocellulose membrane (GE healthcare, UK) and analysed by Western blot. Initially, the 
protein gels were incubated in transfer buffer (48 mM Tris, 39 mM glycine, 20% methanol 
and 1.3 mM SDS) for 5 minutes together with the nitrocellulose membrane and filter 
papers as described in Sambrook and Russel (2001). Following the transfer, membranes 
were incubated in 5% milk dissolved in PBST (1X PBS containing 0.1% (v/v) of Tween20) 
and agitated at room temperature for 1 h to prevent non-specific binding. Blocked 
membranes were then treated with the appropriate primary antibodies using the optimized  
dilution for either 30 or 60 min depending on the antibody used (Table 2.7). Subsequently, 
membranes were washed 3X with PBST and incubated with a secondary antibody 
conjugated with alkaline phosphatase for 60 min (Table 2.8). To remove any background, 
membranes were washed 3X with PBST. Bound proteins were visualized using alkaline 
phosphatase buffer (100 mM Tris-HCl (pH=9.5), 100 mM NaCl and 5 mM MgCl) 
containing 66 μl of NBT and 33 μl of BCIP (Table 2.2). The membrane was washed with 
dH2O and any excess liquid was removed using filter paper. Band densitometry was 
carried out using GelQuantNET softwar (BiochemLabSolutions). Statistical analysis was 
performed as described in Section 2.2.43. 
 
2.2.5 MICROSCOPY, IMMUNOFLUORESCENCE/IMMUNOHISTOCHEMISTRY 
TECHNIQUES 
2.2.5.I Fluorescence microscope 
EGFP-positive cells were imaged using an inverted fluorescence microscope (Axiovert 
135, ZEISS) 10X objective. Data were captured using a ProgRes® microscope camera 
(JENOPTIK Optical Systems).  
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a. Quantitative image analysis 
The EGFP fluorescence cells were measured by ImageJ software. Region with the same 
area was drawn around each cell to be measured. For each images, the fluorescence of 
13 EGFP positive cells was calculated. An identical region was also placed in an area 
without fluorescence to be used for background subtraction. The average fluorescence 
intensity in the area of interest was calculated for each measured cells. The following 
formula was used to calculate the corrected total cell fluorescence (CTCF). 
 
CTCF= Integrated Density– (Area of selected cell x Mean fluorescence of background) 
 
Fold change in egfp expression, related to the untreated transduced HEK cells, were 
calculated and plotted on a graph using GraphPad Prism version 5 for Windows 
(GraphPad Software Inc., USA). All parameters during image acquisition and 
quantification were the same. 
2.2.5.II Confocal microscopy 
Transduced BacMam cells (Sections 2.2.3.V and VI) were fixed, at different time points, in 
4% paraformaldehyde solution (Thermo Fisher Scientific Inc.). Adherent cells were grown 
on glass coverslips in 35mm tissue culture dishes supplied by PAA Laboratories Ltd and 
at the required time, cells were washed twice with PBS before being treated for 1 h with 
0.5 ml of 4% (v/v) paraformaldehyde. Suspension cells were harvested by centrifugation 
at 500 xg for 5 min; subsequently, the supernatant was discarded and the cell pellet was 
washed twice in 1X PBS before being fixed with 0.5 ml 4% (v/v) paraformaldehyde. Fixed 
cells where then washed once 1X PBS and re-suspended in 1 ml of fresh PBS. Samples 
were stored at 4°C or processed immediately as follows.  
Fixed adherent samples were washed with 1X PBS containing 1% BSA (Sigma-Aldrich 
Co. Ltd) and 0.1% (v/v) Triton X-100 (Sigma-Aldrich Co. Ltd) which permeabilizes the cell 
membrane. Fixed suspension cells were deposited onto a clear defined area of a glass 
slide (Shandon cyto-spin 3 slides) using CytoSpin centrifuge (Shandon Cytospin 3, 
Thermo Scientific) before being treated with 1X PBS-BSA-Triton X-100. Samples were 
washed twice using 1X PBS and twice with 1X PBS-BSA blocking solution before being 
incubated for 1 h with the appropriate primary antibody (Table 2.7).   
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Cells were then washed three times with PBS-BSA and treated with secondary antibodies 
at the relevant dilution for 60 min (Table 2.8). Any unbound antibody was washed out and 
coverslips were mounted onto microscopy slides using Vectashield (Vector Laboratories), 
a mounting media containing the nuclear label 4',6-diamidino-2-phenylindole (DAPI). A 
clear nail-varnish was used to seal the mounted samples before being stored in the dark 
at 4°C. 
Confocal microscopy was performed on fixed cells and tissue sections using a Zeiss LSM 
510 Meta confocal system using either X40 or X63 oil immersion lens. Multitrack analysis 
was carried out in order to analyse green fluorescence (488nm excitation, band pass filter 
505-530nm), red and blue (DAPI) fluorescence (543nm excitation, long pass filter 560nm 
for red, and 405 excitation, band pass filter 420-480nm for blue). Image data were 
analysed using LSM Image browser software. 
2.2.5.III Histological analysis of kidney tissue  
Transduced and non-transduced porcine kidneys (Sections 2.2.3. VI) were sectioned (5 
mm horizontal and 1 cm vertical) for histological analysis. Paraffin-embedded tissue 
sections are the mostly used technique for immunochemistry and were utilized in this 
project. To preserve morphology, kidney sections were immediately fixed in 4% (v/v) 
formaldehyde and incubated for 3 h at room temperature. Fixed kidney tissues were 
dehydrated by incubating the samples in an increasing concentration of alcohol solutions, 
70%, 90% and two changes of absolute ethanol (100%) of 1 hour each. This ensured that 
all the water was removed. When dehydration was completed, tissues were treated with 
an intermediate fluid that was miscible with ethanol and paraffin, xylene. Xylene was then 
drained off and specimens were placed in a disposable embedding mould to be infiltrated 
with two-three 30 min. changes of paraffin wax-embedding the kidney tissues in paraffin 
wax. Tissue paraffin blocks were sectioned to a thickness of 5 µm using a Spencer 820 
microtome. Sections were collected with forceps and transferred to a 37°C water bath to 
ensure straight edges and the removal of excess wax. Tissues specimens were then 
mounted on positively charged microscope slides (Superfrost® Plus Micro Slide, VWR 
International) and dried in an incubator at 37°C.  
2.2.5.IV Preparation of tissue sections 
To perform histological analysis, paraffin was removed from the surface of the kidney 
sections; tissue sections were incubated twice in xylene for 5 min at room temperature. 
Sections were then rehydrated in 100%, 70% and 30% ethanol solutions for 1 min each.   
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The slides were then washed with dH2O for 5 min before being used in further 
applications.  
2.2.5.V Hematoxylin and eosin (H&E) staining 
Histological specimens of kidney tissue were stained with H&E (Mayer, 1896) following 
manufacturer guidelines (Sigma-Aldrich Co. Ltd). Haematoxylin dye stains basophilic 
structures such as nuclei, ribosomes and rough endoplasmic reticulum a purple/blue 
colour. In contrast, the acidic dye eosin stains eosinophilic structures like cytoplasmic 
proteins a pink/red colour. Stained sections were mounted using Vectashield (Vector 
Laboratories) and examined using an Axioplan microscope (Carl Zeiss microscopy Ltd) 
and images captured using a ProgRes® C3 microscope camera (JENOPTIK Optical 
Systems). 
2.2.5.VI Periodic acid-schiff (PAS) staining 
PAS is a staining method used to detect polysaccharide, glycoproteins, glycolipids and 
tissue basement membranes; the periodic acid oxidises the tissue carbohydrates 
producing a pair of aldehyde groups in each broken monosaccharide ring. Subsequently, 
in the second reaction, the aldehyde groups react with the Schiff reagent staining the 
tissue component to which the carbohydrates are attached (purple-magenta colour). The 
intensity of the colour is related to the concentration of hydroxyl groups present in each 
monosaccharide unit. A basic stain (e.g. haematoxylin) is often used as a counterstain to 
visualize other tissue elements. PAS staining was used to characterise tubular and 
glomerular basement membranes following the manufacturer guidelines. Dehydrated 
tissue sections were mounted using Vectashield (Vector Laboratories). Stained sections 
were examined and imaged as described in H&E stain (Section 2.2.5.V). 
2.2.5.VII Immunohistochemistry of sections 
To detect intracellular proteins, deparaffinised and hydrated kidney sections were 
permeabilised with 1X PBS containing 0.1% (v/v) Triton X-100. Tissue sections were 
blocked in 1X PBS-BSA prior to being incubated in the appropriate primary antibodies for 
60 min at room temeperature (Table 2.7). Slides were washed three times in 1X PBS and 
incubated with the indicated secondary antibodies for 60 min (Table 2.8) at room 
temperature. Finally, any unbound antibody was removed using PBS and sections were 
mounted with Vectashield (Vector Laboratories). Confocal analysis was carried out as 
described in Section 2.2.II  
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2.2.6 ENZYMATIC ASSAYS 
Enzymatic assays were used following the manufacturers guidelines and summarised in 
the Table 2.13. 
 
2.2.7 METHODS TO ANALYSE REPORTER GENES 
2.2.7.I Flow cytometry 
Mammalian cells containing a egfp and their controls were harvested and re-suspended in 
1 ml of 1X PBS. The percentages of EGFP-positive cells was analysed by flow cytometer 
on a Gallios® flow cytometer (Beckman Coulter Inc). Samples were prepared in a 
polypropylene tube (Greiner bio-one) by diluting 0.5 ml of cells in 0.5 ml of IsoFlow sheath 
fluid. Calibration beads (10 μl) were also added to each sample to determine the number 
of cells. A quantitative analysis was carried out using the flow cytometer data; 
transduction efficiency was acquired by comparing the number of fluorescent cells with 
the fluorescence intensity obtained for non-treated control cells 
2.2.7.II Fluorescence plate reader 
Fluorescence cells were harvested and counted before being seeded at a density of 2x105 
cells/ well in a 96-well plate (flat clear bottom with black walls; Corning®). Fluorescence 
was recorded at an excitation wavelength of 485 nm and an emission wavelength of 535 
nm using an Infinite® 200pro microplate reader (Tecan Group Ltd). Data were 
automatically inserted into an Excel Microsoft® file and the mean value of 16 readings per 
well calculated. Data were normalised against control cells. 
Table 2.13. Enzymatic assays used in this study 
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2.1 Statistical analysis  
All data were analysed using GraphPad Prism version 5 for Windows (GraphPad Software 
Inc., USA) with results displayed as mean ± SEM. Each experiment was performed in 
triplicate. Statistical analysis was performed using both one- and two-way ANOVA with a 
Bonferroni post-test that compare replicative mean values, unless otherwise stated. A p-
value of <0.05 was considered statistically significant.  
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3.1 INTRODUCTION  
The ability of BacMam viruses to delivery recombinant genes into mammalian cells is well 
documented (reviewed by Kost et al., 2010; Chatterjee et al., 2013). To date BacMam has 
been widely used for the production of therapeutic proteins and for in vivo / ex vivo gene 
delivery applications (reviewed by Kost et al., 2010; Wang et al., 2010). The production of 
BacMam particles is relatively easy when compared to mammalian viruses; for example, 
BacMam are produced (1x108 to 2x108 pfu/ml) and released into the insect cell culture 
media, unlike adenovirus that requires cell lysis during production (reviewed by Kost et al., 
2010). However, obtaining high purity and high titres (1x1010 pfu/ml) of BacMam are 
critical for its application in gene therapy. The presence of impurities could initiate host 
immune response, leading to unwanted reactions, as well as enhancing or inhibiting 
transduction efficiencies (Tenenbaum et al., 1999; reviewed by Rodrigues et. al., 2007). 
Therefore, the development of an efficient scalable concentration method that allows the 
production of a pure and highly concentrated BacMam virus is of primary importance. 
In the last decade, several methods have been described for purifying and concentrating 
baculovirus (Barsoum, 1999; Wu et al., 2007; Gerster et al., 2013). Ultracentrifugation, 
with or without a sucrose cushion, has been widely used (O’Reilly et al., 1994; reviewed 
by Aucoin et al., 2010). However, this is a time-consuming method and typically, less than 
50% of the infectious material is recovered after the concentration step (O’Reilly et al., 
1994). Furthermore, there are several disadvantages with this method such as small 
volume capacity of high-speed rotors; difficulty in re-suspension of the virus pellet due to 
the presence of impurities (e.g. insect cell debris, cell proteins and host cell DNA); the 
formation of virus aggregates and loss of infectivity due to hydrodynamic shear stress. In 
the last two decades, these limitations have prompted researchers to seek to improve 
baculovirus concentration methods.  
Barsoum (1999) was the first to report the use of a chromatography method, based on a 
cation-exchange resin, to concentrate baculovirus between 25- and 60-fold without 
causing any major virus aggregation (Patent number US 6326183 B1). Duisit et al. (1999) 
showed that baculovirus was able to strongly bind, through electrostatic interactions, to a 
heparin type I-sepharose column; however, because baculovirus fractions were partially 
eluted in 0.5 M NaCl solution and mostly eluted in 1M NaCl they were not infectious in 
insect cells. Two different hypotheses were assumed: 1M NaCl irreversibly inactivated the 
virus or alternatively, high salt fractions could correspond with a heterogeneous population 
of infectious or non-infectious baculovirus (Duisit et al., 1999).   
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Subsequently, other researchers investigated different chromatographic approaches to 
concentrate baculovirus particles, including ion-exchange (Wu et al., 2007; 
Transfiguracion et al., 2011; Grein et al., 2012), affinity (Chen et al., 2009), size exclusion 
and resin-based chromatography (Hu et al., 2003; Transfiguracion et al., 2007) as well as 
using tangential flow ultrafiltration membranes (Michalsky et al., 2009). All of these 
methods varied in a number of aspects such as the mechanism used to concentrate viral 
particles, the initial virus volume used, time required, cost and yield of active baculovirus 
recovered. Therefore, finding the conditions best suited for baculovirus concentration still 
remains a critical step.  
The goal of this study was to identify a reproducible and efficient method to concentrate 
BacMam viruses. To this end a number of small-scale analytical methods were tested, 
including high-speed centrifugation without a sucrose cushion (Beckman Coulter Avanti®, 
J-25I, rotor J-25.5) and polyethylene glycol (PEG, Sigma-Aldrich) with a molecular weight 
(MW) of 4000 Dalton (Da). Additionally, Fast-Trap (Merck) and short monolithic 
chromatographic columns (CIM; BIA Separations) were also evaluated as alternative 
concentration methods. The second objective of this research was to concentrate large 
volumes (1.2 to 2.4 litres) of virus that could produce enough BacMam for ex vivo kidney 
transduction by low-speed centrifugation (Beckman Coulter Avanti® J-25I, rotor JA-14). 
Concentration methods were analysed on the basis of (1) virus recovery yield, (2) purity 
and (3) infectivity in insect cells.  
In this Chapter only high- and low-speed centrifugation methods are presented; whereas, 
PEG, Fast-Trap and CIM concentration methods are included as supplementary data in 
the CD attached to this thesis (Chapter 3-S1, 3-S2 and 3-S3, respectively).  
 
3.2 BACMAM CONCENTRATION BY HIGH-SPEED CENTRIFUGATION  
BacMam viruses were generated (see supplementary data CD attached to this thesis) 
expressing either the egfp or sod-2 gene under the control of the cytomegalovirus-
immediate early (CMV-IE) promoter. Viruses were amplified in Sf-9 cells (Section 2.2.3.II) 
and then titrated by plaque assay (Section 2.2.3.III.a) before being used to assess the 
different concentration methods. QPCR (Section 2.2.3.III.b) was used to measure the viral 
DNA present within the samples; while, plaque assays were carried out to determine the 
yield of active virus after concentration.  
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Recovery and activity yields were calculated by dividing the total number of viral particles 
in the concentrated virus (CV) by that in the original virus (OV) stock used; this value was 
then multiplied by 100 to obtain a percentage (%).  
 
 
 
 
High-speed centrifugation is a quick and easy method for concentration of BacMam 
viruses. In this thesis a centrifugation step, without the need for a sucrose density 
gradient, was developed and optimized (Section 2.2.3.IV.a). 
 
3.2.I Experimental optimization 
To analyse whether long centrifugation periods had a detrimental effect on virus recovery 
yields, BacMam viruses were subjected to different times of centrifugation. Briefly, three 
AcCMV_EGFP samples of 21 ml each were centrifuged at 75600 xg (25 000 rpm) for 1, 4 
and 24 hours (h), respectively (Beckman Coulter Avanti J25-I with J-25.5 rotor). After 
centrifugation the supernatant, devoid of BacMam virus, was discarded into an 
appropriate biohazard waste and a small amount was collected for further analysis. The 
virus pellet (concentrated-pool) was resuspended in 1X PBS, to a final volume of 1 ml, at 
4°C for 16 h before being collected and analysed. A schematic representation of the 
concentration method is shown in Figure 3.1; BacMam virus was harvested and clarified 
from insect cell debris by centrifugation at 4 550 xg for 20 minutes (min) at 4°C (steps 1 
and 2). Subsequently, the clarified BacMam was transferred into a polycarbonate tube 
and concentrated by centrifugation at 75 600 xg (step 3 and 4). The concentrated-pool 
was re-suspended and virus titre analysided by QPCR and plaque assay (step 5). 
Figure 3.2 shows the results of the recovery yields and virus infectivity over-time for the 
concentrated AcCMV_EGFP. Results obtained by QPCR analysis (Figure 3.2 A) indicated 
that 1 h of high-speed centrifugation efficiently pelleted BacMam, 98% of virus was 
recovered (Figure 3.2 A, 1 h), compared to the virus stock prior centrifugation (100%). A 
total titre of 2.22x106 Qpfu/ml (QPCR plaque forming unit per millilitre), less than 1%of the 
AcCMV_EGFP virus, from the original stock, was found to remain in the supernatant after 
the centrifugation (data not shown).   
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However, QPCR titration of the concentrated pool, after either 4 h or 24 h high-speed 
centrifugation, resulted in a significantly decreased recovery yield, 49% and 50% 
respectively (Figure 3.2 A, 4 and 24 h), when compared to pre-concentrated 
AcCMV_EGFP and AcCMV_EGFP centrifuged for only 1 h (F (3, 18)= 11.94; p= 0.0002). 
Harvested supernatants were also analysed for the presence of AcCMV_EGFP virus 
where 1 and 12%, respectively, were found to still be present following centrifugation 
(data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Schematic representation of BacMam concentration using high-speed 
centrifugation. (1) Sf-9 cells were infected with BacMam virus at multiplicity of infection (MOI) 0.1 
in order to elicit the release of viral particles into the cell medium. (2) Five days post-infection, the 
virus-containing medium was collected and clarified by centrifugation (4 550 xg, 20 min at 4°C). (3) 
The virus-containing supernatant was aliquoted into a 50 ml polycarbonate centrifuge tubes; the 
virus was then concentrated by centrifugation (75 600 xg at 4°C). (4) After high-speed 
centrifugation, the virus pellet (concentrated-pool) was resuspended in 1X PBS whilst the 
supernatant was discarded. (5) The concentrated BacMam virus was titrated by QPCR and plaque 
assay.  
 
Plaque assay analysis was performed to determine the amount of active virus after 
concentration. Figure 3.2 B, shows that AcCMV_EGFP infectivity decreased to 
approximately 70% after 1 h of high-speed centrifugation compared to the pre-
concentrated virus stock (100%) and that extending the centrifugation time to 4 and 24 h, 
did not further decrease infectivity (71 and 65%, respectively). These recovery yields were 
not statistically significant (F (3, 8)= 2.141; p=0.17). Furthermore, plaque assay analysis of 
the supernatants, harvested from 1 h, 4 h and 24 h centrifugation runs, detected almost 
no virus presence; 1% or less (data not shown).   
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Overall, these results suggested that centrifugation at 75 600 xg for 1 h results in a 30% 
loss of the virus and increasing centrifugation time did not result in more losses. 
Importantly, no statistical difference was found between QPCR and plaque assay results 
when compared to each other (F (5, 22)= 4.588; p >0.05). From this preliminary study, 1 h 
of high-speed centrifugation was selected as the optimal time of concentration for use in 
subsequent studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. Time course concentration of AcCMV_EGFP using high-speed centrifugation. 
The AcCMV_EGFP recovery and infectivity yield were evaluated pre- and post-concentration using 
(A) QPCR and (B) plaque assay. Bars represent mean ± standard error (SEM; n=5) of results from 
a single experiment; *p= 0.0002 indicates a significant difference between 1 h high-speed 
centrifugation and 4 and 24 h centrifugation (one-way ANOVA). 
 
3.2.II Validation of optimized concentration conditions  
AcCMV_EGFP and AcCMV_SOD-2 were used to validate the optimized concentration 
method described above Three aliquots of 19 ml for each virus were used in three 
independent experiments as describe on Section 3.2.I. The collected virus pellets were 
then resuspended in 1X PBS and then analysed by QPCR and plaque assay. The virus 
titres, recovery and infectivity yields are shown in Table 3.1.  
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The average titres obtained by QPCR analysis for AcCMV_EGFP and AcCMV_SOD-2 
after concentration were 4.1x109 Qpfu/ml  and 3.7x109 Qpfu/ml with recoveries of 84% and 
81%, respectively (Table 3.1 A). Moreover, QPCR analysis detected less than 1% of viral 
particles, in the supernatant harvested after centrifugation (Table 3.1 A). These results 
were not statistically different (F (2, 11)=1.143; p=0.3540) from those observed in the 
optimization study (Section 3.2.I). Subsequently, virus activity was confirmed by plaque 
assay analysis. The total yields after concentration were 2.33x109 pfu/ml for 
AcCMV_EGFP and 2x109 pfu/ml for AcCMV_SOD-2, this corresponded to an infectivity 
yield of 61.4% and 52.6%, respectively (Table 3.1 B). However, no active viral particles 
were observed when Sf-9 cells were infected with the supernatant harvested after 
centrifugation (Table 3.1 B). 
In conclusion, statistical analysis demonstrated that recovery and infectivity yields were 
significantly different when compared to each other by one-way ANOVA (F (3,12)= 8090; 
p<0.0001). 
 
Table 3.1. BacMam virus concentration by high-speed centrifugation. 
 
 
 
 
 
 
 
 
 
 
 
* Each value represents the average of three replicative samples of a single experiment. 
 
3.2.III One-step virus growth analysis 
Once the concentrated BacMam viruses, AcCMV_EGFP and AcCMV_SOD-2 (Section 
3.2.II), were accurately titered (Sections 2.2.3.III.a and b), it was necessary to carry out a 
growth curve analysis.   
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The purpose of this single experimental study was to determine whether or not BacMam 
concentration by high-speed centrifugation had a detrimental effect on virus infectivity and 
replication. To avoid any confusion, pre-concentrated BacMam were called 
AcCMV_EGFP and AcCMV_SOD-2 and were included as controls; whereas, 
concentrated BacMam were designated AcCMV_EGFP/C and AcCMV_SOD-2/C. One-
step growth analysis was carried out by the addition of each BacMam virus to triplicate 
cultures of Sf-9 cells (20 ml) using an multiplicity of infection (MOI) of 5. Triplicate samples 
for each culture were collected at 0, 6, 12, 24 and 48 hours post-infection (hpi). Virus 
production at each time point was then analysed by QPCR (Section 2.2.3.III.b).  
The growth curve for AcCMV_EGFP vs. AcCMV_EGFP/C (Figure 3.3 A) indicated that 
budded virus (BV) production increased exponentially between harvest times. The growth 
profile of AcCMV_EGFP/C mimicked that of AcCMV_EGFP at 12 hpi. However, a slight 
increase in BV production was detected between 24 and 48 hpi in the control virus 
AcCMV_EGFP (1.39x108 Qpfu/ml and 2.4x108 Qpfu/ml, respectively) compared to 
AcCMV_EGFP/C (7x107 Qpfu/ml and 1.5x108 Qpfu/ml, respectively). Overall, there was 
approximately a two-fold increase in the titre of the non-concentrated virus; the difference 
in BV production was significantly different at 24 and 48 hpi (F (4, 59)= 256.43; p<0.0001).  
 
 
. 
 
 
 
Figure 3.3. Virus growth curve analysis of AcCMV_EGFP and AcCMV_SOD-2 after 
concentration by high-speed centrifugation. Sf-9 cells seeded at 2 x 10
6
 cells/ml were infected 
with either AcCMV_EGFP and AcCMV_EGFP/C (A) or AcCMV_SOD-2 and AcCMV_SOD-2/C (B) 
at an MOI of 5 and budded virus (BV) samples were harvested at 0, 6, 12, 24 and 48 hpi. BV titres 
were estimated using QPCR (n=3) and error bars are indicated (mean ± SEM).  
 
Similarly, the growth profiles of AcCMV_SOD-2 and AcCMV_SOD-2/C demonstrated an 
exponential increase between 0 and 48 hpi (Figure 3.3 B). Both growth curves showed the 
same pattern of BV production between 0 and 12 hpi although following this time point 
virus production increased for AcCMV_SOD-2.  
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 The growth curves showed that at 24 and 48 hpi AcCMV_SOD-2 was generated at titers 
of 7.7x107 Qpfu/ml and 1.8x108 Qpfu/ml; while, titers of 1.7x107 Qpfu/ml and 1.3x108 
Qpfu/ml were obtained for AcCMV_SOD-2/C. Two-way ANOVA analysis of raw data 
showed no significant difference in virus production between the two viruses at 0, 6 and 
12 hpi (p>0.05); however, they were statistical different at 24 and 48 hpi (F (4, 59)= 
256.43; p<0.0001).  
 
3.3 LOW-SPEED CENTRIFUGATION FOR CONCENTRATION OF LARGE VOLUMES 
OF BACMAM VIRUS 
The increased interest in BacMam for ex vivo / in vivo gene delivery applications requires 
an efficient method to produce large volumes of purified and concentrated virus. Indeed, 
long-term viral stability, high purity and high titres are required for in vivo applications. The 
goal of this study was to evaluate a BacMam concentration protocol on a scale suitable to 
obtain high viral titres for porcine kidney transduction whilst minimizing virus loss (Section 
2.2.3.IV.b). 
Different volumes of AcCMV_EGFP were used in this study and the utility of a low-speed 
centrifugation procedure to concentrate BacMam virus was investigated. AcCMV_EGFP 
viral particles, harvested from infected Sf-9 cells, were clarified by centrifugation (4 550 xg 
for 20 min at 4°C) before being pelleted by low-speed centrifugation at 23 000 xg (12 000 
rpm) for 16 h (Avanti® J-25 I, JA-14 rotor; Beckman culture). Following centrifugation, the 
supernatant (devoid of BacMam virus) was harvested for further analysis whilst the virus 
pellet was re-suspended in 1X PBS (1-15 ml). The concentrated virus pellet was 
resuspended at 4°C for approximately 20 h. Plaque assays were then carried out to 
determine virus titre; yields were calculated using the formula illustrated in Section 3.2. 
Table 3.2 shows AcCMV_EGFP recovery results from four independent experiments.  
Less than 1% of active virus was detected in the supernatant fractions in all four tested 
volumes (Table 3.2, A, B, C, D) suggesting that BacMam particles were efficiently 
concentrated. However, recovery yields were variable, ranging from 38% to 63.5% after 
concentration. As shown in Table 3.2 A, when 250 ml of virus suspension was used to 
concentrate AcCMV_EGFP (1.3x108 pfu/ml), 38.5% of the viral particles were recovered 
with a titre of 1.25x1010 pfu/ml and only a small amount of active viral particles were 
detected in the supernatant sample (0.08%).   
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The average starting titre of 400 ml of AcCMV_EGFP, in the second experiment, was 
2x108 pfu/ml (Table 3.2 B). Following concentration, viral titre was an average of 
2.18x1010 pfu/ml in a volume of 2 ml, resulting in a recovery of 54.4% (Table 3.2 B). 
Further analysis of supernatant, harvested after centrifugation, indicated that 0.3% of 
particles were retained.  
 
Table 3.2. AcCMV_EGFP concentration by low-speed centrifugation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A BacMam volume of 1200 ml showed a recovery of 50% following centrifugation and 
approximately 61-fold increase in virus titre, from 1.8x108 pfu/ml to 1.09x1010 pfu/ml 
(Table 3.2 C). Almost no BacMam activity (0.1%) was detected in supernatants (Table 3.2 
B).   
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Subsequently, for the final experiment AcCMV_EGFP volume was increased to 2400 ml. 
As shown in Table 3.2 D, more than half of the starting virus particles were recovered 
(60.6%) in a volume of 15 ml, with an average tire of 1.05x1010 pfu/ml; this corresponded 
to 95-fold increase above the starting AcCMV_EGFP titre (1.1x108 pfu/ml). One-way 
ANOVA analysis of AcCMV_EGFP recovery yields revealed no statistical difference in 
virus recovery amongst the four experiments (F (3, 5) = 4.981; p=0.0581). 
 
3.4  PURITY ANALYSIS OF CONCENTRATED BACMAM SAMPLES 
The purity of the concentrated AcCMV_EGFP obtained from both high-speed and low-
speed (1200 ml) centrifugation (Sections 3.2 and 3.3) was determined by SDS-PAGE 
analysis (Section 2.2.4.II) and silver staining (Section 2.2.4.III.b). Virus identification was 
performed by western blot analysis (Section 2.2.4.IV) using antibodies against either the 
virus envelope protein (anti-GP64) or the capsid protein (anti-VP39) (Section 2.1.5, Table 
2.6). A non-concentrated AcCMV_EGFP virus was included as a control to compare the 
purity of the concentrated virus and to confirm the presence of specific-baculovirus 
proteins (GP64 and VP39). Briefly, concentrated and non-concentrated AcCMV_EGFP 
viruses were denatured by boiling in 1% loading buffer (Section 2.2.4.I) and 1x106 pfu/ml 
of viral particles were separated on a 12% SDS-PAGE gel. Subsequently total proteins 
were visualized by silver staining according to the manufacturer guidelines. The SDS-
PAGE profile is shown in Figure 3.4. 
As expected, numerous bands were detected in the non-concentrated sample (Figure 3.4 
A, lane 2); one major band with molecular weight between 55 kDa and 75 kDa was 
visualized corresponding to GP64. In contrast, the host cell proteins were absent in 
AcCMV_EGFP concentrated by high-speed centrifugation (Figure 3.4 A, lane 3). As 
shown in Figure 3.4 A: lane 4, a number of bands are also visible in the sample 
concentrated by low-speed centrifugation; these are comparable to the non-concentrated 
AcCMV_EGFP virus (Figure 3.4 A, lane 2). Based on the SDS-PAGE profile of 
concentrated BacMam, two main proteins were detected with molecular weights of 64 kDa 
and 39 kDa (illustrated in Figure 3.4 by the arrows). 
Supernatants harvested after centrifugation were also analysed by SDS-PAGE (Figure 3.4 
B). One major band, with a molecular weight between 55-75 kDa, was detected in the 
supernatant obtained after high-speed AcCMV_EGFP centrifugation (Figure 3.4 B, lane 
2).   
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Whereas more protein bands were detected in the supernatant harvested after virus 
concentration by low-speed centrifugation (Figure 3.4 B, lane 3). These proteins may be 
related to the host cells, to the medium (e.g. fetal bovine serum; FBS) or to the virus itself.  
A western blot analysis was performed to confirm the identity of the 64 kDa and 39 kDa 
protein bands observed in the silver-stained SDS-PAGE gel. Samples were loaded on a 
12% SDS-PAGE gel and then transferred onto a nitrocellulose membrane. Proteins were 
detected with BacMam specific antibodies, anti-GP64 and anti-VP39, labelled with 
alkaline phosphatase (Section 2.1.5, Table 2.6). Figure 3.5 shows the western blot 
analysis profile of non-concentrated and concentrated AcCMV_EGFP samples.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4. Silver-stained SDS–PAGE analysis of concentrated AcCMV_EGFP. (A) SDS-
PAGE profile of concentrated AcCMV_EGFP; lane 1, PageRuler Plus Prestained Protein Ladder; 
lane 2, non-concentrated AcCMV_EGFP control; lane 3, high-speed and lane 4 low-speed 
centrifuged AcCMV_EGFP. Arrows indicate the size of GP64 and VP39. (B) SDS-PAGE profile of 
supernatant harvested after AcCMV_EGFP concentration. Lane 1, PageRuler Plus Prestained 
Protein Ladder; lane 2, supernatant after high-speed centrifugation and lane 3, supernatant after 
low-speed centrifugation.   
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Western blot analysis confirmed the presence of BacMam proteins with their correct 
molecular weights (Figure 3.5). Immunoblotting with anti-GP64 identified a ~64 kDa band 
representing the GP64 envelope protein (Blissard, & Rohrmann, 1989) in both 
concentrated AcCMV_EGFP samples (Figure 3.5 A, lanes 3 and 4); however, only the 
lower edge of the band was visualized in the non-concentrated virus (Figure 3.5 A, lane 
2). As illustrated in Figure 3.5 B by the arrow, the anti-VP39 antibody also recognized a 
~39 kDa band corresponding to VP39 protein in the non-concentrated and concentrated 
BacMam (Figure 3.5 B; lanes 2, 3 and 4). The relative intensity of GP64 and VP39 were 
quantified by densitometry and data are shown in Figure 3.5 (above the western blot). As 
shown in Figure 3.5 A, the expression levels of the envelope protein were 63% and 22% 
for the AcCMV_EGFP concentrated by high-speed centrifugation (lane 3) and low-speed 
centrifugation (lane 4) respectively. While, the relative intensity of GP64 in the non-
concentrated virus sample was also quantified (the lower edge) and was found to be 6% 
(Figure 3.5 A; lane 2). Densitometry analysis indicated comparable VP39 expression 
levels between the non-concentrated virus and the high-speed viral preparation (Figure 
3.5 B lane 2 vs. lane 3) with band intensities of 36.9% and 39%, respectively.  
 
3.5 DISCUSSION 
During the last decade, the increased use of BacMam as a gene delivery vehicle has 
required the development of more efficient methods for virus purification and 
concentration. Indeed, the use of BacMam for gene therapy applications is dependent on 
its purity and usually requires high doses of virus in order to achieve a therapeutic effect 
(Vicente et al., 2009). The vast majority of studies to date have utilized purification and 
concentration protocols based on ultracentrifugation and chromatography (reviewed by 
Aucoin et al., 2010). Therefore, the initial part of this research study evaluated the ability 
of a number of techniques to generate a high titre BacMam stocks in small analytical 
volumes such as high-speed centrifugation for use in in vitro transduction studies. In vivo 
applications may require larger amounts of BacMam virus e.g. for repeated applications of 
virus or require higher concentrations of virus to ensure efficient gene delivery and 
expression. Therefore, low-speed centrifugation was also evaluated as a large capacity 
method of concentration. The two different methods are discussed below. 
3.5.I BacMam concentration by high-speed centrifugation  
Centrifugation steps have been routinely used to concentrate viral particles from different 
sources (O’Reilly et al., 1994). In particular, high-speed centrifugation has been reported 
for the concentration of BacMam (Condreay et al., 1999).  
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Condreay et al. (1999) generated a BacMam virus containing gfp under the control of the 
CMV-immediate early (IE) promoter which was concentrated by centrifugation at 35,000 
xg for 60 min. The pelleted virus was re-suspended in PBS supplemented with 1% 
(vol/vol) FBS. Similarly, they used the concentrated virus in transduction experiments and 
demonstrated high levels of GFP in a number of cell lines. However, Condreay and 
colleagues (1999) did not quantifiedquantify the recovery yield of active virus following 
concentration. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. Western blot analysis of concentrated AcCMV_EGFP using three different 
concentration methods. Expression levels of GP64 (A) and VP39 (B). Lane 1, PageRuler Plus 
Prestained Protein Ladder. Lane 2, non-concentrated AcCMV_EGFP included as a control. 
AcCMV_EGFP concentrated by: lane 3, high-speed centrifugation; lane 4, low-speed 
centrifugation. Densitometry analysis of western blot results (n=3) was performed and data are 
shown as means ±SE (above western blot). Western blots were stained with anti-GP64 and anti-
VP39 primary antibodies and alkaline phosphatase conjugated anti-mouse IgG secondary 
antibody. Arrows indicate GP64 and VP39.  
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Philipps et al. (2005) described the centrifugation of a recombinant baculovirus, carrying 
gfp under the control of the AcMNPV basic protein promoter (p6.9), for 1 h at 45,000 xg 
(~22000 rpm). The resulting virus pellet was re-suspended in 1 ml of PBS and recovery 
yield calculated by end-point dilution method. They showed that the concentrated retained 
similar levels of infectivity compared to the starting material (64.5%) with a 28-fold 
increase in viral titre. Based on these reports, three different times of centrifugation were 
evaluated and compared in this study. Based on both QPCR and plaque assay data, an 
average of 70-98% of AcCMV_EGFP was recovered after 1 h of centrifugation, while 49-
71% of virus was recovered after 4 h of centrifugation (Figure 3.2). Increasing the time of 
centrifugation, from 4 to 24 h, showed 50-65% recovery of AcCMV_EGFP virus (Figure 
3.2). However, the recovery yields obtained with the three different centrifugation times 
were not significantly different from each other which was consistent with previous reports 
(e.g. Philipps et al.,2005). Moreover, the recovery yields obtained in this study were 
similar to the 64-71% recovery reported by Transfiguracion et al. (2007) following 
ultracentrifugation (37,000 ×g for 3.5 h) on a 25% sucrose cushion.  
Active virus was present in the supernatant samples harvested from all three 
centrifugation times tested, with an average titre of 2.5x105 pfu/ml, corresponding to <1% 
of virus from the starting material (data not shown). These observations were in 
accordance with previous reports. Philipps et al. (2005) showed that approximately 1% of 
the BacMam particles were found to remain in the supernatant fraction after 
centrifugation. 
Following ultracentrifugation, approximately 30% of virus was lost which could be 
explained by the irreversible formation of virus aggregates. Aggregation of viral particles 
remains one of the major problems in the purification and concentration of viruses 
(Barsoum, 1999; Transfiguracion et al., 2007; Vicente et al., 2009). To circumvent this 
disadvantage a number of strategies have been developed in the last decade; these have 
included the use of a 25% sucrose cushion and non-ionic detergent during the 
ultracentrifugation step (O’Reilly et al., 1992; Transfiguracion et al., 2003; Kato et al., 
2011).  
Based on the preliminary experiments shown in Figure 3.2 and in accordance with 
previous studies, it was speculated that 1 h high-speed centrifugation should be sufficient 
to obtain high-titre BacMam stocks. Recovery yields after concentration ranged between 
61-84% for AcCMV_EGFP, and between 52-81% for AcCMV_SOD-2 (Table 3.1).   
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Both viruses showed a similar recovery yield, although yields obtained by QPCR (84% 
and 81%, respectively) were higher than those obtained by plaque assay (61.4% and 
52.6%, respectively). This likely reflects the tendency of QPCR to overestimate virus titres 
by including non-infectious virus DNA and the tendency of plaque assays to under 
estimate titres, due to inherent virus particle loss e.g. by adhering to plastic ware. 
Statistical analysis between QPCR and plaque assay results showed them to be 
significantly different. However, the recovery yields obtained in this study were not 
dissimilar to recovery yields reported in the literature when high-speed centrifugation, ion-
exchange chromatography, ultracentrifugation with sucrose cushion and cross-flow 
ultrafiltration were used to concentrate BacMam viruses (Barsoum, 1999; Philipps et al. 
2005; Transfiguracion et al., 2007; Vicente et al., 2009).  
A growth curve analysis was performed to determine whether high-speed centrifugation 
had any detrimental effect on virus infectivity. BV production of AcCMV_EGFP/C 
(concentrated virus) and AcCMV_EGFP (non-concentrated virus) increased exponentially 
between 0 and 48 hpi (Figure 3.3 A). Statistical analysis showed a significant difference in 
BV production of AcCMV_EGFP with an increase of approximately 2-fold when compared 
to AcCMV_EGFP/C at 24 and 48 hpi. As shown in Figure 3.3 B, BV production of 
AcCMV_SOD-2/C showed a similar pattern to that seen in the growth analysis of 
AcCMV_EGFP/C (Figure 3.3 A). Production of BV of AcCMV_SOD-2/C mimicked that of 
AcCMV_SOD-2, with an exponential increase between 0 hpi and 48 hpi. However, 
ANOVA analysis revealed a statistical difference between the two viruses at 24 and 48 
hpi. Therefore, the concentrated BacMam, described in this study had slightly reduced 
infectivity compared to non-concentrated virus. This decreased production may be due to 
shear stress during centrifugation reducing BV stability. However, little is known about the 
effect of shear force on viruses (Summers & Volkman, 1976; Michalsky et al., 2008). 
The data obtained in this study demonstrated that ultracentrifugation is a reproducible 
process; recovery yields obtained were within the same order of magnitude as those of 
published reports further confirming process robustness. Furthermore, these results 
supported the previous assumption that high-titre BacMam stocks can be easily generated 
with this procedure. However, the amount of virus that can be processed by this method is 
limited by the low volume capacity of high-speed centrifuge rotors.  
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3.5.II Low-speed centrifugation for concentration of BacMam virus  
Successful concentrations of animal viruses have been achieved using large culture 
volumes; for example, volumes in excess of 1000 ml of lentivirus have been concentrated 
with recovery up to 70% by overnight (16 h) low-speed centrifugation (reviewed by 
VandenDriessche et al., 2002).  
In this study, a modified method based on low-speed centrifugation (developed by Prof. 
Robert Possee, NERC Centre for Ecology and Hydrology, Oxford, UK) was evaluated for 
the production of high-titre BacMam stocks. This method allowed volumes of virus higher 
than 1 litre (L) to be concentrated using a standard low speed centrifuge. Plaque assays 
were performed on the supernatant fractions from the centrifuged samples confirming that 
almost all of the active BacMam virus was pelleted; containing less than 1% virus. Results 
demonstrated that 39-61% of active AcCMV_EGFP was recovered amongst the tested 
volumes (Table 3.2). Although 40% to 60% of virus was lost, this viral concentration 
protocol consistently increased the titre of AcCMV_EGFP by ~100-fold (1x1010 pfu/ml).  
These data are comparable to the recovery yields obtained with enveloped retroviruses 
and lentiviruses. Prachař et al. (1988) were the first to report a successful concentration of 
retroviruses, from volumes of up to 6 L, by low-speed centrifugation. An average titre 
between 1.3x1010 and 1.2x1012 cfu/ml (colony-forming units per millilitre) was obtained 
following retrovirus concentration by low-speed centrifugation (6000 xg for 16 h), with 
recovery ranging from 87% to 92% (Nanmoku et al., 2003).  
This method is particularly relevant for ex vivo gene delivery studies where transduction of 
large solid organ requires high-titre BacMam in low volumes in order to reach maximum 
transduction efficiencies.  
3.1 Assessment of BacMam purity 
Viral purity was assessed after AcCMV_EGFP concentration with methods discussed in 
Sections 3.2 and 3.3. For this purpose, silver stained SDS–PAGE, western blot and 
densitometry analysis were used. The protein profile illustrated in Figure 3.4 A, revealed 
the presence of a 64 kDa and a 39 kDa band which represented the envelope and capsid 
proteins of baculovirus, respectively. The molecular weights of these proteins 
corresponded to the proteins described in previously published studies (Transfiguration et 
al., 2007; Wu et al., 2007; Gerster et al., 2013).   
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In these studies, purified wild-type and recombinant baculovirus were analysed by SDS-
PAGE and proteins with apparent molecular weights of 64 and 39 kDa were identified, 
correlating to GP64 and VP39 proteins. Additional proteins band were visible in 
AcCMV_EGFP preparations after low-speed centrifugation (Figure 3.4 A, lane 4) in 
comparison to the concentrated virus obtained after high-speed centrifugation (Figure 3.4 
A, lane 3). The reduced number of proteins band demonstrated the high purity of the viral 
preparation (Figure 3.4 A, lane 3).  
A major band was visible in the non-concentrated AcCMV_EGFP, migrating between 55 
and 75 kDa (Figure 3.4 A, lane 2). The bovine serum albumin (BSA) protein represents 
the major component of FBS, which is routinely added to a concentration of 5% (v/v) to 
virus stocks. From this observation, it was assumed that this strong protein band 
represented GP64 that co-migrates with the BSA protein (~69 kDa) present in the viral 
solution. Furthermore, the non-concentrated AcCMV_EGFP virus (control virus) served as 
a positive control for the detection of both GP64 and VP39 viral proteins; the presence of 
these proteins was used to characterize the BacMam samples obtained from high- and 
low-speed concentration. Only the lower edge of GP64 was detected in the control virus 
(Figure 3.5 A, lane 2) and based on the previous stated observation, it was suggested that 
the GP64 antigenic epitope, necessary for antibody recognition, was physically obscured 
by the overlapping BSA protein. Western blot analysis, using anti-GP64 antibody, of 
supernatant harvested following AcCMV_EGFP concentration also confirmed that the 
intensive band of 55-75 kDa observed in the SDS-PAGE gel (Figure 3.4 B) was not the 
virus envelope protein and therefore, it was assumed to be the BSA protein. This was 
supported by the observation made by Gerster et al. (2013). They detected a strong band 
which migrated to the same distance of GP64 in fractions from starting material and flow-
through after CIM® QA baculovirus purification. They identified this band as BSA protein 
using mass spectrometry. 
The purified and concentrated BacMam viruses were identified by confirming the 
presence of the two viral proteins in all sample preparations; this was achieved by the use 
of antibodies against GP64 (Figure 3.5, A) and VP39 (Figure 3.5, B). These results are in 
accordance with those obtained from previous baculovirus concentration and purification 
studies (Transfiguration et al., 2007). Transfiguration et al. (2007) performed western blot 
analysis following BacMam concentration and size-exclusion chromatography (SEC) 
purification; a 64 kDa band was confirmed to be the GP64 envelope protein.   
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In conclusion, concentration methods were assessed for their ability to produce high-titre 
BacMam stocks. Both methods were successful to varying degrees and concentrated 
BacMam viruses maintained their infectivity. The concentrated virus fractions were easily 
re-suspended in a serum-free medium and relatively pure viral stocks were obtained. 
Therefore, it was decided to utilize high-speed centrifugation method for the in vitro 
experiments described in Chapter 5. Low-speed centrifugation was the method of choice 
for obtaining the high-titre virus stocks that were needed for the ex vivo study described in 
Chapter 6 of this thesis. 
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4.1 GENERAL OVERVIEW 
Transient gene expression is a widely used method for the rapid production of 
recombinant proteins for in vitro study and ex vivo/ in vivo therapeutic applications. To 
date, recombinant protein production still remains an important cornerstone for research in 
biopharmaceutical companies and academia. During the last two decades, significant 
improvements have been made in delivering therapeutic exogenous genes to different 
target cells (reviewed by Bouard et al., 2009). However, interest has progressively 
increased over recent years in developing new approaches for enhancing therapeutic 
gene expression levels and efficacy (reviewed by Assenberg et al., 2013).  
The mammalian expression system is an attractive option compared to other systems 
(Majors et al., 2008) and the most commonly used mammalian cell lines for transient gene 
expression comprise COS (fibroblast-like cell line derived from monkey kidney tissue), 
BHK (baby hamster kidney), CAP-T (human amniocyte-derived cells) and avian EB66 
(duck embryonic stem cell-derived), as well as HEK (human embryonic kidney) and CHO 
(Chinese hamster ovary) cells (Brown & Mehtali, 2010; Geisse & Voedisch, 2012; 
reviewed by Assenberg et al., 2013). In particular, viral vectors have been extensively 
used for transient gene expression, these include vectors derived from retrovirus, 
adenovirus, adeno-associate virus (AAV) but also from baculovirus (BacMam) (Condreay 
et al., 1999; Sarkis et al., 2000; reviewed by Jin et al., 2014). However, the efficacy of the 
virus-mediated transgene expression is limited by a number of factors including the initial 
contact of the virus with the target cells, transport of the viral DNA to the host nucleus and 
subsequent recombinant gene expression (reviewed by Bouard et al., 2009).  
Previously, a number of studies investigated whether chemical compounds such as 
histone deacetylases inhibitors (HDACis), DNA synthesis and topoisomerase inhibitors 
could enhance in vitro virus gene transfer and expression in mammalian cells (Russell et 
al., 1995; Mizuno & Yoshida, 1998; Zhang et al., 2012; Gosnell et al., 2014). Therefore, 
based on published studies, four chemical compounds (hydroxyurea, etoposide, 
protamine and cycloheximide) were chosen and evaluated, as novel agents to augment 
exogenous gene expression in BacMam transduced HEK293 cells. Furthermore, sodium 
butyrate has been previously demonstrated to markedly enhance BacMam-mediated gfp 
expression in CHO cells (Condreay et al., 1999); thus, its effect on transgene expression 
was also evaluated in this study and used as a positive control for increased fluorescence. 
Chemical compounds effects were also evaluated on BacMam-mediated transgene 
expression in CHO cells and results are included as supplementary data in the CD 
attached to this thesis (Chapter 4-S3).   
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4.2 HEK293 CELL TRANSIENT GENE EXPRESSION: PARAMETER OPTIMIZATION 
The effect of different chemical treatments (Chapter 2, Table 2.1) on BacMam-mediated 
transgene expression was evaluated in HEK293 cells. Preliminary experiments aimed to 
identify the optimal chemical concentration; therefore, cells were either pre-incubated 
overnight with different concentrations of hydroxyurea (5, 20, 40, 75 and 100 mM), 
etoposide (0.5, 1.5, 3, 4.5 and 10 µM) or 3 h prior-transduction with cycloheximide (1, 5, 3 
and 5 µg/ml). Treated cells were then transduced with AcCMV_EGFP at a MOI 50 and 
incubated for 24 hpt. HEK293 cells were also transduced with AcCMV_EGFP virus in the 
presence of different concentrations of protamine (0.5, 5, 10, 50 and 100 µg/ml).  
Controls included cells with medium supplemented with 10 mM of sodium butyrate 
followed by transduction with AcCMV_EGFP (MOI 50). Furthermore, mock-transduced 
(no virus) and untreated (no chemical) AcCMV_EGFP transduced cells were included as 
controls. At 24 hpt, treated and untreated transduced cells were analysed for egfp 
(enhanced green fluorescence protein) expression using a fluorescence microscope. 
Quantitative image analysis, based on the quantification of pixel intensities, was then 
performed to calculate the total fluorescence for 13 individual cells using ImageJ software 
(Section 2.2.5.I.a). The numbers of cells were chosen based on the maximum number of 
EGFP positive cells in the transduced untreated control cells. The fold change in 
fluorescence was calculated and plotted as graph bar next to the photomicrographs.  
As expected, fluorescence microscopy analysis revealed that the addition of sodium 
butyrate to the cell culture medium after transduction resulted in a three-fold increase in 
the number of EGFP positive cells and exhibited an intensely green fluorescence (Figures 
4.1 to 4.4, panel C) compared to the untreated control (Figures 4.1 to 4.4, panel B). The 
fluorescence photomicrographs, shown in Figure 4.1, panel D also demonstrated the 
enhancing effect of hydroxyurea on egfp expression. As compared with the untreated 
transduced control cells (Figure 4.1, panel B), pre-transduction treatment of cells with 
hydroxyurea at concentrations of 5, 20, 75 and 100 mM induced a two- to three-fold 
increase in fluorescence (Figure 4.1, panel D). The maximum fluorescence was achieved 
by pre-treating the cells with 40 mM of hydroxyurea; this concentration increased the 
fluorescence intensity three-fold compared to the transduced control cells (Figure 4.1, 
panel B). Statistical analysis showed that the expression levels of hydroxyurea treated 
transduced cells were significantly higher than the untreated transduced cells (F (6, 82)= 
11.12; p<0.0001). Therefore, 40 mM was the concentration used for subsequent 
experiments.   
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Figure 4.1. Effect of different hydroxyurea concentrations on transgene expression in 
AcCMV_EGFP transduced HEK293 cells. Representative photomicrographs of bright field (left 
images) and fluorescence (right images) taken at 24 hpt using a 10X objective and graph bar 
illustrating fluorescence fold change of results from a single experiment. HEK293 cells, treated and 
untreated with different concentrations of hydroxyurea, were transduced at MOI 50 with 
AcCMV_EGFP. Fold change was calculated by dividing the average fluorescence level of EGFP 
cells in the presence of sodium butyrate or hydroxyurea with the EGFP signal intensity of 
AcCMV_EGFP (virus alone) transduced HEK cells. (A) Untreated mock-transduced cells (negative 
control). (B) Untreated HEK293 cells transduced with AcCMV_EGFP. (C) AcCMV_EGFP 
transduced cells were incubated in the presence of 10 mM of sodium butyrate. (D) HEK293 cells 
were treated with the indicated concentration of hydroxyurea before AcCMV_EGFP transduction. 
Scale bar = 10 µm. *p<0.0001 indicated a significant difference between treated transduced cells 
and AcCMV_EGFP untreated transduced cells (One-way ANOVA). 
 
 
Similar results were observed for etoposide; etoposide treatment with concentrations of 
1.5, 3 and 4.5 µM significantly enhanced (F (4, 47)=81.65; p<0.0001) fluorescence 
intensity by approximately two-fold respectively (Figure 4.2, panel E) compared to the 
untreated AcCMV_EGFP transduced cells (Figure 4.2, panel B). Cells treated with 0.5 and 
10 µM of etoposide (Figure 4.2, panel E) were not statistically different from transduced 
control cells (F (2, 35)=0.3601; p=0.7001) and only showed one-fold increase in egfp 
expression, respectively. Because the maximum value of fold change in fluorescence was 
obtained with 1.5 µM etoposide, this was the concentration chosen for use in future 
experiments.  
  
5 mM          20mM        40mM         75mM        100mM 
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Figure 4.2. Effect of different etoposide concentrations on transgene expression in 
AcCMV_EGFP transduced HEK293 cells. Representative photomicrographs of bright field (left 
images) and fluorescence (right images) taken at 24 hpt using a 10X objective and graph bar 
illustrating fluorescence fold change of results from a single experiment. Culture of HEK293 cells, 
treated and untreated with different concentrations of etoposide, were transduced at MOI 50 with 
AcCMV_EGFP. Fold change was calculated by dividing the average fluorescence level of EGFP 
cells in the presence of sodium butyrate or etoposide compounds with the EGFP signal intensity of 
AcCMV_EGFP (virus alone) transduced HEK293 cells. (A) Untreated mock-transduced cells 
(negative control). (B) Untreated HEK293 cells transduced with AcCMV_EGFP. (C) Transduced 
cells were incubated in the presence of 10 mM sodium butyrate. AcCMV_EGFP. (E) HEK293 cells 
were treated with the indicated concentration of etoposide before transduction. Scale bar = 2 mm. 
*p<0.0001 indicated a significant difference between treated transduced cells and AcCMV_EGFP 
untreated transduced cells (One-way ANOVA). 
 
 
 
As shown in Figure 4.3; panel F, protamine treatment did not have any significant effect (F 
(5, 67)= 1.787; p=0.1273) when tested at concentrations of 0.5, 5, 10 and 50 µg/ml (less 
than one-fold, respectively); and at 100 µg/ml egfp fluorescence was significantly reduced 
(F (5, 67)= 1.787; p<0.05).  
Similar results to protamine were observed after treatment with cycloheximide (Figure 4.4, 
panel G) and statistical analysis revealed no difference (F (3, 48)= 0.6662; p=0.5770) in 
fluorescence intensity between the concentrations tested and the untreated transduced 
control cells (Figure 4.4, panel B). No toxicity was observed in cells treated with protamine 
and cycloheximide; whilst some cytotoxic effects were observed in transduced HEK293 
cells pre-treated with hydroxyurea (75 and 100 mM) and etoposide (4.5 and 10 µM).  
 
  
0.5µM        1.5µM         3µM         4.5µM        10 µM 
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Figure 4.3. Effect of different protamine concentrations on transgene expression in 
AcCMV_EGFP transduced HEK293 cells. Representative photomicrographs of bright field (left 
images) and fluorescence (right images) taken at 24 hpt using a 10X objective and graph bar 
illustrating fluorescence fold change of results from a single experiment. HEK293 cells, treated and 
untreated with different protamine concentrations, were transduced at MOI 50 with AcCMV_EGFP. 
Fold change was calculated by dividing the average fluorescence level of EGFP cells in the 
presence of sodium butyrate or protamine compounds with the EGFP signal intensity of 
AcCMV_EGFP (virus alone) transduced HEK293 cells. (A) Untreated mock-transduced cells 
(negative control). (B) Untreated HEK293 cells transduced with AcCMV_EGFP. (C) Transduced 
cells were incubated in the presence of 10 mM sodium butyrate. AcCMV_EGFP. (F) HEK293 cells 
were co-incubated with the indicated concentrations of protamine during AcCMV_EGFP 
transduction. Scale bar =10 µm. *p<0.0001 indicated a significant difference between treated 
transduced cells and AcCMV_EGFP untreated transduced cells (One-way ANOVA). 
  
0.5µg/ml     5µg/ml   10µg/m    50µg/ml     100µg/ml 
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Figure 4.4. Effect of different cycloheximide concentrations on transgene expression in AcCMV_EGFP transduced HEK293 cells. Representative 
photomicrographs of bright field (left images) and fluorescence (right images) taken at 24 hpt using a 10X objective and graph bar illustrating fluorescence 
fold change of results from a single experiment. HEK293 cells, treated and untreated with different concentration of cycloheximide, were transduced at MOI 
50 with AcCMV_EGFP. Fold change was calculated by dividing the average fluorescence level of EGFP cells in the presence of sodium butyrate or 
cycloheximide compounds with the EGFP signal intensity of AcCMV_EGFP (virus alone) transduced HEK293 cells. (A) Untreated mock-transduced cells 
(negative control). (B) Untreated HEK293 cells transduced with AcCMV_EGFP. (C) Transduced cells were incubated in the presence of 10 mM sodium 
butyrate. AcCMV_EGFP. (G) HEK293 cells were pre-treated with the indicated concentration of cyclohexamide before transduction. Scale bar = 10 µm. 
*p<0.0001 indicated a significant difference between treated transduced cells and AcCMV_EGFP untreated transduced cells (One-way ANOVA). 
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4.3 EFFECT OF CHEMICAL COMPOUNDS ON BACMAM TRANSGENE EXPRESSION 
IN HEK293 CELLS 
Optimization studies, in Section 4.2, shown that BacMam-mediated transgene expression 
was considerably improved by addition of sodium butyrate, hydroxyurea and etoposide. 
The optimal concentrations identified in Section 4.2 for hydroxyurea (40 mM) and 
etoposide (1.5 µM) were used in the following studies. Protamine (50 µg/ml) and 
cyclohexamide (1.5 µg/ml) were also further tested.  
To compare the effects of these chemical compounds on transgene expression, triplicate 
dishes of HEK293 cells (0.8x105 cells/well), in four independent experiments, were pre-
exposed to hydroxyurea (40 mM), etoposide (1.5 µM), cyclohexamide (1.5 µg/ml) or 
sodium butyrate (10 mM) or co-incubated with protamine (50 µg/ml) and transduced with 
AcCMV_EGFP virus (MOI 50). Cultures were examined 24 later by fluorescence 
microscopy and fluorescence intensity quantified as previously described. Representative 
data from a single experiment are shown in this thesis Section. 
As expected, sodium butyrate significantly increased (F (5, 62)= 7.499; p<0.0001) 
fluorescence intensity by three-fold (Figure 4.5, panel C) compared to the untreated 
control cells (Figure 4.5, panel B). Hydroxyurea showed a two-fold increase (Figure 4.5, 
panel D) which was also significantly higher than control cells (F (5, 62)= 7.499; 
p<0.0001). Transduced cells treated with etoposide (Figure 4.5, panel E) were 
approximately two-fold higher than AcCMV_EGFP untreated cells but were not 
significantly different (F (3, 46) = 2.017; p=0.1247). Only a slight increase in expression 
was observed in HEK293 cells transduced with AcCMV_EGFP co-incubated with 
protamine (Figure 4.5, panel F). Whereas, no increase in fluorescence was observed in 
cells pre-treated with cycloheximide (Figure 4.5, panel G); this may have been due to its 
cytotoxic effect. 
To evaluate the influence of chemical compounds and cationic lipids on cell viability, a 
Trypan blue dye exclusion assay was carried out (Section 2.2.6). As shown in Figure 4.6; 
Bars 3 to 6, chemical treatment with sodium butyrate (86%), hydroxyurea (85%), 
etoposide (88%) and protamine (87%) did not significantly reduce cell viability (F (5, 15)= 
2.826; p=0.0542) compared to control cells, mock (91%) or AcCMV_EGFP (90%) 
transduced cells (Figure 4.6; Bars 1 and 2, respectively). The viability of transduced HEK 
cells treated with cycloheximide (Figure 5.12, Bar 7) decreased significantly from 91% to 
73% (F (11, 27)= 7.140; p< 0.0001).  
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Figure 4.5. Egfp expression in HEK293 cells transduced with AcCMV_EGFP in the presence 
or absence of chemical compounds. Representative photomicrographs of bright field (left), and 
fluorescence (right), images taken at 24 hpt using a 10X objective and graph bar illustrating 
fluorescence fold change of a representative single experiment. Fold change was calculated by 
dividing the average fluorescence level of treated AcCMV_EGFP cells with the EGFP signal 
intensity of AcCMV_EGFP (virus alone) transduced HEK293 cells. (A) Mock-transduced HEK293 
cells (negative control). (B) Untreated HEK cell transduced with AcCMV_EGFP (virus alone). (C-G) 
Transduced HEK293 cells pre- or post-treated with different chemical compounds: (C) sodium 
butyrate, (D) hydroxyurea, (E) etoposide, (F) protamine and (G) cyclohexamide. Scale bar = 10 
µm. *p<0.0001 indicated a significant difference between treated transduced cells and 
AcCMV_EGFP untreated transduced cells (One-way ANOVA). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6. Cytotoxic effect of chemical on HEK293 cells. HEK cells (0.8x10
5
 cells/ml) were 
chemically treated before or after transduction. 24 hpt cell viabilities were determined using Trypan 
blue exclusion assay. The data presented are the mean ± standard deviations from triplicate 
samples of a representative single experiment. *p<0.0001 indicated a significant difference 
compared to controls cells.  
     D                 E                  F                  G 
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The results obtained by fluorescence microscopy were further confirmed by flow 
cytometry (Section 2.2.7.I). Representative flow cytometry dot plot images are shown in 
Figures 4.7. The plots were divided into two sections to distinguish populations of cells 
that were considered EGFP negative (green dots in the lower region) and EGFP positive 
(red dots in the upper region). Fluorescence intensity (FL1, y‐axis) was plotted on a log 
scale against the forward scatter signal (FS, x‐axis), which is directly related to cell size. 
As illustrated in Figures 4.7 A, low fluorescence (5%) was detected in populations of 
mock-transduced cells representing background fluorescence from cells and was 
subtracted from the values obtained from transduced samples. Following AcCMV_EGFP 
transduction of untreated cells, 32% of HEK293 cells emitted fluorescence, compared to 
the mock-transduced cells (Figures 4.7 panels B vs. A).  
As shown in Figure 4.7, flow cytometer dot plots indicated that 24 hpt, treatment with 
sodium butyrate (panel C), hydroxyurea (panel D) and etoposide (panel E) greatly 
enhanced the number of EGFP-expressing cells (70%, 70% and 63%, respectively); 
however, expression levels similar to the untreated control (panel B) were observed for 
AcCMV_EGFP transduced cells in the presence of protamine (panel F) or treated with 
cycloheximide (panel G). These results were consistent with earlier observations (see 
Figures 4.1-4.4).  
The fold change in fluorescence after transduction with AcCMV_EGFP alone (positive 
control) was calculated (Figure 4.8, A) and plotted as a bar diagram (Figure 4.8, B). 
Statistical analysis of the data revealed a significant difference (F (5, 11)= 245.1; 
p<0.0001) between egfp expression levels of cells treated with sodium butyrate, 
hydroxyurea or etoposide and untreated transduced cells (Figure 4.8); these chemical 
treatments showed an approximately two-fold increase in transgene expression.  
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Figure 4.7. Representative dot plot images of a single experiment from flow cytometry analysis of AcCMV_EGFP transduced HEK293 cells treated 
with chemical compounds. EGFP fluorescence intensity (FL1, y‐axis) was plotted against the forward scattered light (FS, x-axis). Both axes are log- scale 
and each dot represents a single cell; approximately 80,000 cells are represented in each plot. The line in the plots depicts the boundary between the two 
populations of EGFP-positive (red) and EGFP-negative (green) cells. The counting beads are indicated in dark blue. The top two panels represent control 
cells: (A) dot plot of mock-transduced cells (negative control) and (B) AcCMV_EGFP transduced cells (untreated cells; positive control). Flow cytometry plots 
of transduced HEK293 cellstreated with 10 mM sodium butyrate (C), 40 mM hydroxyurea (D), 1.5 µM etoposide (E), 50 µg/ml protamine (F) and 1.5 µg/ml 
cycloheximide (G).  
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Figure 4.8. Fold change in EGFP fluorescence intensity in transduced HEK293 cells after 
addition of chemical compounds. Fold change was calculated by dividing the average 
fluorescence intensity level of EGFP cells in the presence of chemical compound with the EGFP 
signal intensity of AcCMV_EGFP (virus alone) transduced HEK293 cells. (A) Table showing the 
number of EGFP positive cells and the fluorescence fold change. (B) Graph bar illustrating the fold 
change in egfp expression normalized to the AcCMV_EGFP (virus alone) transduced HEK293 
cells. The data presented are the mean ± standard deviations from triplicate samples. *p<0.0001 
indicated a significant difference with the control sample. 
 
 
In conclusion, fluorescence microscopy and flow cytometry analysis confirmed that egfp 
expression in transduced cells was enhanced by the presence of chemical compounds 
hydroxyurea and etoposide. On the basis of these findings, the effects of 40 mM 
hydroxyurea and 1.5 µM etoposide compounds were further investigated in BacMam 
transduced cells.  
In order to determine the broader utility of these chemical compounds they were tested 
with viruses expressing bcl-2. HEK293 cells treated with chemical compounds, individually 
or in combination (Table 4.1) and were transduced with AcCMV_BCL-2 viruses (MOI 50). 
LacZ expression was tested in this study and results are included in the supplementary 
data CD attached to this thesis (Chapter 4-S1). 
The effect of these chemicals on bcl-2 expression was evaluated in two independent 
experiments by western blot analysis (Section 2.2.4.IV). AcCMV_BCL-2 transduced 
treated and untreated cells were harvested at 24 hpt and cell pellets were processed for 
SDS-PAGE (Sections 2.2.4.I and II). Proteins were then transferred from the gel onto a 
nitrocellulose membrane (Section 2.2.4.IV) and immunoblotted using an antibody against 
BCL-2 (Chapter 2; Tables 2.7 and 2.8).  
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Table 4.1. Different chemical treatments used in HEK293 cells. 
 
 
 
 
 
 
 
Expression levels of bcl-2 for a single representative experiment are shown in Figure 4.9 
for all the culture conditions. β-tubulin expression was also included as it was used as a 
loading control (lower membrane). The anti-BCL-2 antibody identified a ~25 kDa band 
corresponding to the expected size of recombinant BCL-2 protein in all transduced cells 
(Figure 4.9, lanes 2 to 8, highlighted by the arrow); however the intensity of the band 
differed between all the cell culture conditions.  
As shown in Figure 4.9, densitometry analysis confirmed that bcl-2 expression was 
significantly higher (F (6, 14)= 193.3; p<0.0001) in transduced cells treated with sodium 
butyrate (21%; lane 3), hydroxyurea (13%; lane 4) and etoposide (13%; lane 5) compared 
to transduced untreated control cells (3.2%; lane 2). 
Furthermore, the intensity of BCL-2 bands, shown in Figure 4.9, were significantly greater 
(F (6, 14)= 193.3; p<0.0001) in transduced cells treated with hydroxyurea + sodium 
butyrate (19%; lane 6), sodium butyrate + etoposide (20%; lane 7) and hydroxyurea + 
etoposide (12%; lane 8) than that of the control cells (3.2%; lane 2). Although bcl-2 
expression in transduced cells, treated with different chemical combinations, was higher 
than that observed in transduced untreated cells, their effect was not greater than that 
induced by sodium butyrate alone (21%). These results were similar to those observed 
with the reporter gene lacZ (included in the supplementary data CD, Chapter 4-S1).  
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Figure 4.9. Transgene expression in chemically treated and untreated HEK293 cells 
transduced with AcCMV_BCL-2. Expression levels of BCL-2 in BacMam transduced HEK cells 
24 hpt. Lane 1, PageRuler Plus Prestained Protein Ladder; lane 2, transduced untreated cells 
(positive control); transduced HEK293 cells treated with sodium butyrate (lane 3), hydroxyurea 
(lane 4), etoposide (lane 5), hydroxyurea + sodium butyrate (lane 6), sodium butyrate + etoposide 
(lane 7) and hydroxyurea + etoposid (lane 8). Densitometry analysis of western blot was performed 
and data are shown as means ± SE (n=3; above western blot); *p<0.0001 indicated a significant 
difference compared to transduced untreated cells. Western blots were stained with anti-BCL-2 
primary antibody and alkaline phosphatase conjugated anti-mouse IgG secondary antibody. β-
Tubulin was included as a loading control. 
 
4.4 COMPARISON OF TRANSGENE EXPRESSION LEVELS IN HEK293 CELL, 
DELIVERED VIA PLASMID TRANSFECTION OR VIRAL TRANSDUCTION, WITH 
CHEMICALS  
In order to determine whether chemical compounds could enhance transgene expression 
levels by a similar order of magnitude when delivered by transfection or transduction, 
HEK293 cells were transfected with a transfer vector using baculoFectin (Section 
2.2.3.I.a) or transduced with BacMam (Section 2.2.3.V). For the purpose of this single 
experimental study, the transfer vector pAcEGFP and BacMam AcCMV_EGFP, both 
encoding for egfp, were employed. HEK293 cells were treated with sodium butyrate, 
hydroxyurea, etoposide or their pairwise combination before or after delivery of the 
recombinant gene. Based on preliminary studies described in this chapter, the optimal 
working concentration for each chemical was chosen. Treated cells were then incubated 
for 5 h, at room-temperature, with pre-prepared complexes of baculoFectin-pAcEGFP in 
serum-free medium, or transduced by AcCMV_EGFP for 1 h, at room-temperature. 
Following 24 h of incubation, transfected, transduced and controls cells were analysed by 
fluorescence microscopy and fluorescence intensity measured using a fluorescence plate 
reader (Figures 4.10 and 4.11).  
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Figure 4.10. Effect of chemical compounds, individually or in pairwise combination, on egfp 
expression in transduced HEK293 cells. Representative photomicrographs of bright field (bottom 
images), and fluorescence (top images) taken at 24 h following incubation using the 10X objective 
and graph bar illustrating fluorescence fold change. (A) Mock-transduced HEK293 cells (negative 
control). (B) Untreated HEK cell transduced with AcCMV_EGFP (virus alone). Transduced HEK293 
cells pre- or post-treated with (C) sodium butyrate, (E) hydroxyurea, (F) etoposide, (G) hydroxyurea 
+ etoposide, (H) hydroxyurea + sodium butyrate and (I) sodium butyrate + etoposide. (D and L) 
Fluorescence intensity fold change was calculated by dividing the average fluorescence level of 
EGFP cells in the presence of chemical compounds with the EGFP signal intensity of 
AcCMV_EGFP untreated HEK293 cells. Scale bar =10 µm. *p<0.0001 indicated a significant 
difference between treated cells and untreated cells (One-way ANOVA; n=3). 
 
As shown in Figure 4.10, no fluorescence was observed in either mock-transduced or 
non-transfected HEK293 cells (Figure 4.10 A). The maximal egfp expression level in 
transduced HEK293 cells, treated with individual chemicals, was observed with sodium 
butyrate (Figure 4.10 C). Moreover, as shown in Figure 4.10, the transgene expression 
was also increased by addition of hydroxyurea (E) or etoposide (F) compared to untreated 
transduced cells (B), but lower than those observed in the presence of sodium butyrate 
(C).  
Quantification of fluorescence intensity, further confirmed that transgene expression was 
significantly enhanced more than 20-fold when using sodium butyrate and approximately 
14- and eight-fold with hydroxyurea and etoposide respectively (F (6, 51)= 342.1; 
p<0.001). Although the increase in egfp fluorescence intensity in transduced cells was 
considerably higher in all three tested pairwise chemical combinations, it was significantly 
greater in cells treated with the chemical combination hydroxyurea + sodium butyrate 
(Figure 4.10 H) and etoposide + sodium butyrate (Figure 4.10 I). Indeed, fluorescence 
measurements revealed that egfp expression levels were significantly enhanced (F (6, 
51)= 342.1; p<0.001) by 16-, 47- and 41-fold in the presence of hydroxyurea + etoposide, 
hydroxyurea + sodium butyrate and etoposide + sodium butyrate, respectively (Figure 
4.10 G, H and I, respectively).  
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Figure 4.11. Effect of chemical compounds, individually or in pairwise combination, on egfp 
expression in transfected HEK293 cells. Representative photomicrographs of bright field (bottom 
images), and fluorescence (top images) taken at 24 h following incubation using the 10X objective 
and graph bar illustrating fluorescence fold change. (A) Mock-transfected HEK293 cells (negative 
control). (B) Untreated HEK cell transfected with pAcEGFP (virus alone) DNA using baculoFectin 
reagent. Transfected HEK293 cells pre- or post-treated with (C) sodium butyrate, (E) hydroxyurea, 
(F) etoposide, (G) hydroxyurea + etoposide, (H) hydroxyurea + sodium butyrate and (I) sodium 
butyrate + etoposide. (D and L) Fluorescence intensity fold change was calculated by dividing the 
average fluorescence level of EGFP cells in the presence of chemical compounds with the EGFP 
signal intensity of AcCMV_EGFP or pAcEGFP untreated HEK293 cells. Scale bar =10 µm. 
*p<0.0001 indicated a significant difference between treated cells and untreated cells (One-way 
ANOVA; n=3). 
 
 
Under the same cell culture treatments as the transduction experiments, pAcEGFP 
transfected cells showed a much lower level of egfp expression (Figure 4.11). As shown in 
Figure 4.11, by comparison with transfected untreated cells (B), addition of hydroxyurea 
resulted in low egfp expression (E); whilst, sodium butyrate (C) and etoposide (F) 
significantly increased (F (6, 56)= 223.4; p<0.001) transgene expression more than five-
fold. Similar observations were made when pAcEGFP transfected HEK293 cells were 
exposed to chemical combinations; treatment with hydroxyurea + etoposide or 
hydroxyurea + sodium butyrate had a negative effect on transgene expression (Figure 
4.11 G and H, respectively). Maximal egfp expression in pAcEGFP transfected HEK293 
cells was detected in the presence of etoposide + sodium butyrate (Figure 4.11 I); these 
transgene levels were significantly different (F (6, 56)= 223.4; p<0.001) than control cells 
(Figure 4.11 B).  
In order to assess consistency of results across the delivery methods, transfer vectors and 
BacMam viruses encoding lacZ, sod-2 and bcl-2 were also assessed and a summary of 
these experimental results are included into the supplementary data CD attached to this 
thesis (Chapter 4-S2).   
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Taking together these findings indicated that the chemical compounds sodium butyrate, 
hydroxyurea and etoposide modulate with different orders of magnitude the transgene 
expression in HEK293 cells. In particular, etoposide and hydroxyurea compounds and the 
pairwise combinations of sodium butyrate + hydroxyurea and sodium butyrate + etoposide 
treatments consistently increased BacMam-delivered transgene expression. Whilst, 
individual etoposide treatment as well as in combination with sodium butyrate (sodium 
butyrate + etoposide) enhanced the transgene expression in pAcEGFP transfected 
HEK293 cells.  
 
4.5 TIME COURSE OF EGFP EXPRESSION IN HEK293 CELLS AFTER ADDITION OF 
SODIUM BUTYRATE + ETOPOSIDE  
Based on previous results (Section 4.4), the compound combination sodium butyrate + 
etoposide was chosen to assess their time-dependence effect on BacMam-mediated 
transgene expression. A single experiment was carried out using triplicate samples of 
HEK293 cells, with or without 10 mM sodium butyrate + 1.5 µM etoposide; cells were 
transduced with AcCMV_EGFP or transfected with pAcEGFP. HEK293 cells were then 
harvested over-time and analysed by fluorescence microscopy (Section 2.2.5.I); 
fluorescence intensity was also measured using a fluorescence plate reader (Section 
2.2.7.II). Figures 4.12 illustrate the egfp fluorescence intensity fold change in response to 
chemical treatment before or after cells were transduced with AcCMV_EGFP or pAcEGFP 
transfected.  
As shown in Figure 4.12 A, after 24 h of incubation, egfp expression increased 
approximately nine-fold in sodium butyrate + etoposide treated and AcCMV_EGFP 
transduced HEK cells compared to untreated transduced control cells. This increase in 
expression levels, remained unchanged between 24 and 288 h post-transduction with an 
approximately 9-fold increase in egfp expression in all sodium butyrate + etoposide 
treated cells; and expression was significantly higher than untreated transduced control 
cells (F (1, 52)= 1438; p<0.0001). Under the same cell culture conditions, at 24 h post-
transfection the egfp expression in treated cells was enhanced two-fold above the 
pAcEGFP transfected control cells (Figure 4.12 B). This time course study also showed 
that the effect of sodium butyrate + etoposide on egfp expression remained unchanged 
(p>0.05) amongst the treated transfected cells, with an increase in expression 
approximately two- to three-fold above transfected control cells, between 48 and 288 h 
post-transfection (Figure 4.12 B).   
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Statistical analysis demonstrated a significant increase in egfp expression in treated cells 
compared to untreated transfected cells (F (1, 49)= 530.3; p<0.0001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12. Time course of the effect of sodium butyrate/etoposide on BacMam-mediated 
egfp expression in HEK293 cells. Cells were treated with 10 mM of sodium butyrate and 1.5 µM 
of etoposide before or after be transduced with AcCMV_EGFP (MOI 50) or transfected with 
pAcEGFP using baculofectin. At the indicated time, samples of cells were harvested and egfp 
fluorescence intensity was quantified as described in Chapter 2, Section 2.2.7.II. The egfp 
fluorescence intensity fold change was calculated by dividing the mean intensity of transduced or 
transfected HEK293 cells treated with sodium butyrate/etoposide, with the egfp signal intensity of 
transduced or transfected untreated control cells. Data from a single experiment are presented as 
mean ± S.E.M. (n=3); * p<0.0001 indicated a significant difference in expression of treated cells vs. 
untreated control cells. 
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Overall, egfp expression was enhanced in both transfected and transduced cells by 
sodium butyrate + etoposide treatment; however, a significant increase (F (3, 20)= 92.93; 
p<0.0001) in expression was observed in treated AcCMV_EGFP transduced cells (Figure 
4.12 A) compared to treated pAcEGFP transfected cells (Figure 4.12 B). It can be 
concluded from preliminary studies that the addition of chemicals to AcCMV_EGFP 
transduced cells increased expression 4.5 times higher than cells directly transfected with 
plasmid pAcEGFP. 
 
4.6 DISCUSSION 
BacMam technology has undergone great improvements over the last few years and 
recent studies have suggested their potential use as a gene delivery tool in numerous 
applications (reviewed by Airenne et al., 2012; and by Paul et al., 2014). However, one of 
the major limitations of BacMam gene delivery is the limited expression levels of 
transgene that it mediates (Shen et al., 2008; Lo et al., 2009). 
A number of strategies have been developed in order to improve BacMam performance 
as a gene delivery tool for in vitro and in vivo applications. These have included genetic 
modification of the envelope protein GP64, modification of cell culture media composition 
and pH (potential of hydrogen) as well as conjugation of BacMam surface proteins with 
chemicals such as cationic polyethylenimine and polyethylene glycol (reviewed by 
Grabherr et al., 2001; reviewed by Paut et al., 2014). Transgene modification by 
epigenetic factors has been reported to play an important role in modulating BacMam 
mediated expression (Hu et al., 2003; Guo et al., 2010; Paul et al., 2010; Tang et al., 
2011). Therefore, regulating transgene expression in mammalian cells represents an 
important step towards the full scale-utilization of BacMam viruses in a variety of clinical 
applications (Hu et al., 2003; Lo et al., 2009; Guo et al., 2010; Yin et al., 2010; Tang et al., 
2011). 
The main goals of the work described in this thesis chapter was to investigate the 
influence of epigenetic regulation (such as acetylation, methylation and compaction of 
chromatin), brought about by exposure of cells to chemical compounds on transgene 
expression in BacMam transduced HEK293 cells. The experimental approach of this 
chapter has been mainly based on the use of the BacMam virus carrying the egfp gene 
under the control of the CMV-IE promoter. Numerous studies have suggested egfp as a 
useful reporter to quantify gene expression (Hack et al., 2000; Lissemore et al., 2000; 
Soboleski et al., 2005).   
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In particular, EGFP fluorescence intensity can be measured using either fluorescence 
microscopy or by flow cytometry analysis; these are the techniques used in this thesis 
chapter. Fluorescence microscopy offers a unique approach to the study of living cells due 
to its sensitivity, specificity and importantly, its direct visualization of fluorescence-positive 
cells (Soboleski et al., 2005; Yuste, 2005). While, flow cytometry provides greater 
accuracy of fluorescence intensity at various wavelengths and light-scattering properties. 
It can determine the number of fluorescence-positive cells within a cell population (% 
positive cells), as they flow in single file through an illumination zone with detectors. Flow 
cytometry can also measure the magnitude of a pulse representing the intensity of the 
fluorescence emitted. Furthermore, flow cytometry allows the analysis of cell-specific 
characteristics such as cell size, separation of distinct populations of cells, protein and 
DNA content (reviewed by Rieseberg et al., 2001). 
 
4.6.I Preliminary studies using chemical compounds in HEK293 cells 
Early reports have shown that certain chemicals can increase virus-mediated gene 
expression in mammalian cells. Sodium butyrate was the first HDACis to be identified in 
1978 by Boffa and is produced by bacterial fermentation of dietary fibres as a four-carbon 
short-chain fatty acid. Sodium butyrate has been successful used in experimental cancer 
therapy (Nudelman et al., 1992; Warrell et al., 1998). It relaxes chromatin by inducing the 
hyperacetylation of chromosomes which enhance the accessibility of genes to the 
transcriptional machinery and thereby facilitates gene expression in mammalian cells 
(Chen et al., 1997; Condreay et al., 1999; Sarkis et al., 2000; Guo et al., 2010; Tang et al., 
2011). It also affects metabolism and other enzyme system by enhancing such as those 
involved in phosphorylation and methylation of proteins (Archer & Hodin, 1999). Studies 
focusing on improving BacMam expression in mammalian cells have demonstrated that 
the addition of sodium butyrate to BacMam transduced mammalian cell lines, dramatically 
increased the levels of transgene expression (Condreay et al., 1999; Sarkis et al., 2000; 
Guo et al., 2010). Condreay et al (1999) demonstrated that in four cell lines derived from 
kidney tissue (BHK, CV-1, Cos-7 and HEK cells), 10 mM of sodium butyrate enhanced 
BacMam-mediated gfp expression between five- and 20-fold compared to the mean 
fluorescence of transduced untreated cells. Therefore, in this preliminary study, sodium 
butyrate was included as a known enhancer of expression and used to treat HEK293 cells 
at concentration of 10 mM as a positive control.   
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The purpose of this preliminary study was to identify chemical compounds capable of 
enhancing BacMam transgene expression in mammalian cells, based on literature 
reviews. Studies aimed at improving AAV transduction efficiency and transgene delivery 
showed that hydroxyurea (a DNA synthesis inhibitor) and etoposide (a type II 
topoisomerase inhibitor) increased transgene expression in human fibroblast cultures and 
in human marrow mesenchymal cells (Russell et al., 1995; Ju et al., 2004); hydroxyurea 
further enhanced the level of adenovirus-mediated transgene in human colon and 
hepatocellular carcinoma cells (Huang et al., 2005), whilst co-treatment of UMR106 
osteosarcoma cells with adenovirus + etoposide effectively increased transgene 
expression with minimal effects on normal cell physiology (Triplett et al., 2005). The 
precise mechanism of action of hydroxyurea and etoposide on virus mediated transgene 
expression is not yet clear, but it appears that they alter chromosome structure by various 
mechanisms all of which activate DNA repair mechanisms. Therefore, this suggests that 
repair synthesis activities associated with DNA repair may be involved in virus 
transduction rather than replicative DNA synthesis (Russell et al., 1995).  
Other studies on adenovirus and AAV gene delivery demonstrated that gene transfer 
efficiency can be improved by the addition of polycations such as protamine (Lanuti et al., 
1999). In these reports it was hypothesized that protamine enhances transgene 
expression by either neutralizing electrostatic repulsion between the virus and the cell 
membrane or by linking virus particles with cell surfaces. To date, there are no reports in 
the literature describing the use of any of these compounds for enhancing the efficiency of 
BacMam-mediated gene delivery. Therefore, the effect of hydroxyurea, etoposide and 
protamine on transgene expression in BacMam transduced HEK293 cells was 
investigated.  
The effect of cycloheximide, an inhibitor of protein biosynthesis, on AAV transduction has 
also been evaluated in stationary human fibroblast cells (Russell et al., 1995). 
Clycloheximide has been proved to significantly increase the nuclear import channel pore 
size after 3 h of treatment (Feldherr et al., 2001). It acts mainly by interrupting both 
initiation and elongation steps of translation by interacting with the P site on the ribosomal 
subunit 60S (Obrig et al., 1971). Mizutani et al. (2000) demonstrated that 5 h of treatment 
with cycloheximide increased Borna disease virus (BDV) transcription in Madin-Darby 
canine kidney (MDCK) cells persistently infected by BDV. Feldherr et al. (2001) showed 
no effect of cycloheximide on either the transport rate or passive diffusion of FITC 
(fluorescein isothiocyanate)-labeled ovalbumin or BSA proteins through the nuclear pore. 
Interestingly, the mechanism by which BacMam delivers genes into the nucleus of the 
host cell is still poorly characterized (reviewed by Au et al., 2013).   
Chapter 4 
 
122 
 
Therefore it was decided to also investigate the effect of cycloheximide on BacMam gene 
delivery in HEK293 cells. 
Initially, the optimal chemical dosage to ensure high levels of transgene expression and 
low cytotoxicity was assessed by treating HEK293 cells with various concentrations of 
hydroxyurea, etoposide, protamine and cycloheximide compounds. Treatment of 
AcCMV_EGFP transduced cells with 10 mM sodium butyrate resulted in a three-fold 
increase in egfp fluorescence compared to untreated transduced cells (Figures 4.1 to 4.4, 
panel C vs panel B); this was consistent with previous studies in other cell lines (Condreay 
et al., 1999; Sarkis et al., 2000). Condreay and colleagues showed an approximately 
three-fold increase in gfp expression levels following the addition of 10 mM of sodium 
butyrate to BacMam transduced cervical epithelial (W12) cells. Similarly, addition of 
sodium butyrate to cell media after BacMam transduction resulted in three-fold increase in 
the number of GFP-positive cells and in the intensity of mean fluorescence in HeLa cells 
and in a neuroblastomal cell line, CHP212 (Sarkis et al., 2000).  
Fluorescence microscopy and quantitative image analysis demonstrated that pre-
transduction treatment of HEK293 cells with different concentrations of hydroxyurea, 
ranging from 5 to 100 mM, significantly increased egfp fluorescence intensity by 
approximately two- to three-fold (Figure 4.1, panel D). In particular, 40 mM hydroxyurea 
increased egfp expression more than three-fold. This result was consistent with published 
studies. Russell et al. (1995) identified 40 mM hydroxyurea as the optimal concentration 
producing a three- to four-fold increase in AAV transduction efficiency in dividing human 
fibroblast cultures compared to the transduced stationary culture and 30-fold increase 
when compared to dividing untreated transduced fibroblast cells.  
Increased egfp fluorescence intensity was also observed in transduced cells pre-treated 
with etoposide. The maximum increase in the reporter gene expression in the presence of 
1.5 µM etoposide was approximately two-fold higher than untreated transduced cells 
(Figure 4.2, panel E vs panel B). The fluorescence intensity in transduced HEK cells 
treated with etoposide concentrations above or below 1.5 µM was similar to control cells; 
these observations were consistent to those made by other studies. Incubation of 
osteosarcoma cells with a lower dose of etoposide (100 nM) during the first 24 h of 
adenoviral infection resulted in a significant increase in transgene expression, 
approximately two-fold, with no increased cytotoxicity compared with vehicle-treated 
controls (Triplett et al., 2005). In contrast, etoposide (3 µM) increased AAV transduction 
efficiency in dividing human fibroblast cultures three-fold higher than untreated dividing 
cultures (Russell et al., 1995).  
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Quantitative image analysis indicated that co-transduction cells with AcCMV_EGFP + 
protamine at various concentrations (0.5 to 100 µg/ml) did not augment transgene 
expression in these cells. (Figure 4.3; panel F vs panel B). These results were different 
from published observations. Swaney et al. (1997) observed a five-fold increase in lacZ-
positive cells when retrovirus pre-treated with protamine (4 µg/ml) was used to transduced 
CHO cells. Similarly, flow cytometry analysis indicated that AAV transduction efficiency in 
HepG2 (human hepatoma) cells and number of GFP expressing cells were significantly 
increased in the presence of 5 µg/ml of protamine (Yang & Hsieh, 2001).  
In the work described in this thesis chapter it was also demonstrated that there was no 
increase in transgene expression between HEK293 cells incubated with different 
concentrations of cycloheximide and untreated transduced cells (Figure 4.4, panel G vs 
panel B). Although low concentrations of cycloheximide were tested in this study, results 
confirmed observations made by Russell et al., (1995); cycloheximide (50 mg/ml) failed to 
increase AVV transduction efficiency in both dividing and stationary human fibroblast 
cells. 
 
4.6.II Chemical compounds effect on egfp and bcl-2 expression  
Since it was observed that chemical compounds administered prior or post BacMam 
transduction had a positive effect on transgene expression, further study was carried out 
to assess the reproducibility of the method. It was also decided to test the chemical 
compounds protamine (50 µg/ml) and cyclohexamide (1.5 µg/ml) to further confirm their 
effect on the transgene expression. 
Results illustrated in Figure 4.5 showed that egfp fluorescence intensity was significantly 
increased (two- to three-fold) in transduced cells treated with the chemical compounds 
sodium butyrate (panel C), hydroxyurea (panel D) and etoposide (panel E). These results 
were consistent with those of other studies who reported that sodium butyrate significantly 
improved transduction efficiency of BacMam and the expression level of exogenous 
genes (Condreay et al., 1999; Sarkis et al., 2000; Guo et al., 2010; Yin et al., 2010). 
Hydroxyurea and etoposide have been shown previously to enhance transgene 
expression mediated by adenoviral vectors in various cell types (Russell et al., 1995; 
Triplett et al., 2005). Shieh et al. (2006) demonstrated that low-dose etoposide 0.1 µg/ml 
(1.6 µM) increased approximately two-fold the transduction efficacy of adenovirus 
encoding cytosine deaminase (cd) through up-regulation of the hTERT promoter activity in 
telomerase-positive bladder cancer cells.  
Chapter 4 
 
124 
 
Subsequently, cell viability analysis revealed no obvious cytotoxicity in transduced 
HEK293 cells treated with chemicals, 85-87% (with the exception of cycloheximide) 
compared to control cultures (90-91%) (Figure 4.6; Bars 3-6 vs 1-2, respectively). These 
data were in agreement with previous reports (Triplett et al., 2005; Yin et al., 2010). 
To further confirm fluorescence microscopy observations, the number of EGFP-positive 
cells was quantified by flow cytometry. As cells intersect the laser beam, intrinsic cellular 
characteristics can be reflected, analysed, and shown in a scatter plot. In the cytograms of 
this study, EGFP fluorescence intensity (FL1) is shown in the y axis and forward scatter 
(FS) is plotted on the x axis, which represents the relative cell size. From the dot plot 
images, it appears evident that changes in cell size depend on the culture treatment rather 
than BacMam transduction; indeed, the FS of mock-transduced cells appeared similar to 
the FS of the AcCMV_EGFP transduced cells (untreated cells), ranging from 100 to 1000 
of the logarithmic (Log) scale (Figure 4.7 A vs. B). In contrast, as shown in Figure 4.7, 
upon BacMam transduction and sodium butyrate (panel C), hydroxyurea (panel D) or 
etoposide (panel E) treatment, it is possible distinguish a decrease in the cell size 
population (10 to 100 of the Log scale), compared to the control dot plot images (panels A 
& B). The relative cell size for AcCMV_EGFP transduced cells treated with protamine and 
cycloheximide varied between 10 to approximately 1000 of the FS Log scale (Figure 4.7 
panels F and G, respectively). Chico & Jäger (2002) and Janakiraman et al. (2006) 
demonstrated, using flow cytometry, that baculovirus increased viable insect cell 
size/diameter following infection. However, to date, there is no evidence that BacMam 
induce change in mammalian cell size; BacMam virus do not replicate in mammalian cells. 
Furthermore, the dot plot analysis showed that the percentage of EGFP-positive cells had 
markedly increased from 32% in cells transduced with virus alone (untreated cells) to 63-
70% in transduced cells treated with sodium butyrate, hydroxyurea or etoposide (Figure 
4.7, panels C, D and E vs B) but not with protamine or cycloheximide (Figure 4.7, panels 
F and G vs B).  
Quantitatively, the fluorescence fold change demonstrated that a significant increase of 
approximately two-fold in the presence of chemical compounds compared to transduced 
untreated cells (Figure 4.8). These data were consistent with Yin et al. (2010) who 
demonstrated by flow cytometry that sodium butyrate (5 mM/L) consistently improved 
approximately two-fold the transduction efficiency and GFP fluorescence intensity of 
SW1116 tumour cells transduced with BacMam at different MOI.   
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In conclusion, results from this study provided further support to the preliminary data 
described above in Section 4.6.I and confirmed that egfp expression in transduced cells 
was significantly improved by sodium butyrate, hydroxyurea and etoposide compounds : 
Although, It was decided to omit the chemical protamine from future experiments it should 
be noted that protamine is a well-established and safe drug used in human clinical 
settings (Sorgi et al., 1997); it improves uptake of a number of viruses by reducing the 
repulsive-charge interactions between the viral envelope and the host cell membrane 
(Cornetta & Anderson, 1989; Lanuti et al., 1999; Lin et al., 2012). Therefore, further 
studies will be necessary to better understand the mechanisms of action of protamine in 
increasing BacMam entry into mammalian cells. Similarly, based on the results from this 
study, cycloheximide was excluded from subsequent experiments; however, more studies 
are needed to further elucidate whether this compound could have either a detrimental or 
beneficial effect on viral processing rather than on transgene expression. Indeed, in the 
early 1970s, Craig & Raskas demonstrated that the presence of cycloheximide, during the 
early phase of adenovirus replication in cultured human KB cells, caused an increase in 
the virus-specific content of newly synthesized mRNA (Craig & Raskas, 1970). In contrast, 
other studies suggested that presence of cycloheximide during virus infection inhibited the 
synthesis of viral proteins and the replication of viral RNA (Hay et al., 1997; Sanfilippo et 
al., 2004; Landeras-Bueno et al., 2011).Subsequently, the effect of sodium butyrate, 
hydroxyurea and etoposide chemicals was further evaluated individually or in 
combination, in HEK293 cells. In particular, their effect on bcl-2 gene expression was 
examined in BacMam transduced cells. 
A four- to six-fold enhancement in bcl-2 expression was found in cells treated with 
individual compounds (Figure 4.9, lanes 3-5 vs lane 2). This study also demonstrated that 
transduced cells expressing bcl-2 responded to the chemical combination treatments 
positively, increasing four to six-fold the transgene levels (Figure 4.9, lanes 6-8). Although 
bcl-2 expression in these cells was higher than that observed in transduced untreated 
cells, their effect was not greater than that of individual chemical treatments. These results 
were similar to those reported in the literature (Russell et al., 1995; Triplett et al., 2005; Lo 
et al., 2009; Yin et al., 2010). The use of etoposide (100 nM) increased gfp expression 
approximately three-fold in UMR106 cells and two-fold in rat embryo fibroblast (RF52) 
cells compared to vehicle-untreated controls (Triplett et al., 2005). Guo et al. (2010) 
showed an approximately two-fold increase in BacMam-mediated human sodium/iodide 
symporter (hNIS) expression in sodium butyrate (1 mM/L) treated A549 cells.  
Chapter 4 
 
126 
 
4.6.III Comparison of BacMam vs plasmid DNA transgene delivery in the 
presence of chemical compounds. 
One of the advantages of using plasmid DNA for gene delivery applications is a reduced 
immunogenic effect when compared with mammalian viral vectors; however, several 
factors may contribute to low transfection efficiency such as degradation by nucleases 
and cationic liposome toxicity (Wolff & Budker, 2005). In the last two decades, 
researchers have directed attention toward increasing plasmid DNA transfection 
efficiency; amongst these studies, Gorman et al. (1983) were the first to show that sodium 
butyrate (2 mM to 10 mM) treatment, immediately following transfection, increased by 
three- to four-fold the number of cells able to transiently express foreign DNA. It has also 
been reported that plasmid DNA harbouring the human IgG-heavy and light chain (chCE7 
F(ab′)2) fragments transfected into HEK293 cells in combination with sodium butyrate 
increased expression of recombinant antibody fragments (Nahreini et al., 2003).  
Despite different approaches being used, the efficiency of transfection, level of transgene 
expression and limitation to scale-up after non-viral DNA delivery still remain low when 
compared to virus-mediated delivery (Tang et al., 2011; Hohsfield et al., 2013). A recent 
study evaluated different gene delivery methods for commercially available fluorescence 
genes in amphibian (A6) and CHO cells (Ramirez-Gordillo et al., 2011). In every instance, 
they demonstrated that efficiency of gene delivery using the BacMam system was greater 
than that found using electroporation or transfection with lipid-mediated reagents 
(Lipofectamine™2000, Metafectene® and Pro). The present study compared the effect of 
chemical compounds on efficiency and expression of plasmid DNA transfection and 
BacMam transduction in HEK293 cells.  
Although, BacMam transduction of chemically untreated HEK293 cells was slightly less 
efficient than DNA transfection, significantly higher level of egfp expression were observed 
in transduced cells treated with individual chemicals (eight – to 20-fold) as compared with 
pAcEGFP transfected chemically treated cells (five-fold). Treatment with three chemical 
combinations further increased egfp fluorescence in the transduced cells (16-47-fold) 
compared to approximately six-fold in individually treated transfected cells (Figure 4.10 A 
vs. B). Consistent with previous results in this study, hydroxyurea in combination with 
either + etoposide or + sodium butyrate greatly increased transgene expression over five-
fold compared to transduced untreated cells (Figure 4.9). These findings were also 
consistent with published reports (Russell et al., 1995; Hendrick et al., 2001; Sugano et 
al., 2005; Mohan et al., 2007; Lo et al., 2009).   
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Vadolas et al., (2004) demonstrated a significant dose-dependent increase in the relative 
levels of egfp expression (three- to seven-fold) following treatment of sodium butyrate and 
hydroxyurea in stably transfected K562 (human immortalised myelogenous leukemia) 
cells. They observed maximal transgene expression with 100 µM hydroxyurea (75±10%) 
and 1000 µM sodium butyrate (82±29%); however, they showed that combinations of both 
chemicals resulted with an additive effect on egfp expression after 5 days (159±72%). In 
addition, the differences in delivery efficiency between transduction and transfection 
observed in the present study were consistent with those made by Lo et al. (2009); who 
observed that the number of GFP-positive cells was significantly higher in BacMam 
transduced cells than in transfected cells across three different cell lines. Lo and 
colleagues also demonstrated by flow cytometry that sodium butyrate (10 mM/L) 
treatment tremendously increased (seven-fold) gfp fluorescence intensity in transduced 
HEK293 cells, 48 hpt; however, 20-fold increase in egfp expression was achieved in the 
present study (Figure 4.10). 
Overall, this study demonstrated that etoposide treatment was able to increase transgene 
expression but to a less extended compared to sodium butyrate and hydroxyurea 
compounds used undividually. However, etoposide in combination with sodium butyrate 
consistently improved with different orders of magnitude plasmid-mediated egfp 
expression in HEK293 cells. While, combined treatment of sodium butyrate + etoposide 
and sodium butyrate + hydroxyurea increased BacMam-mediated transgene expression in 
HEK293 cells.  
4.1 Temporal effect of chemical compounds. 
Based on the observations discussed in Section 4.6.III, the time-dependence effect of 
sodium butyrate + etoposide on plasmid- and BacMam-mediated egfp expression was 
assessed in HEK293 cells. Results showed that egfp fluorescence intensity was 
approximately nine-fold higher in treated transduced cells compared to untreated 
transduced cultures. Relatively constant egfp expression levels were observed over-time 
(Figure 4.12, A). Similarly, a two-fold increase in egfp expression was detected in treated 
transfected cells when compared to control cells (untreated transfected cultures). The time 
course study also demonstrated that egfp expression levels remained unchanged 
between 48 and 288 hpt (Figure 4.12 B).  
Although the combined effect of sodium butyrate + etoposide enhanced egfp expression 
in both transfected and transduced HEK293 cells, levels of egfp were significantly 
increased in the transduced cells by five orders of magnitude above the transfected cells.   
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These preliminary results were consistent with previous studies to investigate the 
transduction efficiency of BacMam compared to other systems (Lo et al., 2009; Ramirez-
Gordillo et al., 2011; Tang et al., 2011). In contrast, Sarkis et al. (2000) demonstrated that 
5 mM of sodium butyrate alone increased mean fluorescence intensity four-fold in 
BacMam transduced telencephalic cells at 48 hpt. Subsequently they observed a 
decreased level of expression at 96 hpt (two-fold). Consistent with the observations made 
by Sarkis and colleagues, sodium butyrate enhanced antibody yield 10-fold in transiently 
transfected HEK293E cells between 120 h and 216 h post-transfection (Backliwal et al., 
2008). 
The present study showed that individual or combined chemical treatments with sodium 
butyrate, hydroxyurea and etoposide enhanced the level of transgene expression in 
BacMam transduced HEK293 cells with different orders of magnitude; the enhancement 
was variable but similar between reporter and target gene. The observed differences in 
expression may be partly attributable to the different methods used to analyse transgene 
expression (e.g. plate reader, flow cytometry, image quantification and western blot). It 
can also be hypotesized that gene response to different chemicals may vary. However, 
the data from these experiments clearly support previous findings regarding the direct 
effect of sodium butyrate on transduced cultures but also indicated for the first time that 
BacMam-mediated transgene expression can be modulated and enhanced by addition of 
40 mM hydroxyurea. Both sodium butyrate and hydroxyurea have been used individually 
in a number of clinical trials such as sickle cell disease to induce reactivation of fetal 
hemoglobin (Fathallah & Atweh, 2006; reviewed by Canani et al., 2011; and Green & 
Barral, 2014). Therefore, it was decided to assess whether sodium butyrate alone could 
ameliorate the severity of injury in a simulated in vitro model of I/R injury in human kidney 
2 (HK-2) cells (Chapter 5) as well as in combination with hydroxyurea in an ex vivo 
porcine kidney model (Chapter 6).  
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5.1 INTRODUCTION 
Ischaemia (transient disruption of blood supply) followed by reperfusion (restoration of the 
blood flow) is a pivotal mechanism of organ injury in various medical conditions; I/R injury 
is a common cause of injury in myocardial infarction, circulatory shock, various toxic 
insults, and surgical interventions (reviewed by Lorenzen et al., 2013). Importantly I/R 
injury still remains a major cause of acute kidney injury (AKI) with high morbidity and 
mortality (Versteilen et al., 2004) and is a major determinant of graft survival in kidney 
transplantation (Cassis et al., 2014). The National Institute for Health and Care Excellence 
(NICE) reported in 2013 that AKI was present in 13–18% of all people admitted to UK 
hospitals, predominantly in older adults.  
The etiology of renal I/R injury is complex. Induced renal epithelial cell injury has been 
shown to be related to a number of biochemical, physiological and morphological 
alterations such as ROS, decreased intracellular ATP levels as well as activation of 
apoptotic pathways (Lee et al., 2004; Yang et al., 2005). Many studies have demonstrated 
that cell death via the apoptosis pathway significantly contributed to the pathophysiology 
of renal I/R injury (Gobe et al., 2000; Bonegio & Lieberthal, 2002; Linkermann et al., 2012; 
Stiegler et al., 2013). A large number of experimental studies have shown that 
overexpression of antioxidant (sod, gss, gpx3) and anti-apoptotic (bcl, bcl-2l1, bcl-xl) 
genes protected against cellular injury in various in vitro injury models (Chen et al., 1998; 
Yin et al., 2001; Cruthirds et al., 2005; Xie & Guo, 2006 and 2007; Chen et al., 2009; 
Stiegler et al., 2013; Bagcik et al., 2014). 
Gene delivery studies in mammalian cells have demonstrated the protective effect of bcl-2 
efficiently deliverered by defective herpes-simple virus (Lawrence et al., 1996) and 
adenovirus-mediated gene transfer (Bilbao et al., 1999). Ni et al. (2013) also showed that 
adenoviral mediated bcl-xl overexpression significantly protected human umbilical vein 
endothelial cells from H2O2-induced cell damage and apoptosis. Amongst all of the 
antioxidant enzymes, the three SOD isoforms (SOD-1, SOD-2 and SOD-3) have been the 
most widely studied for their protective properties against I/R injury (Chapter 1, Section 
1.3.4.II). Over two decades ago, Johnson & Weinberg (1993) demonstrated a small 
protective effect by administering SOD-3 into injured tissues; it was hypothesized by 
Bayati et al. (1988) that this marginal effect was due to plasma elimination of SOD within 
several minutes of its administration. Since this time, various attempts have been made to 
increase intracellular SOD levels and extend their circulating life (Yin et al., 2000; 
reviewed by Levonen et al., 2008; Liang et al., 2009).   
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Stable transfection of sod-2 provided protection to alveolar epithelial cells from both 
hyperoxia and superoxide-induced injuries (Ilizarov et al., 2000). Adenovirus-mediated 
sod-2 delivery increased sod-2 expression and activity three-fold as well as effectively 
reducing hepatic oxidative stress (Wheeler et al., 2001).  
The aim of this study was to examine the effect of BacMam delivered sod-2 and bcl-2 
genes in ameliorating I/R injury in an in vitro model that closely mimicked renal I/R injury. 
After reviewing the literature, no other studies were found describing an experimental 
renal I/R injury model in which the effects of protective genes delivered by BacMam 
viruses was investigated. Therefore, a novel BacMam transduction model was developed 
and optimized based on previously established ATP depletion-recovery protocols (Liang 
et al., 2009). The ATP depletion-recovery protocols was first optimized and evaluated in 
HEK293 cells and results are included in the supplementary data CD attached to this 
thesis (Chapter 5-S1). Subsequently, the in vitro model was assessed using HK-2 cells 
and results are described in this thesis Chapter. 
Overexpression of sod-2 for protective function was supported by evidence that the 
mitochondria are the main cellular sites of oxygen radical production; consequently they 
represent an early target of oxygen injury via enhanced production of ROS which is 
followed by mitochondrial dysfunction (Quinlan et al., 2013). Mitochondria also play a key 
role in activating cell death pathways during I/R injury (reviewed by Weiss et al., 2003). 
Furthermore, bcl-2 was chosen based on its well documented role in preventing cell death 
induced by various insults (reviewed by Czabotar et al., 2014) but also because bcl-2 
regulates the mitochondrial transition pore which is important in the regulation of 
apoptosis (reviewed by Czabotar et al., 2014).  
 
5.2 IN VITRO ATP DEPLETION-RECOVERY MODEL OF HK-2 CELLS 
Preliminary study in HEK293 cells demonstrated that BacMam-mediated sod-2 
overexpression was able to partially attenuate ATP depletion-reperfusion injury (see 
supplementary data CD attached to this thesis; Chapter 5-S1); therefore, the in vitro 
model of simulated ischaemia described for HEK293 cells was then adapted for use in 
proximal tubular cells. Several studies have demonstrated that tubular epithelial cells, in 
particular cells from the S3 segment, are very susceptible to ischemic injury resulting in 
loss of epithelial cell polarity, disruption of the actin cytoskeleton and dis-assembly of 
junctional complexes for cell-cell contacts (reviewed by Weinberg, 1991; Lee & Emala, 
2002; Breggia & Himmelfarb, 2008; Luo et al., 2010; reviewed by Bonventre & Yang,   
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2011). Protecting proximal tubular cells from I/R injury has long been considered a good 
strategy for improving the short- and long-term outcomes of renal transplant and 
expanding the use of “marginal donor organs” which are more vulnerable to ischaemic 
injury (Tanaka & Takahara, 2010). Therefore, in this study the human proximal tubular cell 
line (HK-2) was chosen to (1) further assess the ATP depletion-recovery method 
developed and optimized in HEK293 cells and (2) to further establish whether BacMam-
mediated sod-2 overexpression can confer renal protection after I/R injury. Furthermore, 
all viruses stock used in this study were concentrated by high-speed centrifugation 
(Chapter 3, Section 3.2) and dissolved in phosphate buffered saline (PBS) solution. 
5.2.I Chemical depletion of intracellular ATP in HK-2 cells 
The first objective of this study was to determine whether antimycin A and 2-deoxy-
glucose treatment would result in a severe cellular injury which increased as a function of 
time. In a single experiment, ischaemic injury was induced by depleting intracellular ATP 
using antimycin A (10 μM) and 2-deoxy-glucose (10 mM) dissolved in PBS solution. 
Triplicate dishes of HK-2 cells were either incubated under normal culture conditions (in 
keratinocyte serum-free medium; KSFM) or exposed over-time (0 to 60 min) to ATP-
depleting compounds. Furthermore, because chemicals were dissolved in PBS, it was 
also decided to assess whether incubation of HK-2 cells with PBS (no chemical) could 
induce cytotoxicity. Therefore, non-injured cells incubated with PBS were also included in 
this study as control. Subsequently, intracellular ATP levels were quantified and 
normalized to the number of cells used in the assay (2x104 cells) and expressed as 
Relative Luciferase Units (RLU) in Figure 5.1. 
As shown in Figure 5.1, similar intracellular ATP levels were detected at 0 h for all the 
different conditions (1781-2020 RLU). Subsequently, treatment with chemicals produced a 
significant (F (2, 12)= 13.72; p<0.001) ATP depletion (691 RLU) within 30 min of their 
addition to the cells (Figure 5.1, red line) when compared with control cells (black & grey 
lines). The lowest levels of ATP were detected after 45 min of simulated ischaemia (368 
RLU); whereas, slightly increased ATP levels (493 RLU) were observed at 60 min post 
injury (Figure 5.1, red line). These results confirmed that the in vitro model of simulated 
ischaemia, based on ATP-depletion, induced injury in HK-2 cells.  
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Figure 5.1. Time-course of ATP decay during simulated ischaemia in HK-2 cells. Control cells 
were either incubated in KSF medium or in PBS. HK-2 cells were exposed to antimycin A and 2-
Deoxy-D-Glucose and ATP levels were then determined every 15 min. using a Cell TitreGlo assay 
(Promega). * p<0.001 indicated a significant difference between control and injured cells (two-way 
ANOVA; n=3;). 
 
5.2.II Validating the effect of AcCMV_SOD-2 on an optimized in vitro I/R 
injury model 
The next series of experiments were designed to determine the in vitro beneficial effect of 
sod-2 in transduced injured HK-2 cells. Initially, in order to achieve the highest BacMam 
transduction efficiencies experimental conditions (MOI, cell viability and transgene 
expression levels) were optimized for the HK-2 cell line and are included in the 
supplementary data CD attached to this thesis (Chapter 5-S2). Furthermore, based on the 
results obtained in Section 5.2.I, it was decided to further optimize the injury exposure 
times; these experiments are included in the supplementary data CD attached to this 
thesis (Chapter 5-S3). 
Based on the optimization studies, four independent experiments were carried out using 
the following BacMam transduction conditions and in vitro I/R injury protocol. HK-2 cells 
were transduced with AcCMV_NULL and AcCMV_SOD-2 using MOI 150; cells were 
incubated for 72 h at 37°C 5% CO2. At 72 hpt HK-2 cells were subjected to 60 min of I/R   
* 
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injury followed by 72 h of reperfusion. Non-injured HK-2 cells were also included as a 
control. During reperfusion cells were harvested at 0, 6, 24, 48, 72 hpr (hour post-
reperfusion) and analysed for intracellular ATP levels and cell viability. Representative 
results of a single experiment are shown in Figure 5.2. 
As expected, injured cells overexpressing sod-2 showed a trend of increasing intracellular 
ATP levels between 0 and 72 hpr compared to AcCMV_NULL injured cells (Figure 5.2 A). 
Following 60 min of ATP depletion, 0 hpr, AcCMV_NULL and AcCMV_SOD-2 injured cells 
showed very similar ATP levels (20% 19%, respectively); these were significantly lower (F 
(4, 24)= 48.23; p<0.001) compared to non-injured control cells (Figure 5.2 A, solid and 
striped red bars vs. solid black bar). After 6 h of reperfusion, a substantial ATP recovery 
(54%) was detected in AcCMV_SOD-2 injured cells compared to AcCMV_NULL injured 
cells (39%); however, these levels were still significantly lower (F (4, 24)= 48.23; p<0.001) 
than control cells (Figure 5.2 A). 
As shown in Figure 5.2 A, compared to 6 hpr a slight increase in ATP content was noted 
at 24 hpr in both AcCMV_NULL (42%) and AcCMV_SOD-2 (64%) injured HK-2 cells; 
despite this increase, these levels were significant lower (F (4, 24)= 48.23; p<0.001 and F 
(4, 24)= 48.23; p<0.05, respectively) compared to control cells. By 48 hpr, intracellular 
ATP levels in AcCMV_SOD-2 injured cells had already improved to levels similar to those 
of non-injured control cells, 91% compared to 100%, respectively. Whilst, relative to non-
injured control cells and AcCMV_SOD-2 injured cells, ATP levels were still significantly 
lower (F (4, 24)= 48.23; p<0.001) in AcCMV_NULL injured cells (38%). As shown in 
Figure 5.2 A, at 72 hpr, injured HK-2 cells overexpressing sod-2 completely recovered the 
cells intracellular ATP levels (146%); they were significantly higher (F (4, 24)= 48.23; 
p<0.001) to those of control non-injured cells. In contrast, ATP levels in AcCMV_NULL 
injured cells only partially recovered at 72 hpr (86%) and remained lower than control cells 
(Figure 5.2 B). Statistical analysis also revealed that ATP levels in AcCMV_NULL injured 
cells were significantly lower (F (4, 24)= 48.23; p<0.001) than those of AcCMV_SOD-2 
injured HK-2 cells.  
Cell viability was then measured in control and transduced injured HK-2 cells. As shown in 
Figure 5.2 B, compared to 96% viability observed for control cells (solid black bar),  cell 
viability was significantly decreased after I/R injury in both AcCMV_NULL (F (4, 20)= 
5.259; p<0.05) and AcCMV_SOD-2 (F (4, 20)= 5.259; p<0.001) injured cells, 90% and 83 
%, respectively (Figure 5.2 B, solid and striped blue bars). Although, at 6 hpr, cell viability 
increased slightly to 91% in AcCMV_NULL injured cells, it was still significantly lower (F 
(4, 20)= 5.259; p<0.001) than non-injured control cells; whereas, at 6 hpr AcCMV_SOD-2   
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injured cells reached a similar cell viability of control cells (96% vs. 97%, respectively). In 
contrast, at 24 hpr, cell viability in AcCMV_NULL injured HK-2 cells (95%) was the same 
as control cells (95%), whilst cells transduced with AcCMV_SOD-2 decreased to 90%.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2. Cell viability and intracellular ATP levels in I/R injured HK-2 cells. HK-2 cells were 
transduced with either AcCMV_NULL or AcCMV_SOD-2 at MOI 150. At 72 hpt transduced HK-2 
cells were subjected to 60 min of simulated ischaemia. Intracellular ATP levels (A) and cell viability 
(B) were quantified over-time. Bars represent mean ± SEM (n=3) of a single representative 
experiment; *p<0.001 (in A at 0 and 6 hpr and in B at 0 hpr) and p<0.05 (in A at 24 hpr) indicated a 
significant difference between control cells (non-injured) and AcCMV_SOD-2 transduced injured 
cells; while, **p<0.001 (in A at 0, 6, 24 and 48 hpr and in B at 48 hpr) an p<0.05 (in B at 0 and 6 
hpr) indicated a significant difference between control cells and AcCMV_NULL transduced injured 
cells. 
 
As expected, following 24 h of reperfusion AcCMV_SOD-2 injured cells showed a trend of 
increasing cell viability compared to injured AcCMV_NULL cells (Figure 5.2 B). In 
particular, cell viability was approximately 93% at 48 hpr and higher than control cells at 
72 hpr (95% vs. 93%, respectively). When compared to AcCMV_SOD-2 injured cells, a   
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significantly decrease in viability was observed for AcCMV_NULL injured HK-2 cells at 48 
and 72 hpr (F (4, 20)= 5.259; p<0.01 and p<0.05, respectively), 86% and 89%, 
respectively (Figure 5.2 B, striped vs. solid blue bars). Additionally, Two-way ANOVA 
analysis showed that at 48 hpr cell viability of AcCMV_NULL transduced cells was 
significantly lower (F (4, 20)= 5.259; p<0.001) than that of non-injured control cells (Figure 
5.2 B, striped blue bar vs. solid black bar). 
 
5.3 Effects of sodium butyrate IN HK-2 cells subjected to I/R injury  
5.3.I Optimizing sodium butyrate concentration in HK-2 cells 
As described in Chapter 4 of this thesis, sodium butyrate is a member of the histone 
deacetylase inhibitor (HDACis) family; it is known to modulate gene expression in 
mammalian cells and to induce apoptotic effects in a number of cancers (Sugano et al., 
2005; Guo et al., 2010). In particular, it has been reported recently, that sodium butyrate 
ameliorated myocardial I/R injury (Hu et al., 2010). However, the exact mechanism of 
action of sodium butyrate is not well understood. In light of the beneficial effects reported 
for sodium butyrate, together with the findings described in Chapter 4 of this thesis, a pilot 
study was carried out to investigate the effect of sodium butyrate in combination with 
BacMam transduction, using an in vitro I/R injury model. 
Initially, sodium butyrate concentration was optimized in HK-2 cells using a BacMam virus 
encoding egfp. HK-2 cells at a density of 1x105 cells/well, were transduced with 
AcCMV_EGFP (MOI 150); culture media containing different concentrations of sodium 
butyrate (1, 4, 7 and 10 mM) was added to cells following transduction. Cell viability and 
egfp expression results of a single experimental study are shown in Figure 5.3.  
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Figure 5.3. Concentration optimization of sodium butyrate and its effect on cell viability in 
HK-2 cells. HK-2 cells were not transduced (control cells) or mock- and AcCMV_EGFP transduced 
at MOI 150 (n=3). Post-transduction cells were treated with different concentrations of sodium 
butyrate (1, 5, 7 and 10 mM). At 24 hpt cells were analysed for egfp expression and cell viability. 
Bar scale 30 ɥm.  
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As shown in Figure 5.3 A, EGFP was only detected in AcCMV_EGFP transduced cells. As 
expected, control and mock-transduced cells appeared to be viable with no fluorescence 
observed by microscopy. Fluorescent cells were detected in AcCMV_EGFP transduced 
HK-2 cells (no sodium butyrate). However, increased fluorescence was observed in 
AcCMV_EGFP transduced HK-2 cells treated with increasing concentrations of sodium 
butyrate ranging from 1 mM to 10 mM (Figure 5.3 A). As shown in Figure 5.3 A, increasing 
sodium butyrate concentration, in particular at 7 and 10 mM, appeared to correspond to 
decreased cell viability. Therefore, the effect of different concentrations of sodium butyrate 
on cell viability was investigated by Trypan blue exclusion assay.  
There was no significant difference (F (6, 11)= 1.332; p=0.3215) in cell viability between 
control cells, mock- and AcCMV_EGFP transduced HK-2 cells, (91%, 90% and 89%, 
respectively; Figure 5.3 B). Addition of 1 mM and 5 mM sodium butyrate induced a slight 
decrease in cell viability compared to AcCMV_EGFP transduced HK-2 cells (89% to 84% 
and 86% respectively; Figure 5.3 B solid blue bar vs. striped blue bars). Consistent with 
the microscopic observations, cell viability decreased further (82% and 80%) in 
transduced HK-2 cells post-treated with sodium butyrate at concentrations of 7 mM and 
10 mM (Figure 5.3 B, striped blue bars). These results suggested that concentrations 
below 5 mM of sodium butyrate were optimal for HK-2 viability.  
5.3.II Sodium butyrate effect against simulated I/R injury 
In previous experiments, the use of sodium butyrate was associated with increased 
BacMam-mediated transgene expression (See Chapter 4); therefore, these pilot 
experiments were carried out to verify whether sodium butyrate treatment would protect 
against in vitro renal I/R injury by increasing BacMam-delivered sod-2 expression. 
Two experimental protocols were designed and are summarized in Figure 5.4. An 
intracellular ATP assay was performed in control and HK-2 injured cells in the presence or 
absence of sodium butyrate. In protocol-1 HK-2 cells were transduced with AcCMV_NULL 
and AcCMV_SOD-2 for 24 h before 60 min of ischaemic injury followed by 48 h of 
reperfusion; whereas, in protocol-2 cultures were transduced and treated with 5 mM of 
sodium butyrate for 24 h. AcCMV_NULL and AcCMV_SOD-2 transduced treated cells 
were then subjected to simulated ischaemia and reperfused for 48 h. Untreated, non-
transduced and non-injured cells were also included as controls.  
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Figure 5.4. Schematic representation of the time-lines and respective conditions used for the two 
I/R injury experimental protocols. 
 
Experimental protocol 1: 
As shown in Figure 5.5 A, compared to the control cells (non-injured), significantly lower 
intracellular ATP levels (F (3, 24)= 81.31; p<0.001) were detected at 0 hpr in both 
AcCMV_NULL and AcCMV_SOD-2 transduced injured cells (31% and 14% respectively). 
However, ATP levels AcCMV_NULL and AcCMV_SOD-2 transduced injured cells were 
significantly different (F (3, 24)= 81.31; p<0.01) from each other (Figure 5.5 A). Following 
6 h of reperfusion, intracellular ATP levels markedly increased (86%) in AcCMV_NULL 
and AcCMV_SOD-2 (87%) injured cells, but they were still significantly lower (F (3, 24)= 
81.31; p<0.05) than control cells (Figure 5.5 A, solid and striped red bars vs. solid black 
bar).  
ATP levels in transduced injured cells following 24 hpr were not significantly different (F 
(3, 24)= 81.31; p>0.05) compared to the control cells (Figure 5.5 A); however, they were 
significantly higher (F (3, 24)= 81.31; p<0.01) in AcCMV_NULL transduced cells (105%) 
compared to AcCMV_SOD-2 transduced cells (90%). As shown in Figure 5.5 A, 
intracellular ATP levels in AcCMV_SOD-2 injured cells did not improve further than control 
cells and AcCMV_NULL transduced injured cells but decreased to 80%, indeed they were 
significantly lower than control cells and AcCMV_NULL injured cells at 48 hpr (Figure 5.5 
A).  
Experimental protocol 2: 
Similar to the results observed in experimental protocol 1, intracellular ATP declined 
significantly at 0 h of reperfusion (F (3, 24)= 81.31; p<0.001) to 22% in AcCMV_NULL + 
sodium butyrate injured cells (Figure 5.5 B, solid red bar) and 11% in AcCMV_SOD-2 + 
sodium butyrate injured cells (Figure 5.5 B, striped red bar) compared to control HK-2 
cells (not treated and non-injured; Figure 5.25 B, solid black bar).   
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As shown in Figure 5.5 B, following 6 hpr intracellular ATP levels markedly improved in 
AcCMV_SOD-2 injured cells pre-treated with 5 mM of sodium butyrate (157%). These 
ATP levels were significantly higher (F (3, 24)= 81.31; p<0.001) compared to control cells 
(100%) and AcCMV_NULL (107%) pre-treated injured cells (Figure 5.5 B, striped red bar 
vs. solid black and red bars, respectively). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5. Effect of sodium butyrate in I/R injured HK-2 cells. (A) HK-2 cells were either 
AcCMV_NULL or AcCMV_SOD-2 transduced at MOI 150. At 24 hpt transduced cells were 
subjected to 60 min of simulated ischaemia. Intracellular ATP levels were then quantified over-time 
(0, 6, 24 and 48 hpr). (B) HK-2 cells were transduced with AcCMV_NULL and AcCMV_SOD-2 
(MOI 150) and treated for 24 h with 5 mM of sodium butyrate. Subsequently, transduced treated 
cells were subjected to 60 min of ischaemia followed by reperfusion for 48 h. Intracellular ATP 
levels were quantified as in (B). Bars represent mean ± SEM (n=3) of results from a single 
experiment; *p<0.001 (A - 0 and 48 hpr,  B - 0 and 6 hpr), p<0.05 (A - 6 hpr) and p<0.01 (B - 48 
hpr) indicated a significant difference between control cells (non-injured) and AcCMV_SOD-2 
transduced ± sodium butyrate injured cells; while, **p<0.001 (0 hpr in A and B) an p<0.05 (A - 6 
hpr, B - 48 hpr) indicated a significant difference between control cells and AcCMV_NULL 
transduced ± sodium butyrate injured cells. 
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ATP levels decreased at 24 hpr in both AcCMV_NULL (80%) and AcCMV_SOD-2 (114%) 
+ sodium butyrate injured cells (Figure 5.5 B, solid and striped red bars). However, 
statistical analysis indicated that the ATP content in AcCMV_NULL + sodium butyrate 
injured cells were significantly lower (F (3, 24)= 81.31; p<0.05) than AcCMV_SOD-2 + 
sodium butyrate injured cells (Figure 5.5 B, solid vs. striped red bar). There was no 
significant difference (F (3, 24)= 81.31; p>0.05) in ATP levels of transduced + sodium 
butyrate injured cells when compared to those of control cells (Figure 5.5 B). In contrast, 
relative to control cells, significantly (F (3, 24)= 81.31; p<0.05) higher ATP levels (130%) 
were detected at 48 hpr in AcCMV_NULL + sodium butyrate injured cells (Figure 5.5 B). 
As shown in Figure 5.5 B, intracellular ATP levels significantly increased (F (3, 24)= 81.31; 
p<0.01) to 137% in AcCMV_SOD-2 + sodium butyrate injured cells (striped red bar) 
compared to control cells (solid black bar). There was no statistical difference (F (3, 24)= 
81.31; p>0.05) in ATP content at 48 hpr between AcCMV_NULL and AcCMV_SOD-2 + 
sodium butyrate injured cells.  
In conclusion, this preliminary study suggested that overexpression of sod-2 in HK-2 cells 
24 h prior to simulated I/R injury did not fully protect and improve ATP levels to those of 
control cells (non-injured). However, pre-ischaemia treatment of BacMam transduced cells 
with 5 mM of sodium butyrate improved cell viability as indicated by increased ATP levels 
after reperfusion. Importantly, the combination of AcCMV_SOD-2 + sodium butyrate 
further increased intracellular ATP levels from early reperfusion times (6 hpr) compared to 
AcCMV_NULL + sodium butyrate in injured HK-2 cells.  
 
5.4 EFFECT OF THERMAL PRECONDITIONING ON I/R INDUCED-INJURY IN 
BACMAM TRANSDUCED HK-2 CELLS  
The purpose of this study was to examine the renoprotective effect of heat preconditioning 
(42°C for 20 min) in combination with BacMam-mediated sod-2/ bcl-2 expression on a 
simulated I/R injury in HK-2 cells. The choice of 42°C was based on the data of Jo et al. 
(2006); they demonstrated that heat preconditioning at this temperature provided 
functional and histologic renal protection during ischaemic acute renal failure in rats. A 
schematic illustration of the experimental protocols is shown in Figure 5.6. Two 
independent experiments were carried out for each protocol showing same results. Firstly, 
the beneficial effect of BacMam transduction for 72 h + heat preconditioning prior to I/R 
injury of HK-2 cells (experimental protocol 1) was investigated and results are included in 
the supplementary data CD attached to this thesis (Chapter 5-S4).   
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Secondly, a more clinically relevant preconditioning model was developed (experimental 
protocol 2), using a shorter timeframe of BacMam transduction, 24 h (Figure 5.6 B).  
 
 
 
 
 
 
Figure 5.6. Schematic representation of the preconditioning experimental protocol used in 
this study. 
 
5.4.I Effect on ATP levels 
The duration of ischaemic injury and the timeframe of recovery represent one of the 
important factors that make an experimental model clinically applicable. In this study, it 
was evaluated whether reducing the time of BacMam transduction to 24 h could exert a 
protective effect when in combination with heat preconditioning strategy. Furthermore, the 
combined action of protective genes, sod-2 and bcl-2, together with heat preconditioning 
was also investigated in this study; HK-2 cells were co-transduced with AcCMV_SOD-2 + 
AcCMV_BCL-2 with a ratio of 1:1. 
Representative results of a single experimental study are shown in Figure 5.7; a trend of 
improved intracellular ATP levels, between 0 and 48 hpr, was observed in BacMam 
transduced + preconditioned injured HK-2 cells. As expected, following 60 min of 
ischaemia (0 hpr) the intracellular ATP levels were decreased significantly (F (4, 49) = 
79.37; p<0.001) in preconditioned AcCMV_NULL (17%), AcCMV_SOD-2 (27%), 
AcCMV_BCL-2 (16%) and in AcCMV_SOD-2 + AcCMV_BCL-2 (31%) injured cells 
compared to the non-preconditioned control cells (Figure 5.7). After 4 h of reperfusion 
these intracellular ATP levels were still significantly lower (F (4, 49) = 79.37; p<0.001) 
than control cells; however they were increased in the preconditioned transduced injured 
cells by 42% in AcCMV_NULL, 58% in AcCMV_SOD-2, 36% in AcCMV_BCL-2 and 61% 
in AcCMV_SOD-2 + AcCMV_BCL-2 (Figure 5.7).  
As shown in Figure 5.7, at 8 hpr a significant increase in ATP levels was observed in 
preconditioned AcCMV_NULL injured cells (F (4, 49) = 79.37; p<0.01), AcCMV_BCL-2   
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injured cells (F (4, 48) = 117.2; p<0.001) and AcCMV_SOD-2 + AcCMV_BCL-2 (F (4, 48) 
= 117.2; p<0.001) injured cells (89%, 96% and 86%, respectively) compared to the ATP 
levels detected in the preconditioned AcCMV_SOD-2 injured cells (41%). Statistical 
analysis revealed no significant difference (F (4, 48) = 117.2; p>0.05) in the ATP levels of 
preconditioned AcCMV_NULL, AcCMV_BCL-2 and AcCMV_SOD-2 + AcCMV_BCL-2 
injured cells compared to control cells (Figure 6.24); whereas, at 8 hpr there was a 
significant difference (F (4, 49) = 79.37; p<0.001) in ATP contents between preconditioned 
AcCMV_SOD-2 injured cells and control cells (Figure 5.7, striped red bar vs. solid black 
bar).  
 
 
 
 
 
 
 
 
 
 
Figure 5.7. Levels of intracellular ATP levels in heat preconditioned transduced I/R injured 
HK-2 cells. HK-2 cells were transduced with AcCMV_NULL, AcCMV_SOD-2, AcCMV_BCL-2 or 
with the combination of AcCMV_SOD-2 + AcCMV_BCL-2 at MOI 150. At 24 hpt transduced HK-2 
cells were heat preconditioned at 42°C for 20 min. Subsequently, transduced preconditioned cells 
were subjected to 60 min of simulated ischaemia followed by reperfusion. Intracellular ATP levels 
were then quantified over-time. Bars represent mean ± SEM (n=3) of a single representative study; 
*p<0.001 and p<0.05 indicated a significant difference between control cells (non-injured) and 
preconditioned BacMam transduced injured cells.  
 
In contrast to 8 hpr, at 24 hpr preconditioned AcCMV_NULL transduced injured cells 
showed ATP levels of 70%, significantly different (F (4, 49) = 79.37; p<0.05) as compared 
to control cells. Although, in preconditioned AcCMV_SOD-2 + AcCMV_BCL-2 injured cells 
ATP levels were reduced from 86% to 78% at 24 hpr, there was no significant difference 
with the ATP levels of control cells (Figure 5.7 striped green bar vs. solid black bar).   
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Increased intracellular levels of ATP were detected in preconditioned AcCMV_SOD-2 
injured cells, 76% (Figure 5.7, striped red bar); whilst, ATP contents in preconditioned 
AcCMV_BCL-2 injured cells were 94%, this was similar to that observed at 8 hpr, 96% 
(Figure 5.7, striped yellow bar).  
As shown in Figure 5.7, at 48 hpr preconditioned AcCMV_SOD-2 (striped red bar) and the 
virus combination AcCMV_SOD-2 + AcCMV_BCL-2 (striped green bar) injured cells 
exhibited same high ATP levels of control cells (99% and 95%, respectively, vs. 100%). In 
particular, significantly improved ATP levels were detected in preconditioned 
AcCMV_BCL-2 injured cells, 128%; these levels were significantly higher when compared 
to control cells (F (4, 49) = 79.37; p<0.01) and to the preconditioned injured transduced 
cells with AcCMV_NULL (F (4, 39) = 79.37; p<0.001), AcCMV_SOD-2 (F (4, 49) = 79.37; 
p<0.05) and with the combination of AcCMVSOD-2 + AcCMV_BCL-2 (F (4, 49) = 79.37; 
p<0.01). In contrast, compared to control cells, ATP levels were not fully recovered in 
preconditioned AcCMV_NULL injured cells (87%) after 48 h of reperfusion (Figure 5.7, 
solid red bar vs. solid black bar); however, these decreased ATP levels were not 
statistically different (F (4, 48) = 81.34; p>0.05) from those of control cells. 
5.4.II Caspase-3 activity 
Subsequently, it was examined whether the protective effect of BacMam transduction and 
heat preconditioning in I/R-induced cell injury was associated with reduced apoptosis. As 
described in Chapter 1, Section 1.3.4.III of this thesis, caspases are cysteine proteases 
that are responsible for the activation of the apoptotic pathways; therefore, because 
caspase-3 is released by damaged degenerating cells, in this study the production of 
activated caspase-3 was quantified over-time (Section 2.2.6). Data from a single 
experiment are shown as fold change in caspase-3 activity relative to control cells (non-
injured) and are illustrated in Figure 5.8.  
At 0 hpr, there was no significant changes (F (4, 39)= 41.30; p>0.05) in the levels of 
caspase-3 activity between control cells and preconditioned injured cells transduced with 
AcCMV_NULL, AcCMV_SOD-2, AcCMV_BCL-2 and AcCMV_SOD-2 + AcCMV_BCL-2 
viruses (Figure 5.8). Following 4 h of reperfusion, the activation of caspase-3 was 
significantly increased in preconditioned AcCMV_NULL injured cells (F (4, 39)= 41.30; 
p<0.01) and AcCMV_BCL-2 injured cells (F (4, 39)= 41.30; p<0.05) by approximately two-
fold, respectively (Figure 5.8). In contrast, the levels of caspase-3 in the preconditioned 
injured cells transduced with AcCMV_SOD-2 alone or in combination with AcCMV_BCL-2 
were still similar to that in the controls cells (Figure 5.8).   
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At 8 hpr, the contents of activated caspase-3 in preconditioned transduced injured cells 
were not significantly different (F (4, 39)= 41.30; p>0.05) from each other and from that 
observed in control cells (Figure 5.8). 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8. Caspase-3 activity in BacMam transduced + preconditioned HK-2 cells after 
simulated I/R injury. HK-2 cells were transduced with AcCMV_NULL, AcCMV_SOD-2, 
AcCMV_BCL-2 or with the combination of AcCMV_SOD-2 + AcCMV_BCL-2 at MOI 150. At 24 hpt 
transduced HK-2 cells were heat preconditioned at 42°C for 20 min. Subsequently, transduced 
preconditioned cells were subjected to 60 min of simulated ischaemia followed by reperfusion. 
Caspase-3 assay was performed following the manufacturer guidelines (Chapter 2, Section 
2.2.38). Bars represent mean ± SEM (n=3) of results from a single experiment; *p<0.01, **p<0.001 
and ***p<0.05 indicated a significant difference between control cells (non-injured) and 
preconditioned BacMam transduced injured cells. 
 
 
Compared to control cells (non-injured), at 24 hpr the caspase-3 activity was significantly 
increased (F (4, 39)= 41.30; p<0.001) in preconditioned injured cells transduced with 
AcCMV_NULL (approximately four-fold), AcCMV_SOD-2 (approximately three-fold) and in 
AcCMV_BCL-2 (three-fold); whereas, preconditioned injured cells transduced with the 
virus combination AcCMV_SOD-2 + AcCMV_BCL-2 showed similar levels of active 
caspase-3 to that of control cells and caspase-3 activity was significantly attenuated (F (4, 
39)= 41.30; p<0.001) compared to preconditioned injured cells transduced with 
AcCMV_NULL, AcCMV_SO-2 and AcCMV_BCL-2 viruses (Figure 5.8).   
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As shown in Figure 5.8, following 48 hpr there was still significantly increased (F (4, 39)= 
41.30; p<0.001) levels of caspase-3 activity in preconditioned AcCMV_NULL injured cells 
(approximately three-fold) compared to control cells and both preconditioned 
AcCMV_SOD-2 and AcCMV_BCL-2 injured cells (Figure 5.8solid red bar vs. solid black 
bar). Levels of caspase-3 activity similar to control cells were detected in preconditioned 
AcCMV_SOD-2 and in AcCMV_BCL-2 injured cells at 48 hpr; while, caspase-3 activity 
was significantly induced (F (4, 39)= 41.30; p<0.001) by two-fold above control cells in 
preconditioned injured cells transduced with the viral combination AcCMV_SOD-2 + 
AcCMV_BCL-2 (Figure 5.8). 
Taken together, these results suggested that heat preconditioning in combination with 
either AcCMV_SOD-2 or AcCMV_BCL-2 partially protected HK-2 cells from apoptosis 
induced by I/R injury compared to AcCMV_NULL injured cells. Furthermore, the increased 
caspase-3 activity observed at 24 and 48 hpr in preconditioned AcCMV_NULL injured 
cells may contribute to, or may results from, the reduced recovery observed with the 
intracellular ATP levels (Figures 5.7). 
5.4.III Total cellular SOD activity 
To determine whether the beneficial effect of BacMam transduction and heat 
preconditioning on I/R injury was related to the antioxidant capacity, a single experiment 
was carried out to investigate the inhibition rate of the total cellular SOD activity (Section 
2.2.6). The SOD activity assay is based on the inhibition of nitroblue tetrazolium (NBT) 
which is converted by SOD into a blue tetrazolium salt. The amount required to inhibit the 
rate of reduction of NBT by 50% is defined as one unit of enzyme activity. SOD activity 
time course during the reperfusion period is shown in Figure 5.9.  
SOD activity following ischaemia (0 hpr) was significantly higher (F (4, 50)= 10.25; 
p<0.001) in preconditioned AcCMV_NULL injured cells (257%) compared to control cells 
(100%) and preconditioned injured cells transduced with AcCMV_SOD-2 (153%), 
AcCMV_BCL-2 (110%) and with the combination of AcCMV_SOD-2 + AcCMV_BCL-2 
viruses (144%; Figure 5.9). After 4 hpr, this markedly increased SOD activity in 
AcCMV_NULL injured cells (Figure 5.9, solid red bar) decreased to 176%; however this 
was significant higher than control cells (F (4, 50)= 10.25; p<0.05) and preconditioned 
AcCMV_BCL-2 transduced injured cells (F (4, 50)= 10.25; p<0.001). Indeed, a reduced 
SOD activity below control cells was detected in preconditioned AcCMV_BCL-2 injured 
cells (65%).   
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Compared to control cells, at 4 hpr the SOD activity was significantly higher (F (4, 50)= 
10.25; p<0.05) in preconditioned injured cells transduced with AcCMV_SOD-2 alone 
(180%), but not affected in preconditioned injured cells transduced with the virus 
combination AcCMV_SOD-2 + AcCMV_BCL-2 (120%). 
 
 
 
 
 
 
 
 
 
Figure 5.9.Effect of I/R injury on SOD activity in preconditioned BacMam transduced HK-2 
cells. Cultures were transduced with AcCMV_NULL, AcCMV_SOD-2, AcCMV_BCL-2 or with the 
combination of AcCMV_SOD-2 + AcCMV_BCL-2 at MOI 150. At 24 hpt transduced HK-2 cells 
were heat preconditioned at 42°C for 20 min. Subsequently, transduced preconditioned cells were 
subjected to 60 min of simulated ischaemia followed by reperfusion. SOD activity assay was 
performed following the manufacturer guidelines (Chapter 2, Section 2.2.37). Bars represent mean 
± SEM (n=3) of results from a single study; *p<0.001 and **p<0.05 indicated a significant difference 
between control cells (non-injured) and preconditioned BacMam transduced injured cells. 
 
Following 8 hpr, SOD activity in preconditioned AcCMV_NULL (125%) and AcCMV_SOD-
2 (95%) injured cells decreased to the levels of control cells (100% Figure 5.9 solid and 
striped bars vs. solid black bar). Furthermore, compared to control cells, a markedly 
decreased SOD activity was detected in preconditioned AcCMV_BCL-2 and in 
AcCMV_BCL-2 + AcCMV_SOD-2 injured cells at 8 hpr. As shown in Figure 5.9, at 
reperfusion times 24 and 48 h the SOD activity amongst all the preconditioned transduced 
injured cells was not statistically different (F (4, 50)= 10.25; p>0.05) from that of control 
cells (solid black bars) 
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5.5 DISCUSSION 
I/R injury is one of the most common causes of AKI; indeed, ischaemic AKI represents 
one of the major problems in transplantation; it is often associated with initial delayed graft 
function, which likely contributes to long-term graft damage (reviewed by Bellomo et al., 
2004; and Heyman et al., 2012).  
The pathophysiologic mechanism of ischaemic AKI is complex and is thought to include 
cell dysfunction (Parikh, 2013), inflammation processes (Akcay et al., 2009) and tubular 
cellular apoptosis (Bengatta et al., 2009). Despite advances in supportive care and novel 
therapeutic strategies, there are no currently available approaches that efficiently prevent 
AKI induced by I/R injury (Kunzendorf et al., 2010; Bauerle et al., 2011). A number of 
gene therapy strategies have been developed based on information obtained from clinical 
studies as well as in vitro and in vivo models of renal injury (reviewed by Basile, 2007). In 
particular, these approaches have been aimed to understand the molecular, cellular, and 
physiologic responses of renal I/R injury. A number of reports identified oxidant stress, 
inflammation, and apoptotic pathways as potential therapeutic targets (reviewed by Basile, 
2007). As described in Chapter 1 Sections 1.3.4.II & III of this thesis, sod-2 and bcl-2 
represent the primary defence against ROS overproduction and apoptosis, respectively, 
caused by I/R injury. In particular, gene transfer studies have described a beneficial effect 
of delivering exogenous sod-2 and bcl-2, by using mammalian viruses, on ischaemic 
tissues such as brain, liver, retinal, heart and kidneys (Chen et al., 2001; 2009; Wu et al., 
2009).  
Mammalian viruses are generally used as gene delivery systems in gene therapy studies 
compared to non-viral vectors due to the high gene transfer efficiency and prolonged 
recombinant gene expression (reviewed by Jin et al., 2014). However, these mammalian 
viruses often induce a significant inflammatory and immune response upon transduction 
which compromises their gene transfer ability. Therefore, the ideal gene delivery systems 
should have high transduction efficiency, low cytotoxicity and exhibits a lower effect on the 
innate immune response. Amongst all the viral-based delivery systems, BacMam viruses 
have been widely described as a useful and safe gene delivery system with low cytopathic 
effects and immune response compared to mammalian viruses; indeed, BacMam are 
believed to hold great promise for certain gene therapy applications (Paul et al., 2012). In 
light of these positive results, the current study was designed to investigate the role of 
sod-2 and bcl-2 in an in vitro simulated renal I/R injury model using BacMam gene 
delivery system to overexpress these protective genes.   
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5.5.I ATP depletion-recovery model in HK-2 cells 
A proximal tubular cell line, derived from adult human kidney, was established for the first 
time by Ryan et al. (1994) and was designed HK-2. An extensive number of reports have 
utilized HK-2 cells for in vitro renal physiology and pathology studies. In particular, HK-2 
cell response to injury has been reported to be similar to primary cultures of human 
proximal tubular cells (Janssen et al., 2001) and they are therefore considered to be a 
good model to study ischaemia. To verify that HK-2 cells were a valid cellular model to 
study the protective effect of BacMam-mediated sod-2 delivery in proximal tubule cells, 
experimental conditions were first optimized and are described in supplementary data CD 
attached to this thesis (Chapter 5-S2).  
Intracellular ATP depletion, fall in tissue oxygen levels with a concomitant rinse in 
intracellular calcium are the main features of renal I/R injury (Greene & Paller, 1994; Lee 
& Emala, 2002). Therefore in this study, ATP-depletion protocol was used as an in vitro 
model to study I/R induced injury in HK-2 cells.  
Results indicated that following simulated-ischaemic injury, ATP levels were significantly 
reduced within 30 min of treatment; levels remained markedly low after 45 and 60 min of 
treatment compared to non-injured cells (Figure 5.1). These results mimicked 
observations made by Doctor et al. (1994); after 30 min of metabolic inhibition with 
rotenone or antimycin A + 2-deoxyglucose, ATP levels dramatically dropped to 1-4% of 
control cells in both tested kidney cells, LLC-PK and MDCK. These results were also 
consistent with Lee & Emala (2002); they examined HK-2 cell death mediated by 
ATP/glucose depletion as an in vitro model of anoxia/ischaemia. By measuring 
percentage of LDH released into the cell culture media Lee and Emala demonstrated that 
the ATP-depletion injures model of HK-2 cell was time-dependent manner; the amount of 
LDH released increased from approximately 40% to 80% within 3 h of ATP-depletion. 
Having confirmed that the in vitro model of simulated ischaemia induced injury in HK-2 
cells, the time points 30 and 60 min were chosen for subsequent optimization studies; 
these have been included as supplementary data in the CD attached with this thesis 
(Chapter 5-S3). Findings from these studies suggested that 60 min of simulated 
ischaemia induced a less severe injury than the shorter time, 30 min; therefore, 60 min of 
simulated I/R injury was chosen for future experiments. 
To validate the optimal conditions and the reproducibility of the protective effect of 
BacMam-mediated sod-2 overexpression, HK-2 cultures were transduced for 72 h before 
I/R injury (60 min of injury and 0 to 72 h of reperfusion).   
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In accordance with the optimization study, sod-2 overexpressing-injured cells showed a 
trend of increasing intracellular ATP levels over-time (from 20% to 140%), with a full ATP 
recovery observed at 72 h, compared to AcCMV_NULL injured cells, 19% to 86% (Figure 
5.2 A). Since the intracellular ATP content is essential for maintaining normal cell 
functions as well as cellular integrity, it should be noticed that any increase, even small, in 
ATP content during I/R injury might contribute to the long-term cellular recovery. Although 
a full ATP recovery was observed at 72 hpr in AcCMV_SOD-2 transduced/injured cells, 
the increase in ATP contents, observed between 6 and 48 hpr, also exerted a protective 
effect against I/R injury. These results were consistent with cell viability data; over the 
course of reperfusion, cell viability in AcCMV_SOD-2 injured cells increased from 83% to 
93% by 72 hpr, compared to AcCMV_NULL injured cells (Figure 5.2 B). These 
observations are also consistent with published models of renal I/R injury in cells 
overexpressing sod-2 (Cruthirds et al., 2005; Pisani et al., 2014). Koo et al. (2005) 
generated a stable alveolar epithelial cells line overexpressing sod-2; they demonstrated 
that the overexpression of sod-2 significantly protected the cells within the first 48 h of 
hyperoxia exposure and significantly increased the number of viable cells (p<0.05). 
5.5.II Potential beneficial effect of sodium butyrate + BacMam-mediated 
gene delivery 
Recently, Machado et al. (2012) demonstrated that sodium butyrate prevented the 
translocation of nuclear factor kappa B (NF-kB) into the nucleus which decreased 
oxidative damage, inflammatory response, tubular damage and attenuated acute kidney 
injury. Additionally, more recent studies showed that sodium butyrate reduced 
inflammatory responses and pulmonary oxidative stress in the lungs of severely burned 
rats (Liang et al., 2013) and also ameliorated I/R-induced liver injury (Qiao et al., 2014). 
Thus, based on the information available in the literature, this pilot study aimed was aimed 
to investigate the possible effects of sodium butyrate in combination with BacMam-
mediated gene delivery after simulated I/R injury in HK-2 cells. 
Microscopy and Trypan blue exclusion assay revealed that increasing sodium butyrate 
concentration was associated with loss of cell viability (Figure 5.3 A). Results showed that 
the optimal concentration of sodium butyrate (low cytotoxicity and high cell viability) in HK-
2 cells was below 5 mM as suggested by the increased amount of non-viable cells with 
sodium butyrate at concentrations of 7 mM and 10 mM (Figure 5.3 B). These data were 
consistent with Matsumoto et al. (2006) study which demonstrated that exposure of renal 
epithelial HK-2 cells to elevated concentrations of sodium butyrate (0–10 mM), 
suppressed in a dose-dependent manner both basal and stimulated pro-fibrotic cytokine   
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transforming growth factor-beta1 (TGF-β1) synthesis, a key mediator of progressive renal 
injury. Importantly, they detected a significant reduction of TGF-β1 synthesis at 
concentrations of sodium butyrate of 5 mM.  
Having determined the optimal sodium butyrate concentration (5 mM), it was next sought 
to examine its effect in combination with 24 h AcCMV_SOD-2 transduction against 
simulated I/R injury. Two experiments were conducted in parallel to determine sodium 
butyrate effect (Figure 5.4): in the experimental protocol 1, HK-2 cells were only 
transduced for 24 h with AcCMV_SOD-2 virus (no-sodium butyrate). 
Kidney cells ATP levels fall to less than 20% of pre-ischaemic values within 1-2 h of 
ischaemia; depending on the ischaemic interval, ATP levels can return between 60-80% 
to control values upon reperfusion (Doctor et al., 1994; Lee & Emala, 2002; Cruthirds et 
al., 2005; Szeto et al., 2011). Results from this study were consistent with these reports. 
Decreases in ATP levels were detected at 0 hpr in injured cells (31% and 14% 
respectively; Figure 5.5 A). ATP levels only partially recovered in AcCMV_SOD_2 injured 
cells (90%) compared to AcCMV_NULL injured cells which a complete recovery of ATP 
was found after 24 and 48 h of reperfusion (Figure 5.5 A). Consistent with Cruthirds et al. 
(2005) which demonstrated that overexpressing sod-2 in NRK cells by stable transfection 
24 h pre-antimycin A exposure induced a trend of increasing ATP levels; following 2 h of 
ischaemia, ATP levels were decreased to less than 20% of control values and increased 
approximately to 70% after 4 h of reperfusion.  
In the second approach used in this study, AcCMV_SOD-2 transduced HK-2 cells were 
treated with 5 mM sodium butyrate for 24 h before simulated I/R injury. The results clearly 
demonstrated a complete recovery of ATP levels within 6 h of reperfusion in sod-2 
overexpressing-treated injured cells compared to AcCMV_NULL treated injured cells; 
these ATP levels were still completely restored (114-137%) compared to AcCMV_NULL + 
sodium butyrate injured cells at 48 hpr (Figure 5.5 B). Results from this study were also 
consistent with Qiao et al. (2014) who demonstrated that pre-treatment with sodium 
butyrate before 60 min of hepatic ischaemia markedly improved hepatic function and 
histology at 6 and 24 h after reperfusion, as indicated by reduced transaminase levels. 
Sun and colleagues demonstrated that administration of sodium butyrate 30 min prior to 
the daily intraperitoneally injection of gentamicin into rats, attenuated gentamicin-induced 
nephrotoxicity by enhancing renal antioxidant enzymes activity such as SODs (Sun et al., 
2013).  
To my knowledge this is the first study on the protective effect of sodium butyrate + 
BacMam-mediated gene delivery on renal I/R-induced injury.   
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Although, this pilot study indicated a full recovery of HK-2 cells from I/R injury in the 
presence of overexpressed sod-2 and 5 mM sodium butyrate, more studies are needed to 
further elucidate whether this beneficial effect was due to the burst of sod-2 expression 
alone, reduced inflammatory response or because of the combined action of both sod-2 
overexpression and reduced inflammatory response.  
5.5.III Thermal preconditioning effect on HK-2 cells I/R induced-injury  
Preconditioning has been recognized as a protective strategy to reduce damage that 
occurs after reperfusion (reviewed by Bonventre, 2002). Tolerance to ischaemia is 
achieved with this method by exposing cells, tissues or organs to transient and brief 
periods of injury prior to long-term I/R injury. The protective effect has been linked to 
various pathways such as reduced cellular apoptosis (Yamasowa et al., 2005), decreased 
inflammatory response (Jiang et al., 2007) and preservation of intracellular ATP (Halestrap 
et al., 2009). A number of protocols have been used in different experimental studies 
induced by ischaemic (Fan et al., 2012), thermal (Huang et al., 2003; Luh et al., 2007) or 
pharmacologic stimuli (Ferreyra et al., 2013). In particular, thermal preconditioning, which 
represents changes in the normal physiological temperature (37°C), and has been 
previously demonstrated to attenuate kidney I/R induced injuries (Jo et al., 2006). The 
detailed molecular mechanism of thermal preconditioning is still unclear; however, studies 
have suggested that the protective effect might be mediated by an increased expression 
of heat shock proteins (HSPs) which are known for their ability to facilitate refolding, 
assembly, and stabilization of denatured proteins (Kondo et al., 2000; McCormick et al., 
2003).  
Intracellular ATP levels 
In this study, two experimental protocols were designed (Figure 5.6). The effect of 
preconditioning using the experimental protocol 1 is included in the supplementary data 
CD attached with this thesis (Chapter 5-S4). Results suggested a full recovery of ATP 
levels in HK-2 cells from I/R injury in preconditioned injured cells overexpressing sod-2 
and bcl-2 compared to preconditioned AcCMV_NULL injured cells (Chapter 5-S4). 
A temporal analysis, using the experimental protocol 2, showed a trend of increasing ATP 
levels in sod-2 and bcl-2 overexpressing (alone or in combination) preconditioned injured 
cells compared to preconditioned AcCMV_NULL injured cells (Figure 5.7). It was 
noteworthy that ATP levels were completely restored by 8 hpr only in preconditioned 
injured cells transduced with AcCMV_BCL-2 alone (Figure 5.7), these were consistent 
with data from the experimental protocol 1 (see supplementary data, Chapter 5-S4).  
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 In contrast, ATP levels only partially recovered during the 48 h of reperfusion in 
preconditioned injured cells transduced with the backbone virus, AcCMV_NULL (Figure 
5.7). These data were also consistent with previous reports; thermal preconditioning (43°C 
for 30 min) reduced cardiocytes cell death as indicated by decreased LDH activity at 18-
20 h after stress (Cumming et al., 1996). Furthermore, in this study BacMam-mediated 
bcl-2 overexpression within 8 hpr increased ATP levels in preconditioned injured cells. 
This was consistent with Chien et al. (2005) who demonstrated that 24 h adenovirus-
mediate bcl-2 delivery to proximal and distal tubular cells in vitro up-regulated bcl-2 
expression and inhibited hypoxia/reoxygenation-induced injury and tubular apoptosis.  
Collectively, consistent with the conclusion from experimental protocol 1 (see 
supplementary data, Chapter 5-S), these results suggested that heat preconditioning 
before simulated I/R injury ameliorated cell viability by increasing the intracellular ATP 
levels during 48 h of reperfusion.  
Caspase-3 activation 
Subsequently, it was hypothesized that sod-2 and bcl-2 overexpression might attenuate 
I/R-induced not only by increasing ATP levels but also by reducing apoptosis. Time-
course analysis showed that heat preconditioning in combination with either 
AcCMV_SOD-2 or AcCMV_BCL-2 (alone or in combination) partially reduced caspase-3 
activation and therefore, prevented apoptosis induced by I/R injury at 48 hpr (Figure 5.8). 
From these data it also appeared that AcCMV_NULL transduction did not attenuate cell 
death as seen by the increased caspase-3 activity at 4, 24 and 48 hpr. These results are 
consistent with previous reports which, demonstrated that apoptosis occurs following ATP 
depletion/reperfusion (Cruthirds et al., 2005; Zhao et al., 2009). Cruthirds et al. (2005) 
demonstrated that there was no increase in caspase-3 activity in the NRK overexpressing 
sod-2 cells following ATP depletion/recovery which, was in contrast to what was observed 
in sod-2 non-expressing injured NRK cells (approximately four-fold increased caspase-3 
levels). Overexpression of bcl-2 using lentivirus has been shown to significantly reduce 
caspase-3 activity following hypoxia and ischaemia reperfusion in aorta endothelial cells 
(Zhao et al., 2009). 
SOD activity  
Although a number of studies reported reduced endogenous SOD enzymes activity after 
renal I/R injury (Wang et al., 2010; Collino et al., 2013; Seifi et al., 2014), several other 
lines of evidence showed that thermal or ischaemic preconditioning augmented various 
protective proteins and especially SOD-2 (Chen et al., 2003; Yang et al., 2007).   
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Therefore, in this study, in order to extend previous observations, the enzymatic activity of 
SOD was measured in control cells and in preconditioned transduced injured cells. Time-
course analysis of the total SOD enzymes activity revealed that within 4 h of reperfusion 
SOD activity significantly increased only in AcCMV_NULL (176%) and AcCMV_SOD-2 
(180%) injured cells above control value (Figure 5.9); however, upon longer time of 
reperfusion (from 8 to 48 h) SOD activity in all preconditioned transduced injured cells 
returned to levels similar to control values. Rahman et al. (2009) administered human sod-
2 in a rat kidney prior renal I/R injury. They showed increased SOD activity following 16 h 
of reperfusion which improved renal function and reduced tissue injury compared to the 
sod-2 non-overexpressing kidneys. 
This was the first in vitro study to utilize BacMam-mediated gene delivery approach to 
overexpress protective genes during I/R renal injury. In particular, the investigations 
conducted in this study demonstrated that (1) using optimized conditions, delivery of sod-2 
prior to the simulated ischaemia, improved cellular resistance to injury with complete 
recovery of ATP levels within 48 h of reperfusion in HK-2 cells. (2) The addition of sodium 
butyrate following BacMam transduction might play an important role in SOD-2-mediated 
early h protection against oxidative-stress in kidney cells, although more studies are need 
to clarify its effect during I/R injury. (3) Furthermore, to my knowledge, this study reported 
for the first time an in vitro protective effect of the recombinant sod-2 and bcl-2 (alone or in 
combination) and heat preconditioning against subsequent ATP-depletion induced injury 
in HK-2 cells. 
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6.1 INTRODUCTION 
In 1906, Jaboulay was the first to attempt kidney transplantation in two patients by 
transplanting a goat kidney into one and a pig kidney into the other. However, both 
transplants failed and the two patients died (reviewed by Morris, 2004). Thirty years later, 
the first human kidney transplant was performed by Voronoy; nevertheless, this also failed 
due to the deleterious effects of warm ischaemia (reviewed by Matevossian et al., 2009). 
The first successful long-term transplant was performed by Murray et al. (1954) between 
identical twins one in good health and the other dying of kidney disease; however, the 
transplant recipient died eight years after transplantation.  
The main purpose of kidney preservation is to maintain the organ in a viable state from 
the time of retrieval until transplantation. Hypothermic preservation solutions such as UW 
solution were developed in the late 1980s to maintain kidney tissue viability by reducing 
metabolic activity and accumulation of toxic substances during the obligatory cold storage 
period (Koo et al., 1998; reviewed by Watson & Dark, 2012). During transplantation, 
organs undergo hypoxic ischaemic and reperfusion injury due to the cold storage and cold 
perfusion re-oxygenation. Indeed, to date I/R injury represents a major limiting factor in 
kidney transplantation which contributes to delayed graft function and subsequent chronic 
graft deterioration (reviewed by Ponticelli, 2013; and Akhtar et al., 2014). Therefore, 
emerging strategies have aimed to prevent the initial renal I/R injury which would improve 
short- and long-term outcomes of kidney transplantation; in particular, these have included 
approaches that can be applied ex vivo to the organ during preservation such as static 
and machine perfusion as well as preservation solutions supplemented with 
pharmacological agents (reviewed by Bon et al., 2012; and Akhtar et al., 2014).  
As described in Chapter 5 of this thesis, overexpressing sod-2 appeared to protect against 
I/R injury in HK-2 cells in vitro renal models. Therefore, to extend the in vitro observations, 
in this preliminary study an ex vivo kidney perfusion method was developed and evaluated 
for highly efficient BacMam-mediated gene transfer using porcine kidney as experimental 
model. Importantly, it was hypothesized that augmentation of BacMam-mediated sod-2 
gene transfer (AcCMV_SOD-2) might improve I/R induced renal injury during cold 
preservation. It should be noticed that this was a pilot study and therefore, all the 
experiments described in this thesis Chapter were only carried out once. 
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6.2 BACMAM GENE TRANSFER DURING EX VIVO KIDNEY PERFUSION 
Five porcine kidneys (Figure 6.1 A) obtained from a local abattoir within 10 min after 
death, were flushed in situ with 3 litres of soltran kidney perfusion fluid to remove impurity 
and blood (Section 2.1.8). As can be seen from Figure 6.1 B, a red coloured solution was 
collected after the first flush which gradually became colourless after the third flush 
indicating the removal of most of the blood present in the kidneys. Immediately after the 
kidneys arrived in the laboratory, they were measured, weighed (Table 6.1) and placed in 
Belzer UW® cold perfusion solution at 4°C. All the virus stocks used in this study were 
also resuspended in BELZER UW® cold preservation solution (Bridge To Life Ltd.) after 
concentration by low-speed centrifugation (Section 4.3).Two protocols were developed 
and evaluated using five experimental groups of kidneys.  
6.2.I Experimental protocol 1 
In experimental group I, one kidney was incubated with cold BELZER UW® solution (206 
ml) and no virus was added to the preservation solution; this represented the control 
group (Figure 6.2 A). The second kidney was transduced ex vivo (experimental group II) 
with BELZER UW® solution (206 ml) supplemented with AcCMV_EGFP BacMam to a 
final concentration of 3x108 pfu/ml (Figure 6.2 B). Similarly, in experimental group III, one 
kidney was transduced ex vivo by incubation with BELZER UW® solution (206 ml) 
supplemented with AcCMV_lacZ BacMam to a final concentration of 1x109 pfu/ml (Figure 
6.2 C). Control and BacMam transduced kidneys were incubated on a rocking platform 
(Figure 6.2 D) at 4°C for 24 h. The ability of BacMam to transfer the reporter gene egfp 
into kidney was then evaluated using a fluorescence plate reader (Section 2.2.7.II), whilst 
lacZ expression was detected by X-gal staining (Section 2.2.6). Cytotoxicity was 
monitored by microscopy using paraffin-embedded sections (Section 2.2.5.IV) after 
hematoxylin and eosin (H&E) and periodic acid-Schiff (PAS) staining (Sections 2.2.5.V 
and VI). 
6.2.I.I Egfp expression 
The distribution of egfp fluorescence 24 hpt was initially evaluated using a Bio-Rad 
ChemiDoc™ MP system and Epi-green illumination (exposure time= 2.7 seconds; 
emission filter= 605/50) and representative images of fluorescence distribution patterns in 
control and AcCMV_EGFP kidney sections are shown in Figure 7.3.  
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Figure 6.1. Flushing kidneys. (A) Representative images of porcine kidneys. Kidneys were 
incised at the slaughter house as part of the food security act (FSA) inspection process. (B) 
Kidneys were then flushed using soltran solution and three representative bottles rare shown 
containing three sequential flushes of kidneys.  
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Table 6.1. Comparison of kidney length, width and weight between control and BacMam 
transduced groups. 
Experimental groups Length 
(cm1) 
Width 
(cm)* 
Weight  
(Kg2) 
Control group (I) 12 7 168 
AcCMV_EGFP group (II) 12.5 6.5 166 
AcCMV_lacZ group (III) 12 6.5 173 
Control group perfused (IV) 13 7 166 
AcCMV_lacZ group perfused (V) 11.5 7 182 
1
 cm: centimetre.  
2
 Kg: kilograms. 
* Width was measured from under the ureter. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2. Experimental protocol 1. (A) Control group (no-virus). In the BacMam ex vivo 
transduced groups, kidneys were incubated in cold BELZER UW® containing either (B) 
AcCMV_EGFP or (C) AcCMV_lacZ. (D) The experimental groups which were incubated at 4°C for 
24 h with gentle rocking.  
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Kidneys were divided vertically in half and then one half cross sectioned to yield one 
external and one internal section, for fluorescence analysis. As shown in Figure 6.3 B, 
dark regions and small black dots (highlighted by white arrows) indicative of EGFP were 
observed in the AcCMV_EGFP transduced kidney (experimental group II) but were absent 
in the control group, which was uniformly coloured (Figure 6.3 A). In particular, it appeared 
that more dark areas with tiny black dots were present in the external section (highlighted 
by three arrows) of experimental group II, which represented the region of transduced 
kidneys immediately in contact with the AcCMV_EGFP virus (Figures 6.3 B and 6.3 B1). 
To confirm these observations, sections were then divided into 6 segments, as illustrated 
in Figure 6.4, and tissues enzymatically dissociated to single cells by collagenase 
incubation (Section 2.2.5.IV). These samples were then analysed by fluorescence 
microscopy (Figure 6.5).  
Increased fluorescence intensity, was detected in cells dissociated from AcCMV_EGFP 
transduced kidney for both external (between two- and six-fold) and internal (between 
two- and four-fold) segments. As expected, the highest fluorescence intensity of egfp 
expression was obtained in cells dissociated from the external sections (E1 and E2) with 
an increase of approximately four- and six-fold, respectively, above control group (Figure 
6.5). The fluorescence fold changes between AcCMV_EGFP E1 and E2 and control E1 
and E2 regions were significantly different from each other (F (11, 48)= 819.1; p<0.001). 
Compared to cells obtained from regions E3, E4 and E5 of the control group, a two-fold 
increase in egfp fluorescence intensity was detected in AcCMV_EGFP transduced E3, E4 
and E5 regions of the external section (Figure 6.5); these fluorescence intensity 
differences were statistically significant (F (11, 48)= 819.1; p<0.001). Consistent with 
previous observations (Figure 6.3, highlighted by the arrow), a significant increase in egfp 
fluorescence (F (11, 48)= 819.1; p<0.001) of approximately four-fold was detected in 
AcCMV_EGFP E6 compared to control E6 (Figure 6.5). 
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Figure 6.3. Visualization of kidney cross sections in experimental groups I & II. Kidneys, incubated for 24 h at 4°C with BELZER UW® solution 
supplemented with or without AcCMV_EGFP virus, were cross sectioned and imaged on a Bio-Rad ChemiDoc MP system using Epi-green illumination. 
False colour images of (A) control group (no-virus) and (B) AcCMV_EGFP transduced group. (B1) Zoom image shows a dark area with tiny black dots in 
AcCMV_EGFP transduced kidney.   
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Figure 6.4. Schematic representations of kidney regions dissociated enzymatically to obtain single cells. (A) Control group and (B) AcCMV_EGFP 
transduced kidney. These were the same kidneys represented in Figure 6.3.  
Chapter 6 
 
163 
 
 
 
 
 
 
 
 
 
Figure 6.5. EGFP fluorescence in control and BacMam transduced kidneys. Kidneys were 
incubated in BELZER UW® solution with or without AcCMV_EGFP virus for 24 h at 4°C. Two cross 
sections for each kidney were prepared and then divided into 6 internal or external regions (Figure 
7.4). Tissues were dissociated and fluorescence intensity was quantified using a plate reader. The 
bar graph represents the fold change in EGFP fluorescence which was calculated by dividing the 
average fluorescence of AcCMV_EGFP dissociated kidney cells with that of the control group. Bars 
represent mean ± standard deviations (n=3); *p<0.0001 indicated a significant difference between 
experimental group I and AcCMV_EGFP transduced kidney (Two-way ANOVA). 
 
As shown in Figure 6.5, a significant increase in fluorescence (F (11, 48)= 819.1; p<0.001) 
was observed in cells obtained from the internal section of AcCMV_EGFP transduced 
kidney, I1, I2 and I3 (two-, three and approximately two-fold, respectively) compared to 
control cells. A significant increase in egfp fluorescence approximately two-fold above 
control group was also detected in AcCMV_EGFP I5 (Figure 6.5). However, the 
fluorescence intensity in AcCMV_EGFP I4 and I6 was only slightly higher than the control 
group (Figure 6.5).  
6.2.I.II LacZ expression 
BacMam transduction into whole kidneys was further evaluated using lacZ. Kidneys were 
sectioned and transferred into large Petri dishes containing 30 ml of PBS supplemented 
with 2% X-gal. PBS with X-gal alone (no-kidney section) was used as a negative control. 
Transduction was carried out using AcCMV_lacZ by gently rocking the kidney with the 
virus at 4°C for 24 h. Subsequent X-gal staining resulted in strong β-galactosidase 
production in both external and internal sections compared to control group (Figure 6.6 A, 
A3 vs. A2). Overall, these findings demonstrated successful ex vivo BacMam-mediated 
gene transfer into kidneys.  
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Figure 6.6. Expression of lacZ gene in cross sectioned porcine kidney. (A1) Experimental 
group I, non-transduced kidney and (A2) AcCMV_lacZ transduced kidney.  
 
 
6.2.I.III Histological evaluation of kidney tissues 
H&E and PAS staining were used to evaluate morphological changes due to BacMam 
transduction. The remaining half of each of the vertically sectioned kidneys from 
experimental groups I and II (section 6.2.I.I) were used for this purpose. As illustrated in 
Figure 6.7, kidneys from experimental group I and II were first divided in two halves 
vertically; one half was cross sectioned and then sub-divided in two equal parts. The top 
part of the cross section was further divided into four sections, and each section was then 
segmented into five smaller pieces (Figure 6.7); these kidney tissue samples were then 
paraffin embedded (Section 2.2.5.IV) for immunopathologic staining. Representative 
stained images are shown in Figure 6.8. Evaluation of tissue histology with H&E showed 
that both control group and AcCMV_EGFP transduced kidney glomerular and tubular 
structures had similar morphology (Figure 6.8 A). The H&E staining also showed some 
proximal tubule brush-border damage, interstitial inflammation and tubular dilation in both 
transduced and non-transduced tissues (Figure 6.8 A, highlighted by the star). These 
observations were further confirmed in sections of kidney stained with PAS (Figure 6.8 B). 
In conclusion, AcCMV_EGFP transduced kidney did not differ morphologically from 
experimental group I (Figure 6.8 B).   
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Figure 6.7. Schematic representation of kidneys sampled at 24 hpt. The same procedure was used for experimental group I and II. Small sections 
were processed and paraffin-embedded for histological analysis.   
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Figure 6.8. Histological examination of control and BacMam transduced porcine kidneys. Representative tissue images obtained using a light 
microscope (objective 10X) with H&E (A) and PAS (B) showing glomeruli (G) and tubule (T). Scale bar= 10ɥm.  
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Tubular cell dilatation and loss of brush border were observed in tissue from both groups I 
and II. Therefore, these observations suggested that the observed changes were most 
likely the result of the procedure and not a consequence of virus administration or an 
adverse immune response to BacMam. Furthermore, these results also indicated that the 
viral dose used here did not cause any significant morphological damage. 
6.2.I.IV Egfp expression in kidney S3.c sections 
To further confirm the observations in Section 6.2.I.I, egfp expression was monitored by 
confocal microscopy (Section 2.2.5.II). The paraffin-embedded kidney sections S3.c 
(Figure 6.7), from both experimental groups I and II, were arbitrary chosen for this 
experiment. The kidney sections were fixed with paraformaldehyde, immunofluorescently 
stained for egfp and then labelled red with Alexa Fluor®-568 conjugated phalloidin 
secondary antibody (Section 2.1.6). Panels A1 and B1 in Figure 6.9, shows bright field 
images of proximal tubular kidney cells of both control and transduced kidneys, 
respectively. Confocal microscopy observations revealed that egfp was highly expressed 
in the tubular cells of the S3.c section obtained from the AcCMV_EGFP transduced 
kidney (Figure 6.9 B2) but not in control kidney (Figure 6.9 A2). In Figure 6.9, a 
representative single kidney tubule is shown in both zoomed A2 and B2 images; egfp was 
highly expressed in the S3.c sections from experimental group II and was undetectable in 
S3.c from experimental control group I (Figure 6.9 B2 vs. A2). 
Control included primary antibody only, secondary antibody only and no antibodies. As 
shown in Figure 6.10 A, background fluorescence was detected as a faint red signal in the 
control S3.c kidney sections incubated either with primary (1) or secondary antibody (2) 
alone; this background fluorescence was not observed in S3.c sections of the 
experimental group II labelled with either primary or secondary antibodies (Figure 6.10 B 1 
and 2).  
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Figure 6.9. Egfp expression in S3.c sections of control and BacMam transduced kidneys. Kidneys were incubated in BELZER UW® solution 
supplemented with or without AcCMV_EGFP virus and incubated at 4°C for 24 h. (A) Control and (B) BacMam transduced kidneys were cross sectioned, 
sub-divided into 4 regions and each region sectioned into 5 small pieces. Tissues were paraffin-embedded and egfp fluorescence analysed by confocal 
microscopy. Bright field images are shown in A1 and B1 panels; whilst, fluorescence images are shown in A2 and B2 panels (oil immersion x63 objective). 
The arrow in panel B1 indicates the presence of air bubbles trapped in the mounting medium. Brightness of the images was modified to enhance definition 
of the red fluorescence signal. Scale bar=10µm.  
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Figure 6.10. Kidney S3.c antibodies control sections. Representative images of s3.c sections 
from control kidney (A) and AcCMV_EGFP transduced kidney (B). Kidney sections were either 
incubated with (1) primary antibody only; (2) secondary antibody alone and (3) no antibody (no-
primary and no-secondary). Brightness of the mages was modified to enhance definition of the red 
fluorescence signal (oil immersion x63 objective). Scale bar= 10µm.  
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A very faint red signal indicative of auto-fluorescence was observed in S3.c sections from 
experimental group I (control kidney) with no-antibody staining (Figure 6.10 A 3). In 
contrast, as shown in Figure 6.10 B 3, a visible red fluorescence signal, which shows the 
border of the tubules, was detected in S3.c sections from experimental group II incubated 
with no-antibodies. This staining distribution can be explained as a reflection of the 
spectral overlap between the emission wavelength of EGFP and the absorbance of the 
Alexa Fluor®-568 antibody.  
 
6.2.II Experimental protocol 2 
A closed-circuit perfusion system for continuous circulation of BacMam in a whole kidney 
ex vivo was developed for this study. This system consisted of a reservoir containing the 
kidney to be perfused and a peristaltic pump (at a constant speed of 10 rpm) connected to 
the kidney using silicon tubing of different diameters. The kidney was attached to the 
perfusion system by cannulating the renal artery with a small silicon tube (Figure 6.11 A). 
Two experimental groups were used in this protocol; one kidney was perfused with cold 
Belzer UW® solution (206 ml) containing no virus (Figure 6.11 A 1); this represented 
experimental group IV (control group). Whereas, the second kidney was perfused and 
transduced (experimental group V) with Belzer UW® solution (206 ml) containing 
AcCMV_lacZ as described in protocol 1 (Figure 6.11 A 2). Experimental groups were 
perfused as shown in Figure 6.11 B, for 24 h at 4°C.  
LacZ gene expression 
In order to validate this BacMam based perfusion system lacZ expression was examined 
by β-galactosidase staining (Figure 6.12). After 24 h post-perfusion (hpp), over expression 
of β-galalctosidase was detected in the transduced kidney compared to sections obtained 
from the control group (Figure 6.12). Furthermore, as shown in Figure 6.12, considerably 
higher efficiency of BacMam transduction was observed in kidney transduced using the 
cold closed-circuit perfusion system compared to the results observed for kidneys 
transduced using the rocking method (Figures 6.12 vs. 6.6). Consequently, experimental 
protocol 2 was chosen for subsequent studies because (1) it more closely mimics in vivo 
conditions, compared to protocol 1 (2) showed the highest BacMam transduction 
efficiency and (3) highest transgene expression. 
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6.3 PROTECTIVE ROLE OF BACMAM-MEDIATED SOD-2 GENE TRANSFER ON 
CELL VIABILITY AND APOPTOSIS DURING EX VIVO KIDNEY COLD PERFUSION 
Previous studies indicated that virus-mediated sod-2 transfer conferred anti-oxidant and 
anti-apoptotic resistance against oxidative stress (Bertera et al., 2003; Duffy et al., 2010; 
reviewed by Fukai & Ushio-Fukai, 2011; Liu et al., 2012). Therefore, in this study the 
effect of AcCMV_SOD-2 administration on cell viability and apoptosis were evaluated 
using a cold closed-circuit perfusion system. Four fresh porcine kidneys (two left and two 
right) were obtained from the local abattoir, flushed in situ and transported to the 
laboratory for analysis. As shown in Figure 6.13, kidneys were divided into two 
experimental groups: group I (perfused control kidneys, no-virus) and group II 
(AcCMV_SOD-2 transduced and perfused kidneys); each group contained a paired kidney 
(one left and one right) excised from the same pig.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.11. Experimental protocol 2. (A) Cannulated kidneys with a small silicon tube; A1: 
Control group (no-virus) and A2: AcCMV_lacZ transduced kidney. (B) Ex vivo perfusion system 
maintained at 4°C.  
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Figure 6.12. Expression of lacZ in porcine kidney after 24 h of ex vivo closed-circuit 
perfusion with or without BacMam. (A1) Negative control containing PBS (30 ml) with 2% X-gal. 
(A2) Experimental group IV, non-transduced perfused kidney and (A3) AcCMV_lacZ transduced 
kidney.  
 
Kidneys were measured and weighed before perfusion and data are shown in Table 6.2. 
Left and right kidneys were the same length and width, with slight differences in weight the 
two experimental group, albeit not significant (F (4, 16)= 0.0; p=1.0000). Subsequently, 
both groups of kidneys were cannulated and perfused at 4°C for 24 h using the closed-
circuit perfusion system (10 rpm) with 200 ml of BELZER UW® cold solution containing 
either no-virus (experimental group I) or with AcCMV_SOD-2 (virus stock 1.09x109 pfu/ml) 
at a final concentration of 3.3x108 pfu/ml.  
 
 
 
 
 
 
 
 
 
 
Figure 6.13. Representative images of porcine kidneys. Four kidneys were obtained from the 
local abattoir and flushed in situ with SOLTRAN solution. Holes in both left kidneys are where 
samples were taken for analysis at 0 h. Kidneys were incised in situ as part of the food security act 
(FSA) inspection process.  
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Table 6.2. Length, width and weight of control and BacMam transduced kidneys  
Experimental groups Side Length 
(cm) 
Width 
(cm)* 
Weight  
(Kg) 
Experimental group I 
(control group)  
Left 
 
Right 
13 
 
12 
6 
 
6.8 
199.10 
 
214 
Experimental group II 
(AcCMV_SOD-2 transduced 
kidney)  
Left 
 
Right 
13 
 
13 
6 
 
6.3 
200 
 
179 
* Width was measured from under the ureter. 
During the 24 h period of perfusion/transduction, tissue samples were collected from 
kidneys of both experimental groups I and II (Figure 6.14 A) using a modified plastic 
syringe barrel (Figure 6.14 B). As shown in Figure 6.14 B, in order to allow the collection 
of small kidney samples the syringe barrel head was removed (where the needle hub 
attaches). Samples from the left kidney of both experimental groups were collected at 0, 
2, 4 and 24 hpp, weighed and enzymatically dissociated into single cells, using 
collagenase, for cell viability analysis. Whereas, tissue samples from the right kidneys 
were collected at 0, 2, 4, and 24, dissociated and used for (1) the detection of sod-2 
expression, (2) induction of hsp70 expression and (3) caspase-3 activity (only samples 
collected at 24 hpp). 
 
 
 
 
 
 
 
 
Figure 6.14. Representative kidney tissue samples (A) and modified syringe used to collect 
them (B). 
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6.3.I Intracellular ATP levels 
Dissociated cells from the left kidneys of group I and II were used to quantify intracellular 
ATP levels which are a marker of cell viability. The ATP levels were normalized against 
the average weight of the tissue samples used (668.5 milligrams) and plotted as 
normalized relative luciferase units (RLU) against time (Figure 6.15). Results showed that 
at 0 hpp similar ATP levels (F (2, 17)= 3.760; p>0.05) were detected between the control 
group (no-virus) and the AcCMV_SOD-2 perfused/transduced kidneys (Figure 6.15, solid 
black bar vs. striped red bar). Decreased ATP levels were detected at 2 hpp in both the 
control perfused kidney and in AcCMV_SOD-2 perfused/transduced kidneys (Figure 
6.15). However, increased ATP levels were detected following 4 h of perfusion; slightly 
higher levels were found in cells dissociated from the AcCMV_SOD-2 
perfused/transduced kidney samples (23453 RLU) compared to those detected in control 
kidney cells (14651 RLU) (Figure 6.15, striped red bar vs. solid black bar); although there 
was no statistical difference (F (2, 17)= 3.760; p>0.05).  
 
 
 
 
 
 
 
 
 
 
Figure 6.15. Intracellular ATP levels in perfused porcine kidneys. Tissue kidney samples were 
collected over-time from the left perfused kidney of control group (experimental group I) and 
AcCMV_SOD-2 transduced group (experimental group II). Kidney samples were enzymatically 
dissociated into single cells and ATP levels measured over-time. *p<0.01 indicated a significant 
difference between the ATP levels of AcCMV_SOD-2 transduced kidney and control kidney. 
 
As shown in Figure 6.15, a significant increase (F (2, 17)= 3.760; p<0.01) of 
approximately three-fold in ATP levels was detected at 24 h of perfusion in cells derived 
from AcCMV_SOD-2 transduced kidney samples (40166 RLU) compared to cells 
dissociated from control perfused kidney containing no-BacMam (13945 RLU).  
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6.3.II Detection of sod-2 transgene 
Western blot analysis (Section 2.2.4.IV) was used to detect the presence of sod-2 in 
dissociated control cells and AcCMV_SOD-2 transduced kidney cells. Perfused kidney 
samples were collected at 0, 2, 4 and 24 h and processed for SDS-PAGE (Sections 
2.2.4.I and II). Proteins were transferred and immunoblotted using anti-SOD-2 antibody 
(Tables 2.7 and 2.8). Whole cell lysate of AcCMV_SOD-2 transduced HEK293 cells was 
included as a positive control. Results confirmed the presence of sod-2 with the correct 
molecular weight ~23 kDa in both perfused/transduced kidney and AcCMV_SOD-2 
transduced HEK293 cells (Figure 6.16 B, highlighted by the arrow). Furthermore, due to 
the high specificity and sensitivity of the antibody towards the endogenous SOD-2 protein, 
bands were also detected in perfused/non-transduced kidney cells (Figure 6.16 A).  
Densitometry analysis of SOD-2 bands indicated that the expression levels at 0 hpp were 
similar (F (13, 41)= 123.5; p>0.05) between control kidney cells (Figure 6.16 A) and 
AcCMV_SOD-2 perfused/transduced cells (Figure 6.16 B), 17% and approximately 18%, 
respectively. Significantly decreased SOD-2 protein levels (F (13, 41)= 123.5; p<0.001) 
were observed at 2 hpp in cells dissociated from both experimental groups I and II (Figure 
6.16); these observations were consisted with low levels of ATP detected in the previous 
experiment (Figure 6.15). 
 
 
 
 
 
 
 
 
 
Figure 6.16.Time course of sod-2 expression in perfused porcine kidneys. Kidney tissue 
samples were collected and dissociated into single cells. (A) Expression levels of SOD-2 in 
perfused/non-transduced kidney (experimental group I) and (B) sod-2 expression levels in 
AcCMV_SOD-2 perfused/transduced kidney cells. Lane PL, PageRuler Plus Prestained Protein 
Ladder and lane PC, positive control (AcCMV_SOD-2 transduced HEK293 cells). Lanes from 0 to 
24 represent the time of sample collection (hpp). Densitometry analysis of western blot results 
(n=3) was performed and data are shown as means ± SE (above western blot).  
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Compared to cells from perfused/non-transduced kidney (Figure 6.16 A), higher levels of 
SOD-2 were detected in AcCMV_SOD-2 perfused/transduced kidney cells at 4 hpp (11% 
and 14%, respectively) and 24 hpp (21% and 24%, respectively) (Figure 6.16 B); however 
these differences in band intensity were not statistically significant (F (13, 41)= 123.5; 
p>0.05).  
6.3.III Apoptosis 
Caspase-3 is known to be the main effector molecule of apoptosis (Kunduzova et al., 
2003) and its activity in kidney tissues was evaluated after 24 h of perfusion/transduction. 
As shown in Figure 6.17, caspase-3 activity increased in non-transduced kidney subjected 
to cold perfusion (solid black bar) compared to AcCMV_SOD-2 perfused/transduced 
kidney (striped red bar) which showed slightly decreased, but not significantly different (F 
(1,21)= 1.254; p=0.2754), caspase-3 levels. These decreased levels of caspase-3 in the 
transduced kidney were correlated with increased levels of ATP at 24 hpp (Figure 6.15). 
 
 
 
 
 
 
 
Figure 6.17. Caspase-3 activity in porcine kidney cold perfused. Tissue samples of the right 
perfused kidney with no-virus or with AcCMV_SOD-2 were collected at 24 hpp. Samples were 
enzymatically dissociated and caspase-3 assay was performed following the manufacturer 
guidelines (Chapter 2, Section 2.2.38). Bars represent mean ± SEM (n=4). 
 
 
6.4 EFFECT OF ADDING HYDROXYUREA + SODIUM BUTYRATE DURING COLD 
KIDNEY PRESERVATION 
A number of published studies have shown the beneficial use of chemical compound such 
as hydroxyurea and sodium butyrate (Lui et al,. 2010; Machado et al., 2012) against 
oxidative stress injury. Indeed, Lui et al. (2010) and de Souza Torres et al. (2012) 
demonstrated that hydroxyurea has an antioxidant activity; hydroxyurea treatment was 
associated with less oxidative stress damage. Therefore, based on published reports and 
on the in vitro data described in Chapter 4 of this thesis, the chemical combination   
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hydroxyurea +sodium butyrate was chosen to evaluate their potential protective effect 
during ex vivo cold kidney preservation. 
For this study, six kidneys were obtained from a local abattoir (Figure 6.18 A) and flushed 
three times with cold SOLTRAN solution. Figure 6.18 B, shows the solution obtained after 
kidney flushes; in the 1st bottle the red colour indicated the presence of blood which 
gradually decreased showing a light rose colour after flushing three times. Four 
experimental groups were assigned and dimensions and weights of the kidneys are 
shown in Table 6.3. 
As shown in Table 6.3, the length and width of the six kidneys were similar (12-13 cm, and 
6-7.2 cm, respectively). The weight of the kidneys assigned to experimental groups I.a, 
II.a, II.b and IV was between 213 and 233 Kg; whilst, the weight of the kidneys allocated 
to experimental groups I.b and III were lower (126-163 kg).  
In Chapter 4 hydroxyurea and sodium butyrate were used at concentrations of 40 mM and 
10 mM, respectively for HEK293 cell cultures. Therefore, the concentrations used for a 
whole kidney in this study were obtained by correlating the weight of HEK293 cell pellets 
(36 mg) with the weight of kidney tissue sample collected at 0 hpp (96 mg). Thus, whole 
kidneys were first treated with 107 mM of hydroxyurea for 4 h at 4°C and then with 27 mM 
of sodium butyrate; incubation was continued for an extra 20 h at 4°C. Additionally, kidney 
cross sections were also incubated for the same time period as the whole kidneys but 
using the same concentration for cell culture (40 mM of hydroxyurea and 10 mM sodium 
butyrate). 
As shown in Figure 6.19 A, experimental groups I.a and I.b (non-transduced control 
kidneys) were perfused by gently rocking in 230 ml of BELZER UW® solution (containing 
no BacMam), at 4°C for 24 h.  
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Figure 6.18. Representative images of kidneys and flushing solutions. (A) six porcine kidneys 
obtained from a local abattoir. Kidneys were incised as part of the food security act (FSA) 
inspection process. (B) Three bottles containing SOLTRAN solution after flushing kidneys within10 
min of their collection.  
 
Table 7.3. Weight and dimensions of non-transduced controls and BacMam transduced 
kidneys  
 
 
 
 
 
     * Width was measured from under the ureter.  
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The experimental group I.a was incubated with the perfusion solution alone; whilst, the 
kidney for experimental group I.b was treated with hydroxyurea + sodium butyrate. These 
perfused kidneys were then used as a control for the experimental groups comprising 
BacMam transduced kidneys in the presence or absence of chemicals. As illustrated in 
Figure 6.19 B, only the AcCMV_SOD-2 transduced kidneys were perfused using the 
closed-circuit system due to the limited number of peristaltic pumps available.  
Similarly, one kidney (experimental group II.a) was incubated with 230 ml of perfusion 
solution supplemented with AcCMV_SOD-2 (virus stock 1.09x109 pfu/ml) at a final 
concentration of 2.5x108 pfu/ml. Whereas, the second kidney (experimental group II.b) 
was incubated with the same AcCMV_SOD-2 virus concentration but in the presence of 
hydroxyurea + sodium butyrate. Kidneys from experimental groups III and IV were cut 
vertically in half and then four cross sections were obtained (Figure 6.19 C and D). For 
both groups, two cross sections were also transduced in 60 ml of BELZER UW® solution 
with either AcCMV_lacZ (final concentration of 6.7x108 pfu/ml) or AcCMV_EGFP (final 
concentration of 7x108 pfu/ml), with and without hydroxyurea + sodium butyrate.  
6.4.I Intracellular ATP levels in perfused/transduced kidneys with 
AcCMV_lacZ or AcCMV_EGFP in the presence or absence of hydroxyurea + 
sodium butyrate 
Intracellular ATP levels in AcCMV_lacZ and AcCMV_EGFP perfused/transduced kidneys, 
with or without chemical compounds, were quantified over-time. Kidney tissue samples 
were collected at 0, 4 and 24 hpp from experimental groups I.a, I.b, III.a and III.b, as 
described in Section 6.3, and enzymatically dissociated into single cells. Intracellular ATP 
levels were normalized as described previously and plotted as RLU against time (Figure 
6.20). As shown in Figure 6.20 A, ATP levels in AcCMV_lacZ perfused/transduced kidney, 
not chemically treated (striped blue bar), at 0 hpp were slightly higher and significantly 
different (F (2, 24)= 154.6; p<0.05) from those of the experimental control group I.a (solid 
black bar), 8666 and 6644 RLU, respectively. These levels decreased significantly (F (2, 
23)= 154.6; p<0.0.01) to 5659 RLU and 2387 RLU at 4 and 24 hpp, respectively, in the 
experimental group III.a (no-chemicals) compared to 15417 and 9955 RLU, respectively, 
detected in control group I.a (Figure 6.20 A, striped blue bar vs. solid black bar).  
Unexpectedly, at 0 hpp the ATP levels in AcCMV_lacZ transduced kidney treated with the 
chemical combination (experimental group III.b) were significantly higher (F (2, 24)= 
154.6; p<0.00.1) than in any of the other 3 experimental groups (Figure 6.21 A, striped 
purple bar).   
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However, these ATP levels decreased but not significantly (F (2, 24)= 154.6; p>0.05) 
when compared to the experimental group I.b after 4 h of perfusion (Figure 7.21 A, striped 
purple bar vs. solid grey bar). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.19. Experimental protocols. (A) Experimental groups I.a and I.b were rocked gently for 
24 h at 4°C. (B) Kidneys cannulated with a small silicon tube for AcCMV_SOD-2 
perfusion/transduction. (C) Kidney cross sections transduced with AcCMV_lacZ and (D) with 
AcCMV_EGFP. Controls and transduced kidneys were treated with or without hydroxyurea + 
sodium butyrate.  
 
As shown in Figure 6.20 A, by 24 h of perfusion, ATP levels were considerable decreased 
in both AcCMV_lacZ perfused/transduced kidney chemically treated with hydroxyurea + 
sodium butyrate (striped purple bar) and control treated kidney sections (solid grey bar) 
compared to control untreated kidneys (Figure 6.20 A, solid black bar). As shown in 
Figure 6.20 B, ATP levels were modestly but significantly increased (F (2, 24)= 50.66; 
p<0.05) at 0 and 24 hpp in AcCMV_EGFP perfused/transduced and untreated kidney, 
9062 RLU (Figure 6.20 B, striped green bar) compared to those of control kidney group 
I.a, 6643 RLU (solid black bar).   
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However, as expected, the intracellular ATP levels did not recover significantly (F (2, 24)= 
50.66; p<0.001) at 24 hpp between the experimental control groups (I.a and I.b) and the 
BacMam transduced groups (II.a and II.b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.20. Intracellular ATP levels in non-transduced and BacMam perfused/transduced 
porcine kidneys, with or without chemicals. Tissue kidney samples were collected over-time 
from control groups (experimental group I.a and I.b) and AcCMV_lacZ (experimental groups III.a 
and III.b) or AcCMV_EGFP (experimental group IV.a and IV.b) transduced groups. Experimental 
groups I.b, III.b and IV.b were treated with hydroxyurea + sodium butyrate. Kidney samples were 
enzymatically dissociated in single cells and ATP level measured over-time. *p<0.05 and **p<0.001 
indicated a significant difference between the ATP levels of perfused/non-transduced and BacMam 
perfused/transduced kidneys. 
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6.4.II Intracellular ATP levels in AcCMV_SOD-2 perfused/transduced 
kidneys in the presence or absence of hydroxyurea + sodium butyrate 
Kidney tissue samples were collected and processed as described in Section 6.3. ATP 
levels detected at 0 hpp in AcCMV_SOD-2 transduced kidneys (6320 RLU), were not 
significant different (F (2, 22)= 85.71; p>0.05) compared to the ATP levels of the 
experimental group I.a, 6641 RLU (Figure 6.21, striped red bar vs. solid black bar). While, 
increased ATP levels were found at 0 hpp in experimental group II.b, treated with 
hydroxyurea + sodium butyrate (10131 RLU); these levels were significantly different (F 
(2, 22)= 85.71; p<0.05) from those of control group I.b, 6641 RLU (Figure 6.21, striped 
orange bar vs. solid grey bar).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.21. Intracellular ATP levels in non-transduced and AcCMV_SOD-2 
perfused/transduced porcine kidneys, with or without chemicals. Tissue kidney samples were 
collected over-time from control groups (experimental group I.a and I.b) and AcCMV_SOD-2 
transduced groups (experimental groups II.a and II.b). Experimental groups I.b and II.b were 
treated with hydroxyurea + sodium butyrate. Kidney samples were enzymatically dissociated in 
single cells and ATP level measured over-time. *p<0.001 indicated a significant difference between 
the ATP levels of perfused/non-transduced kidney and AcCMV_SOD-2 perfused/transduced 
kidney.  
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Increased ATP levels were detected at 4 hpp in both AcCMV_SOD-2 perfused/transduced 
kidney with (16052 RLU) and without (14795 RLU) chemical compounds compared to 
those detected at 0 hpp (Figure 6.21, striped red and orange bars). However, ATP levels 
in non-treated transduced cells were similar and not significantly different (F (2, 22)= 
85.71; p>0.05) to those of the experimental control group I.a (15415 RLU), while levels in 
treated transduced cells were significantly higher (F (2, 22)= 85.71; p<0.001) than control 
group I.b (5318 RLU). As shown in Figure 6.21, a marked and significant increase (F (2, 
22)= 85.71; p<0.001) in ATP levels was detected at 24 hpp in cells derived from 
AcCMV_SOD-2 transduced but chemically untreated kidney samples (16127 RLU) 
compared to the ATP levels observed in the experimental control group I.a (striped red 
bar vs. solid black bar). This approximately two-fold increase in ATP levels was consistent 
with the previous experiment (Figure 6.15). In contrast, intracellular ATP levels 
significantly decreased (F (2, 22)= 85.71; p<0.001) in both control group I.b and 
transduced kidney treated with hydroxyurea + sodium butyrate (experimental group II.b) 
compared to the untreated transduced kidneys (Figure 6.21, striped orange bar vs. striped 
red bar).  
Overall, these preliminary observations suggested that BacMam-mediated sod-2 
overexpression during cold perfusion, might protect against cold preservation damage by 
enhancing the recovery of ATP levels at 24 hpp.  
 
6.5 Discussion 
The primary cause of ischemia in the kidneys is reduced blood flow due to the clamping of 
the renal arteries which may occur during the surgical procedure of renal transplantation 
(reviewed by Watson & Dark, 2012). Accumulation of toxic metabolites, cell membrane 
depolarization and loss of cellular integrity are all events caused by a lack of ATP 
(reviewed by Watson & Dark, 2012). Therefore, strategies for organ preservation are 
fundamentally based on the prevention or suppression of these changes as quickly as 
possible; this is usually achieved by hypothermia, between 0-5˚C, which reduces the cells 
metabolic rate (reviewed by Watson & Dark, 2012). Two main methods have been used 
for renal preservation during kidney transplantation; (1) hypothermic static storage and (2) 
continuous hypothermic perfusion (reviewed by Toledo‑Pereyra et al., 2010). Although a 
large number of perfusion solutions have been developed to use in these two perfusion 
systems, they are not sufficiently effective to prevent preservation-induced injury of the 
tissues (Mangino et al., 2004; Lee et al., 2009).   
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The application of ex vivo gene transfer technology to the field of transplantation offers the 
unique opportunity to modify the donor kidney before implantation by specifically targeting 
I/R cold-preservation induced injury (reviewed by Kelley & Sukhatme, 1999). Numerous 
studies have demonstrated that exogenous administration of SOD markedly reduced ATP 
failure and tissue damage associated with renal I/R injury (Yin et al., 2002; Cruthirds et al., 
2005; Chen et al., 2009). Several different delivery systems have been used to 
overexpress sod genes in vivo or ex vivo in kidneys, and have included viral-based 
vectors e.g. adeno-associated virus (Chen et al., 2003; Chung et al., 2011), adenovirus 
(Yin et al., 2001) and BacMam (Murguía-Meca et al., 2011). However, it is crucial for long-
term beneficial effects that the vector over-expresses the transgene for a prolonged period 
of time, induces low pathogenicity and has the ability to circumvent the host immune 
response. Although adeno-associated virus and adenovirus transduce various tissues with 
high efficiency and can persist for long periods of time, they are of limited utility in in vivo / 
ex vivo gene transfer due to their high pathogenicity as well as immunogenicity (reviewed 
by Kost & Condreay, 2002). Therefore, BacMam are believed to hold great promise for 
gene therapy applications (Paul et al., 2012, reviewed by Airenne et al., 2013).  
Previously, members of our research group demonstrated baculovirus delivery of egfp 
fused to a baculovirus envelope gene (vp39) into whole kidneys (Murguía-Meca et al., 
2011). They also constructed a BacMam containing Ds-Red but were unable to observe 
fluorescence in transduced tissues, although expression was confirmed by rt-PCR. It was 
speculated that unfavourable cell conditions during cold storage may have precluded 
protein production by reducing promoter activity or that the promoter itself may have been 
problematic. This previous work was carried out using early generation virus vectors, 
containing different promoter and coding sequences, compared to the vectors used in this 
study. Therefore, we initially wanted to confirm ex vivo delivery and expression into 
porcine kidney using the vector constructed for this study. Subsequently, the main 
objective was to investigate the hypothesis that BacMam-mediated sod-2 gene transfer 
could minimize renal injury associated with prolonged cold kidney preservation, as 
suggested by the in vitro model described in Chapter 5.  
6.5.I Expression of reporter genes after ex vivo kidney transduction 
Experimental protocol I 
Initial experiments demonstrated the feasibility of ex vivo gene transfer into a whole 
kidney during cold preservation using BacMam supplemented in the perfusion solution. 
Egfp expression in cross sections of kidney was initially detected using a Bio-Rad 
ChemiDoc™ MP system and then confirmed and quantified using a plate reader.   
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After 24 h of gene transfer, egfp fluorescence intensity was between two- and six-fold 
higher in the external section and between two- to four-fold higher in the internal section of 
AcCMV_EGFP kidney compared to the experimental group I (Figure 6.5). These 
observations were consistent with published studies which used mammalian-based 
viruses to transfer genes into kidneys. Chen et al. (2003) evaluated gfp expression in rat 
kidney after intra-renal arterial infusion of a recombinant adeno-associated virus, rAAV2-
GFP. They showed time-dependent expression of gfp in the S3 segment of the proximal 
tubule of kidneys transduced with rAAV2-GFP up to 6 weeks post-transduction. 
Importantly, results from the study described in this thesis were also consistent with 
observations made by Murguía-Meca et al. (2011) who observed after 2 and 8 h of 
perfusion green fluorescence virus particles in ex vivo kidney sections perfused with UW 
solution containing a baculovirus (AcVP39-eGFP). 
AcCMV_lacZ virus was also used to transduce whole-kidney during cold storage. 
AcCMV_lacZ kidney sections stained positive for β-galactosidase expression as evident 
from the diffuse blue colour in both sections, following X-gal staining (Figure 6.6). A four-
fold increase in β-galactosidase activity was observed in adult female Sprague-Dawley rat 
kidneys transduced by injection into the iliac vein via a local incision with adenovirus 
carrying lacZ (Yin et al., 2001). In this study, the control kidney sections (no-BacMam) 
also showed some β-galactosidase activity (Figure 6.6 A3 vs. A2) which was not 
unexpected; previous have been demonstrated that kidneys express endogenous levels 
of β-galactosidase activity (Weiss et al., 1999; Bolon et al., 2008).  
Subsequently, pathological changes in kidney structure were analysed by H&E and PAS 
staining after 24 h of ex vivo transduction and cold storage. Due to the presence of 
endogenous β-galactosidase expression in kidneys, it was decided to use sections from 
AcCMV_EGFP transduced kidney. Although some tubule damage and some signs of 
inflammation were revealed by histologic analysis in both experimental groups I and II, no 
major morphological differences were observed following transduction, when compared to 
non-transduced tissues (Figure 6.8). Yin et al. (2001) analysed the effects of β-
galactosidase delivered by Ad-LacZ; 2 weeks after I/R injury they found that kidneys from 
rats that received Ad-LacZ exhibited tubular cell swelling, loss of brush border, and cast 
formation.  
These data were consistent with observations made by Chen et al. (2003); they observed 
chronic interstitial infiltration with mononuclear cells, tubular atrophy, and scar formation in 
H&E–stained sections of the left kidney transduced with either saline solution (control 
kidney section) or rAAV2-GFP virus.   
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They concluded that these changes were caused by ischemia injury associated with the 
procedure and not as a consequence of adeno-associated virus administration. Results 
from the present study are in agreement with those of Murguía-Meca et al. (2011) who 
examined kidney sections by H&E staining for loss of brush border, dilatation, 
vascularization and necrosis of proximal tubules; they reported no differences in these 
morphological features between transduced and non-trasduced tissues at 0 or 8 hpp.  
In order to further assess BacMam transduction ex vivo, egfp expression was analysed by 
confocal microscopy using paraffin-embedded S3.c kidney sections from non-transduced 
and AcCMV_EGFP transduced experimental groups. Immuno-detection showed egfp-
specific staining in AcCMV_EGFP transduced kidney tissues (Figure 6.9 B2) and no egfp 
expression was detected in kidneys incubated with BELZER UW® solution alone (Figure 
6.9 A2). Expression of BacMam delivered egfp by was predominantly observed in the 
proximal tubules (Figure 6.9 B). No egfp fluorescence was detected in any controls with 
the exception of the AcCMV_EGFP S3.c section incubated with no antibodies (Figure 
6.10). The presence of a red fluorescent signal in the no antibodies control can be 
explained as the results of two spectra overlapping. An alternative explanation of this 
staining pattern, previously reported by Elowitz et al. (1997), is photo-activation of GFP. 
Elowitz and colleagues demonstrated that under low oxygen conditions, the GFP 
fluorescence spectrum changes and begins to absorb green light and emit red light. This 
explanation appears consistent with results from this study as low oxygen concentrations 
represents one of main causes of injury induced by the loss of intracellular ATP during ex 
vivo organ preservation.  
The identification and distribution of egfp in this present study was in accordance with 
previous results obtained by in vivo adenovirus and lentivirus gene transfer into kidneys. 
Gusella et al. (2002) demonstrated by immunohistochemistry egfp fluorescence after in 
vivo intraureteral injection of lentivirus (5x108 transduction units) in mice left kidney but not 
in control contralateral kidney or in kidneys infused with PBS only. They also observed 
localization predominantly in the cortico-medullary junction, particularly in the proximal 
tubules. Similarly, Ortiz et al. (2003), using confocal microscopy, reported gfp expression 
only in tubules of the thick ascending limb of the loop of Henle but not in any cortical or 
inner medullary structures. This was five days after injecting a recombinant adenovirus, 
Ad-CMVGFP, into the outer medullary interstitium of Sprague-Dawley rat kidneys.   
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Experimental protocol II 
In this study, an ex vivo porcine kidney perfusion system was developed and established 
to mimic in vivo kidney conditions as closely as was possible with the materials available. 
Based on literature reviews, roller and peristaltic pumps have been widely used for ex vivo 
organ perfusion (Heikkila et al., 1996; Khalfoun et al., 2000; Miyakawa et al., 2008; 
Schreiter et al., 2012). In line with these studies, a peristaltic pump was used in this study 
for the bidirectional transport of the perfusion medium supplemented with AcCMV_lacZ 
virus (Figure 6.11 B). Following 24 h of perfusion/transduction kidneys were cross 
sectioned and very strong β-galactosidase expression was observed in AcCMV_lacZ 
kidney sections (Figure 6.12 A3). Whereas, only low levels of endogenous β-
galactosidase expression were detected in the control kidney (Figure 6.12 A2); this was 
consistent with the hypothermic cold storage observations (Figure 6.6 A2). This ex vivo 
perfusion/transduction approach proved to be more efficient for gene transfer as observed 
by the more intense blue staining compared to transduced cold stored kidneys. These 
observations were consistent with the study of Heikkila et al. (1996) who perfused ex vivo 
porcine kidneys for 12 h with a solution containing adenovirus using a peristaltic pump. 
They demonstrated the presence of high levels of β-galactosidase with approximately 
85% of the glomeruli positive for lacZ.  
6.5.II Ex vivo gene transfer of sod-2 during hypothermic kidney perfusion 
Cold preservation has facilitated the use of cadaveric organs including kidneys for renal 
transplantation; however, severe damage can occur during the preservation process and 
the reperfusion phase after transplantation (Henke et al., 1995; Saba et al., 2008). A 
number of reports demonstrated that administration of sod-2 during perfusion, ameliorated 
reperfusion-associated injury in cold-preserved ischemic kidneys (Yin et al., 2001; Fennell 
et al., 2002; Kim et al., 2006; Schneider et al., 2010;). In an in vitro study, Salahudeen et 
al. (2000) indicated that cold-storage (4°C) of human renal tubular cells in UW perfusion 
solution, induced an increase in sod-2 expression but not sod-1 or sod-3. Furthermore, in 
a recent study, Saba et al. (2008) demonstrated that short-term cold kidney preservation 
(40 min of cold preservation plus 18 h of reperfusion) resulted in the inactivation of sod-2, 
which induced the inhibition of mitochondrial complexes and subsequent renal injury in an 
in vivo rodent model. Therefore, in this present study the protective role of sod-2 to 
improve cell viability and reduce apoptosis was investigated during prolonged cold 
preservation. Paired kidneys (left and right) were subjected to 24 h of either control 
perfusion (no-BacMam) or AcCMV_SOD-2 perfusion/transduction.   
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Renal tissues were harvested over-time and cells analysed for cellular ATP concentration, 
transgene expression as well as for caspase-3 activity.  
Intracellular ATP levels were slightly increased but not statistically different from control 
kidney at 0 hpp in AcCMV_SOD-2 perfused/transduced kidney (Figure 6.15). A rapid 
decrease in ATP levels was observed after 2 h of perfusion in experimental groups I and 
II; this was followed by a progressive and significant increase in ATP concentration 
between 4 and 24 hpp in kidneys overexpressing sod-2 (experimental group II) but not in 
control kidneys where ATP levels remained similar (Figure 6.15). The results suggested 
that overexpressing sod-2 induced a significant recovery of ATP levels which is crucial to 
maintain cell integrity and viability. Although different conditions were used for the ex vivo 
AcCMV_SOD-2 perfusion model and the in vitro experiments described in Chapter 5 of 
this thesis (Section 5.2.II); both data showed a pattern of increased intracellular ATP 
levels at 24 h following reperfusion/perfusion.  
It was previously reported that during a clinical trial recombinant human sod-2 (rh-SOD) 
exerted a beneficial effect on early irreversible and acute kidney rejection events in rh-
SOD-treated patients (given in a dose of 200 mg intravenously) compared to the control 
group; this positive effect was assumed to be related to its antioxidant action on I/R injury 
of the renal allograft (Land et al., 1994). Yin et al. (2001) examined whether adenovirus 
encoding for sod-1 could protect against I/R–induced renal injury in an in vivo rat model. 
Although they used a different SOD isoform from the one used in this study, they 
demonstrated that sod-1 overexpression provided protection against renal I/R injury by 
significantly reducing LDH levels compared to control kidneys that received lacZ gene. 
Western blot analysis of cell lysates harvested from AcCMV_SOD-2 perfused/transduced 
kidneys revealed efficient production of the 23 kDa SOD-2 protein (Figure 6.16 B). 
Moreover, endogenous SOD-2 protein was also detected by the anti-SOD-2 antibody 
(Figure 6.16 A). Density scanning of these immunoblots showed that the relative 
expression of sod-2 after 4 and 24 h of perfusion in ex vivo AcCMV_SOD-2 transduced 
kidney cells were approximately 4% higher than endogenous levels observed in the 
control cells (Figure 6.16 B vs. A). Yin et al. (2001) evaluated SOD-1 protein expression in 
rat kidneys by western blot analysis 3 days after in vivo adenovirus transduction. They 
observed increased levels of human SOD-1 protein in rats that received Ad-SOD; 
however they also detected very low levels of SOD-1 protein in Ad-LacZ transduced 
kidney cells which corresponded to endogenous sod-1 gene expression. These data were 
also consistent with other studies which overexpressed sod-2 by viral vectors in different 
organs (Knobil et al., 1998; Zanetti et al., 2001; Baud et al., 2004).   
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In contrast with these observations, Fennell et al. (2002) assessed in an in vitro / in vivo 
study the endogenous expression of sod-2 as well as the levels evoked by adenovirus-
mediated sod-2 overexpression. They demonstrated the presence of a 22 kDa protein 
corresponding to the recombinant human sod-2 in transduced cells but not in the 
endothelial cells transduced with either β-galactosidase expressing adenovirus or in 
control cells.  
Subsequently, to determine whether the protective effect of sod-2 overexpression 
detected at 24 h of perfusion was associated with decreased apoptosis, caspase-3 activity 
was measured in control and AcCMV_SOD-2 kidneys. The number of apoptotic cells was 
much greater in control perfused kidney (experimental group I) than in cell derived from 
AcCMV_SOD-2 transduced kidney (experimental group II), in which the SOD-2 level was 
4% and ATP three-fold higher than control kidney (Figure 6.17). Overall, the kidney 
overexpressing sod-2 had a partial protective effect against apoptosis induced by 
prolonged hypothermic perfusion than control kidney. This is consistent with other reports 
in the literature that have demonstrated that exogenous sod-2 protected against apoptosis 
e.g. Linag et al., 2008. Liang and colleagues showed that in vivo overexpression of a SOD 
mimetic (mimetic manganese (III) tetrakis(1-methyl-4-pyridyl)porphyrin) was able to 
partially reduced caspase-3 activity in male Sprague-Dawley rat kidneys that underwent to 
a bilateral clamping of the renal arteries for 45 min followed by reperfusion for 24 h. 
This single pilot study suggested a potential protective effect of ex vivo BacMam-mediated 
delivery of sod-2 against long cold kidney preservation injury. It should be noted that the 
study described in this thesis was a small pilot experiment and triplicate samples were 
harvested only from one control kidney and one transduced kidney. Furthermore, this 
study has focused on the role of overexpressing sod-2 and its beneficial effect, however, 
there are clearly limitations inherent to the ex vivo cold perfusion model used in this 
experiment that need to be addressed in future.  
The main limitation of the perfused ex-vivo model is the limited lifespan of the organ 
perfused and knowing when valid data can be extracted during this lifespan (reviewed by 
Ong et al., 2013). Moreover, the interaction of either physiological perfusion solution or 
autologous blood with the non-biological surfaces of the perfusion circuit might activate 
biological pathways producing an inflammation or immune response (reviewed by Ong et 
al., 2013). Ex vivo cold perfusion models are also limited by the fact that hypothermic 
preservation can significantly decrease the organ metabolic functions, which can preclude 
full recovery (St Peter et al., 2002).   
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Therefore, further studies are needed to more fully investigate the potential beneficial 
effects of overexpressing sod-2 during ex vivo cold kidney perfusion and to provide new 
experimental approach to overcome limitations of the model. 
6.5.III Ex vivo application of Hydroxyurea + sodium butyrate during kidney cold 
preservation 
The chemotherapeutic agent, hydroxyurea is the only disease-modifying therapy 
approved for sickles cell disorders; the main effect of this chemical compound is to 
enhance the antioxidant enzyme activity of sickle erythrocytes such as glutathione 
peroxidase 1, catalase or flavin reductase (reviewed by Silva et al., 2013). Recently, 
Teixeira Neto et al. (2011) reported a possible role of hydroxyurea as an antioxidant drug 
acting by increasing the glutathione levels which controls concentrations of lipid 
hydroperoxides and therefore prevents cell damage by free radicals. Sodium butyrate has 
been considered to possess a potential anticancer activity; however, recently a few 
studies have also demonstrated an anti-inflammatory and immunomodulatory effects 
(Hinnebusch et al., 2002; Meijer et al., 2010). Indeed published reports have shown that 
sodium butyrate exerted a protective effect in a rat ischemic model of stroke (Zhang et al., 
2007; Hu et al., 2014) as well as protected against hepatic I/R injury (Qiao et al., 2014). 
Hence, this present study aimed to evaluate the injury profile, by measuring the 
intracellular ATP levels, in control and transduced kidneys treated with or without 
hydroxyurea + sodium butyrate and thus assess the benefit of these chemicals in 
improving kidney recovery. 
The results of this second pilot study showed a significant difference over-time in the 
recovery of the ATP levels between control kidneys and kidney transduced with BacMam 
carrying reporter genes compared to untreated AcCMV_SOD-2 kidneys; these data were 
in line with the results of the previous experiment (Section 6.3). These data also showed a 
significant and consistent negative effect of hydroxyurea + sodium butyrate in all 3 
experiments with markedly reduced levels of intracellular ATP at 24 hpp (Figures 6.20 and 
6.21). Although, published reports evaluated sodium butyrate or hydroxuyrea alone using 
different approaches, results from this study were not consistent with those from literature 
(Teixeira Neto et al., 2011; Hu et al., 2014; Qiao et al., 2014). Hu and colleagues 
examined the preconditioning effect of sodium butyrate during in vivo myocardial I/R injury 
in a rat model. They showed that following 4 h of reperfusion, the LDH levels in the 
ischaemic group were significantly increased compared with the experimental group that 
received high dose of sodium butyrate (300 mg/kg) which significantly inhibited the 
release of LDH.   
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Similarly, Qiao et al. (2014) investigated the protective effect of sodium butyrate 
preconditioning against hepatic I/R injury in rats and suggested that sodium butyrate 
improved I/R-induced liver injury by reducing transaminase levels, tissue pathologic 
changes and possible by suppressing inflammatory factors production and preventing NF-
kB activation in Kupffer cells.  
A number of studies have confirmed that the direct assessment of ATP content in organs 
represents a suitable parameter for demonstrating ex vivo organ viability (Lietzenmayer et 
al., 1991; von Elverfeldt et al., 2007; Buchs et al., 2014). However, attempting to precisely 
quantify ATP within kidney tissue is a very challenging process due its structural and 
functional heterogeneity (reviewed by Palygin & Staruschenko, 2013). The luciferin-
luciferase reaction was utilized to monitor intracellular ATP levels in this pilot study; 
however, it should be noted that preliminary results were given as normalized relative 
luciferase units (RLU), after background correction because of the superior sensitivity of 
the GloMax® 20/20 luminometer (Promega) used (detection limit: 1 x 10–21 moles of 
luciferase enzyme). Boudjema et al. (1990) and Clavien and colleagus (1992) 
demonstrated that during hypothermic preservation, whilst kidney cell metabolism slowed 
(approximately two-fold less for every 10°C drop in temperature) there was still 
considerable activity at 1°C; they also demonstrated that after 6 h of cold preservation 
intracellular ATP levels dropped by 84%. However, Lazeyras et al. (2009) demonstrated 
that ATP was re-synthesized immediately after hypothermic perfusion (10 h) in the 
presence of oxygen (pO2 ≥ 100kPa), in comparison to a kidney group where no perfusion 
was applied. This study was recently confirmed by Buchs et al. (2014) who demonstrated, 
using magnetic resonance imaging, ATP re-synthesis in 14 kidneys perfused with 
oxygenation at 4°C. In particular, the Buches et al. (2014) study demonstrated viability of 
93% in ex vivo kidneys oxygenated during hypothermic perfusion.  
In summary, this pilot study demonstrated for the first time the successful transfer and 
expression of reporter genes using BacMam gene transfer approach ex vivo in kidneys. 
The results from the present study also provided the first evidence of ex vivo BacMam-
mediated sod-2 expression in a kidney, findings that have not been previously reported 
with BacMam gene transfer. Importantly, this pilot study suggested that overexpressing 
sod-2 in kidneys might provide protection against cold preservation-induced injury which 
may be associated with reduced apoptosis and the recovery of the intracellular ATP 
levels.  
Therefore, future experiments should aim to calculate, from standard curves, the 
concentration of ATP present in each perfusate used during experiments; this will allow a   
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better understanding of whether kidneys preserved in the presence of sod-2 generated 
higher concentrations of ATP during the 24 h of hypothermic perfusion than kidneys 
preserved in the absence of sod-2. 
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The discovery that baculovirus can transduce mammalian cells has greatly increased their 
utility beyond recombinant protein expression and their application towards gene therapy 
has become increasingly popular. This study set out to expand upon previous work by the 
IVRG where baculovirus was used to deliver a reporter gene into whole kidneys. Although 
it had been demonstrated that baculovirus could deliver egfp into a porcine kidney, I 
sought to expand upon these studies by developing BacMam as a tool to deliver and over-
express protective genes against I/R injury. 
In this study, a range of transfer vectors and BacMam viruses were constructed. Vector 
integrity was confirmed by sequencing and BacMam expression was observed by 
microscopy, reporter assays and western blot. These vectors contained reporter genes 
(egfp and lacZ), for easy transgene detection during optimization experiments, but also 
the protective genes sod-2 or bcl-2 however, for future studies a greater range of vectors 
could be constructed to include other genes that may have a protective function against 
I/R injury, such as heme oxygenase-1 (HO-1), glutathione or hypoxia inducible factors 
(HIF1-3). Studies have demonstrated that overexpression of HO-1 or glutathione exert a 
protective function in organs against I/R injury (Xue et al., 2008; reviewed by Ferenbach et 
al., 2010). A more recent report showed that in vivo electroporation-mediated delivery of 
HIF-1α plasmid DNA improved neovascularization in a mouse model of limb ischaemia 
(Ouma et al., 2014). Multiple BacMam vectors could also be transduced into the same 
organ. The advantage of this approach would be that several different stages in the I/R 
injury pathway could be engaged during the same period. This approach has been used 
previously by Durand et al. (2005); they evaluated the combined effect of adenovirus-
mediated gene transfer of sod-1 and catalase on ROS production and inflammation after 
ballon angioplasty. Liang et al. (2010) also evaluated the effect of lentivirus-mediated sod-
1 delivery together with the administration of MitoTEMPO (a mitochondria-targeted 
antioxidant), on mitochondrial function and signalling pathways in an in vitro ATP 
depletion/recovery injury of porcine kidney cells. Bicistronic vectors could also be 
produced, overexpressing multiple genes from a single BacMam, possibly under different 
promoters to control timing and strength of expression. This multi-gene approach would 
initially require optimisation of a wider range of single gene expression studies to ensure 
the genes used indeed had a protective effect and that they then worked synergistically to 
improve individual gene effects.  
In Chapter 3, I speculated that in order to see any beneficial effect after transducing a 
whole kidney it would likely require transduction with high concentrations of purified virus, 
expressing maximal levels of the delivered gene. Therefore, these studies were aimed at 
determining the most efficient way to produce BacMam viruses at high concentration.  
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Initially, different methods of concentrating baculovirus were compared, including 
centrifugation at different speeds, spin filters and chromatography. Ideally, the method 
chosen would be reproducible and simple to use, able to accommodate different volumes 
and cheap to implement. Amongst the methods tested, centrifugation most closely 
matched all of these requirements and despite initial concerns that it may produce 
aggregated virus particles, potentially reducing transduction efficiency, it actually proved 
to be the most reliable process. Future work should aim to determine diameter and 
morphology of the concentrated BacMam particles; this will involve using techniques such 
as transmission electron microscopy. Electron microscopy study will further characterize 
the intact rod-shaped structure and size value of the BacMam particles following 
concentration. Furthermore, flow cytometry analysis could be used to detect viral particle 
aggregates by using BacMam virus carrying reporter genes. The presence of aggregates 
will be associated with fluorescence intensity and used as an indicator of the mean 
aggregate size. Aiming for maximum product purity, future work may explore purification 
steps that would yield highly purified BacMam particles for gene therapy applications. 
Although BacMam transduction and expression is relatively high compared to other virus 
vector systems, we sought to enhance it further to offset potentially low transduction 
efficiencies when using whole organs; this study was reported in Chapter 4. Literature 
searches of the public databases identified a number of reagents reported to enhance 
mammalian viral delivery, including different lipids and chemicals. Generally, in this study 
the lipids gave little improvement in transduction efficiency and as such were 
discontinued. However, the addition of certain chemicals both alone and in combination 
did show improved expression and these were included in subsequent I/R injury 
experiments. As a continuation of the research presented in Chapter 4, the following 
areas of investigation should be considered: (1) further analysis of the effect of chemicals 
on cell viability, since this is an important factor in achieving an effective gene transfer for 
gene therapy study; experiments would be conducted for all combinations of chemical via 
MTT or LDH assay as well as quantification of active caspase-3 by using fluorimetric-
based assay. (2) Understanding the biological consequences of altering DNA replication, 
histone acetylation and topoisomerase activity may provide insight to maximize the utility 
of these compounds during BacMam ex vivo / in vivo transduction of whole organs. 
Therefore, further studies should include DNA microarrays; the comparison of the 
transcriptomes of untransduced cells and transduced cells cultured either with or without 
chemicals may provide information about the genetic regulation of gene expression in the 
treated transduced samples. (3) In addition, large-scale studies should also be carried out   
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to determine whether enhanced transgene expression can still be obtained at scales more 
typical of a real bioprocess. 
Chapter 5 reported the optimisation of an in vitro IRI model using mammalian cells. 
Initially the model was developed in HEK293 cells, but was then extended to HK-2 cells. 
Initial, results were not conclusive using either short (15 min) or long (120 min) periods of 
ATP-depletion followed by BacMam transduction. However, after incorporating the 
BacMam transduction as a pre-step into the process we were able to show partially 
improved ATP levels over-time in HEK293 cells and a full recovery of cellular ATP in HK-2 
cells. This work was an important step towards transducing BacMam into whole organs. 
Clearly overexpression of a single protective gene in vitro may not be representative of 
the likely success of an in vivo approach, perhaps because of the complexity of the I/R 
injury process. Therefore, future experiments should aim to identify novel protective 
components by reviewing current literature as well as by evaluating mRNA from ischaemic 
cells following BacMam transduction using GeneChip expression analysis; microarray 
assay will allow the identification of differentially regulated genes during renal I/R injury 
and may lead to the development a more successful BacMam multi-gene delivery 
approach. Using the learning gained from Chapter 3 and 4, it was decided to include  the 
chemical sodium butyrate;preconditioning with sodium butyrate BacMam transduced cells 
improved cell viability at early time point of reperfusion. However, this was a single pilot 
study and was not obtained enough data to elucidate the role of sodium butyrate in renal 
I/R injury; therefore further studies are needed to confirm this hypothesis.  Importantly, 
further studies should identify sodium butyrate-targeted genes and pathways involved in 
its protection and to assess in detail safety and pharmacotoxicity with regard to renal I/R 
injury. Additionally, future experiments should also assess the therapeutic benefits of 
using compounds, such as hydroxyurea and etoposide, against renal I/R injury. 
Chapter 6 described the use of BacMam to deliver reporter and protective genes into a 
whole kidney. This work was a culmination of the studies carried out in previous Chapters 
and although it was a preliminary experiment, it demonstrated BacMam expression in the 
kidney and ATP assays suggested that overexpression of sod-2 could have a beneficial 
effect ex vivo. As mentioned above, this was a preliminary study and going forward this ex 
vivo model needs to be optimised further, including determining the optimum amount of 
BacMam virus and chemical concentrations. Future studies could also be directed 
towards transducing organs with multiple vector/gene combinations. BacMam virus 
expression appeared to concentrate in certain areas of the organ and future work should 
seek to identify more clearly the virus localisation areas within the organ. This will ensure 
a more targeted and hence more efficient delivery system.  
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 Additionally, more work should also be carried out on determining the immune response 
of the tissues. Although no apparent damage has been observed after transducing 
BacMam viruses into kidneys, it is likely that there are immunological responses that are 
below the levels of detection used in this study. Certainly, as described in the 
supplementary data in the CD attached to this thesis (virus construction & transgene 
expression test, S2), it was observed up-regulation of a number of cytokines and other 
immune response genes by RT2 profiler PCR array, after BacMam transduction into 
HEK293 cells, and a similar approach should be considered for future organ studies. 
Future experiments should consider different approaches for the detection of intracellular 
ATP including (1) real-time electrochemical detection of ATP; this method represents a 
unique approach for the real-time monitoring of the changes in ATP levels in whole 
kidney. (2) Chromatographic methods such as ion-exchange chromatography or high-
performance liquid chromatography (HPLC). Furthermore, 31P magnetic resonance 
spectroscopy should also be considered if kidneys will be perfused with oxygenated 
hypothermic pulsatile perfusion; this technique allows direct assessment of ATP 
concentration, which provides a reliable indicator for organ bioenergetics and viability. 
In conclusion this study has 1) optimised an in vitro I/R injury model in human kidney 2 
(HK-2) cells for BacMam, 2) shown that BacMam delivery of bcl-2 and sod-2, alone or in 
combination, into ischaemic HK-2 cells ameliorated the effects of I/R injury in vitro and 3) 
clearly demonstrated the potential of using BacMam viruses for ameliorating I/R injury ex 
vivo by delivering and overexpressing sod-2 in whole porcine kidneys. 
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